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Protein-based supramolecular polymers (SMPs) are a class of biomaterials which draw 
inspiration from and expand upon the many examples of complex protein quaternary structures 
observed in nature: collagen, microtubules, viral capsids, etc. Designing synthetic supramolecular 
protein scaffolds both increases our understanding of natural superstructures and allows for the 
creation of novel materials. Similar to small-molecule SMPs, protein-based SMPs form due to 
self-assembly driven by intermolecular interactions between monomers, and monomer structure 
determines the properties of the overall material. Using protein-based monomers takes advantage 
of the self-assembly and highly specific molecular recognition properties encodable in polypeptide 
sequences to rationally design SMP architectures.   
The central hypothesis underlying our work is that α-helical coiled coils, a well-studied 
protein quaternary folding motif, are well-suited to SMP design through the addition of synthetic 
linkers at solvent-exposed sites. Through small changes in the structures of the cross-links and/or 
peptide sequence, we have been able to control both the nanoscale organization and the 
macroscopic properties of the SMPs. Changes to the linker and hydrophobic core of the peptide 
can be used to control polymer rigidity, stability, and dimensionality. The gaps in knowledge that 
this thesis sought to fill on this project were 1) the relationship between the molecular structure of 
the cross-linked polypeptides and the macroscopic properties of the SMPs and 2) a means of 
creating materials exhibiting multi-dimensional net or framework topologies. 
Supramolecular Architectures and Mimics of Complex Natural Folds Derived 
from Rationally Designed α-Helical Protein Structures 
Nathan A. Tavenor, PhD 
University of Pittsburgh, 2017
 
 v 
Separate from the above efforts on supramolecular architectures was work on improving 
backbone modification strategies for an α-helix in the context of a complex protein tertiary fold. 
Earlier work in our lab had successfully incorporated unnatural building blocks into every major 
secondary structure (β-sheet, α-helix, loops and β-turns) of a small protein with a tertiary fold. 
Although the tertiary fold of the native sequence was mimicked by the resulting artificial protein, 
the thermodynamic stability was greatly compromised. Most of this energetic penalty derived from 
the modifications present in the α-helix. The contribution within this thesis was direct comparison 
of several α-helical design strategies and establishment of the thermodynamic consequences of 
each. 
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1.0  INTRODUCTION 
1.1 SUPRAMOLECULAR POLYMERS 
Supramolecular polymers (SMPs) are a class of materials that are generated through a series of 
defined non-covalent interactions among monomer units, in contrast to classical polymers which 
are held together by covalent bonds.1-2 Any non-covalent force can be used to drive supramolecular 
polymerization, but those that have been most widely used are van der Waals (i.e. hydrophobic 
interactions in aqueous solvent), H-bonding, host-guest, metal chelation, and charge-charge 
interactions. The strength of each of these forces can be highly dependent on environment, 
allowing SMPs to be assembled and disassembled by external stimuli. The great potential 
application of SMPs as "smart" materials and their relative ease of recyclability arise from this 
responsiveness to environment.2 Another appealing feature of supramolecular polymers is that 
they are self-healing, due to the ability to reform supramolecular interactions after mechanical 
deformation.3 A key limitation of SMPs lies in the difficulty of developing materials that are both 
environmentally responsive and exhibit the mechanical stability of conventional polymers. 
 While supramolecular complexes between specific host-guest molecule pairs have long 
been studied4—both in biotic and abiotic contexts—the first non-biological SMP was not 
described until more recently.2, 5 This SMP was formed by mixing together bifunctional 
diamidopyridines with uracil derivatives (Figure 1).  
2 
 
 
Figure 1. Supramolecular polymers based on uracil.
 (Adapted with permission from reference 5. Copyright © 1990 Verlag GmbH & Co. KGaA, Weinheim.)  
 
Formation of the SMP occurs in a similar manner to nucleic acid complexation, driven by 
complementary H-bonds between acceptors and donors on each molecule. Polymer-like properties 
were observed upon mixing that neither monomer exhibits alone. Note the linker domains in each 
monomer joining the two ends of each supramolecular unit. The use of linkers to join together 
moieties with strong non-covalent interactions is a recurring motif in supramolecular polymers 
and play a prominent role in the materials discussed in this thesis (see Chapters 2 and 4). 
3 
This early work was followed by the seminal design of a self-assembling monomer based 
on the UPy motif (Figure 2).6  
 
 
Figure 2. Hydrogen bonding between bifunctional UPy (2-ureido-pyrimidone) monomers with a variable linker. 
 
The UPy motif utilizes multiple hydrogen bonds surrounded by a hydrophobic pocket formed by 
proximal alkyl chains to create a very strong affinity between monomers. Cross-linked UPy 
moieties undergo supramolecular polymerization to form nanofibers. Recent work has produced a 
supramolecular polymer blend of the UPy motif alongside metal coordination resulting in a system 
with two disassembly phase transitions (one for each supramolecular interaction).7 
 Another prominent H-bonding motif that has found use in supramolecular polymerization 
is based around a benzenetricarboxamide (BTA) core (Figure 3).8  
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Figure 3. Structure of the BTA core with a tunable spacer and cartoon assembly of the supramolecular structure. 
Reproduced with permission from Ref. 9; Copyright 2010 National Academy of Sciences.  
 
BTA derivatives self-assemble through a combination of π-π stacking between the benzene rings 
and H-bonding between the amides. The amide moieties can be functionalized to fine tune the 
properties of the resulting supramolecular polymer. As an example, monomers tagged with 
different fluorophores have been mixed together in order to study the kinetics of supramolecular 
fiber formation using stochastic optical reconstruction microscopy (STORM).10 
 Stacking among aromatic groups is another commonly used strategy in supramolecular 
polymerization. Due to the hydrophobic nature of the interaction, suitable monomers can easily 
self-assemble in aqueous solution, and the resulting polymers are soluble if the periphery is 
functionalized with polar groups. The alignment of π-orbitals in these assemblies has been used to 
develop supramolecular polymers capable of charge transfer to create photoconductive nanowires 
and semiconductors.11 This motif has also been used develop photocatalytic systems to produce 
hydrogen with chromophore amphiphiles.12-13 
 Studies on the host-guest chemistry of synthetic molecules began five decades ago with 
investigations of crown ethers binding metal cations.14 These efforts advanced to include organic 
5 
molecule guests nearly a decade later.15 SMPs built by host-guest interactions allow control over 
directionality and high specificity within the system.1-2, 4, 16 They may be composed of either two 
different homoditopic monomers or a single heteroditopic monomer with host functionality on one 
end and guest functionality on the other (Figure 4). 
 
 
Figure 4. Homoditopic (A-A + B-B) and heteroditopic (A-B) type supramolecular polymerization. 
 
Other stoichiometries and configurations are also possible depending on the structure and degree 
of functionalization of the linker core (i.e. dendrimer cores).16 Host functional groups in SMPs are 
usually cyclic molecules like cyclodextrins, cucurbitils, and calixarene (Figure 5), each of which 
binds a specific type of guest molecule.1  
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Figure 5. Example structures of commonly used host molecules: cyclodextrin, cucurbitil, and calixarene. 
Structure of cucurbitil reproduced with permission of the International Union of Crystallography.17 
 
Cyclodextrins are macrocycles composed of glucose monomers and can bind a variety of guests 
including hydrocarbons, polar compounds (carboxylic acids and amines), and hydrophilic 
polymers.18 Cucurbitils may bind either one or two guest molecules at a time, the identity of which 
depends on ring size; smaller cucurbitils bind gas molecules, metal ions, and aliphatic amines, 
while larger rings enable the binding of bulkier aromatic, adamantyl, and fullerene derivatives.19 
Calixarene binds porphyrin or viologen. Different host-guest systems can be readily combined 
together to produce more complex SMPs due to the orthogonality of the interactions.4 
SMPs formed through metal coordination are an important subset of host-guest systems.4 
Here, two or more organic ligands (the hosts) form a coordination bond with a metal ion (the 
guest). Of particular interest to the work presented in Chapter 4, is the field of supramolecular 
metallopolymers (or coordination polymers). This encompasses everything from simple 1-D 
materials to highly ordered 3-D metal organic frameworks (MOFs). Both metallopolymers and 
metal organic frameworks harness the strong forces of metal coordination to direct the formation 
of supramolecular assemblies.20-22  
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One of the first coordination polymers base on an organic ligand was formed through 
binding of Cu(I) by 4,4′,4″,4‴-tetracyanotetraphenylmethane.23-24 Ligand moieties used to generate 
supramolecular polymers through metal coordination typically bind metal ions in a 2:1 or 3:1 
(ligand:metal) ratio with pyridyl, carboxylate, and alkynyl functionalities being the most 
commonly used motifs.23 These ligand groups are usually connected through a linker—the 
flexibility and length of which can be used to tune molecular properties.  Polymers built through 
metal coordination have a high degree of modularity and tunability since most ligands will bind 
many different metals. Recently, orthogonal binding of two different metals into a supramolecular 
polymer has been achieved.25 Metal coordination has also been combined with host-guest 
chemistry to produce supramolecular polymers with two orthogonal interactions to produce a great 
array of 1-D and 2-D assemblies.4 
The first MOF was described two decades ago exhibiting high thermal stability and the 
ability to host aromatic guest molecules.26 Since that time, the structural modularity of simple 
multi-dentate organic ligands chelating metal ions has been successfully utilized to produce 
diverse crystalline materials with tunable structure and properties. The variety of MOFs resulting 
from this structural control has led to applications in areas such as catalysis, gas capture, and 
sensing.27-31  
Highlighted below are a few recent examples of functional MOF architectures that have 
been developed (Figure 6). 
8 
 
Figure 6. Examples of functional MOF architectures.
 A) A MOF with the ability to convert CO2 into carbonates. Reprinted with permission from Chem. 
Mater., 2016, 28 (17), pp 6276–6281. Copyright 2016 American Chemical Society. B) Thin film MOF architectures 
capable of gas sensing. Adapted with permission from reference 32. Copyright © 2016 Verlag GmbH & Co. KGaA, 
Weinheim. C) Schematic of a MOF with potential use in solar cells. Reprinted with permission from ACS Appl. 
Mater. Interfaces, 2016, 8 (45), pp 30863–30870. Copyright 2016 American Chemical Society. 
 
A MOF based on Cu2+ with bipyridyl and 1,2-ethanedisulfonate ligands was reported with the 
ability to both capture and convert CO2 into carbonates by reacting them with epoxides.33 Methods 
for growing MOFs composed of aromatic carboxylic acids and Cu2+ ions in thin films has resulted 
in devices with the ability to sense water and volatile organic compounds.32 MOFs designed for 
use in solar cells have been reported utilizing 3-D architectures composed porphyrin/pyridine 
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linkers coordinated to Zn(OAc)2 with a thin film of palladium porphyrin as exciton acceptor.34 The 
great utility of MOFs for a wide range of applications has inspired the development of MOF-like 
architectures from protein ligands.  
1.1.1 Naturally Occurring Supramolecular Polymers  
Nature largely utilizes macromolecules to construct supramolecular materials which ultimately 
give rise to the great array of forms and functions of life. Living organisms can be considered as 
highly complex supramolecular machines. The emergent properties unique to life arising from the 
organization and interaction of these supramolecular systems demonstrate that the whole is more 
than merely the summed properties of the components. Examples of important biological 
supramolecular materials based on lipids and proteins are detailed below. Peptide-based materials 
are discussed in more detail in Section 1.2. Although not found in nature, supramolecular materials 
that self-assemble into programmable shapes have been developed from DNA using the 
complementarity and specificity of its bases.35 This field of DNA "origami" has advanced to the 
point where almost any shape can be drawn that software will then prescribe the requisite DNA 
strands to make.36-37 
 Lipids are a class of biomacromolecules that form 2-D and 3-D supramolecular polymers 
in the form of micelles and plasma membrane bilayers.38 Lipids are composed of hydrophobic tails 
with polar head groups. Membrane bilayer properties can be altered between solid gels, liquid 
crystals, and liquid rafts by tuning the type and composition of the lipids present. These materials 
are used to contain and separate biological components into compartments and for signal 
tranduction. This facilitates differentiation between cells and organelles along with transportation 
of cellular cargo.  
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 Compared to lipids, proteins are a much more structurally diverse class of 
biomacromolecule. They play myriad structural and functional roles both within and outside of 
cells. SMP forming proteins are usually structural elements.39 A few examples include (Figure 7): 
amyloid fibrils (involved in neurodgenerative disease),40 collagen (a component of extra-cellular 
matrix support),41 myosin/actin filaments (responsible for contractile motion and transport within 
cells),42 and keratin (vital to epithelial protection and support).43 
 
 
Figure 7. Examples of supramolecular fibers formed by proteins. 
A) Structure of Aβ1-40 fibers derived from solid state NMR. Reprinted from Cell, 154, Jun-Xia Lu, Wei Qiang, Wai-
Ming Yau,Charles D. Schwieters, Stephen C. Meredith, Robert Tycko, Molecular Structure of β-Amyloid Fibrils in 
Alzheimer’s Disease Brain Tissue, Pages 1257-1268, Copyright 2013, with permission from Elsevier. B) Cartoon 
structure of collagen (PDB ID: 1cag) derived from a 1.9 Å resolution X-ray crystal structure.44 C) Schematic of the 
supramolecular interaction between myosin II and actin filaments for contractile function. Reprinted by permission 
from Macmillan Publishers Ltd: Nature Reviews Neuroscience reference 45, copyright 2013. D) Crystal structure (PDB 
ID: 3TNU) of an α-keratin heterodimer; (close-up) Cys residues in proximity for disulfide formation.43 
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These different classes of supramolecular assemblies arise from different secondary structure 
elements: amyloid fibrils are composed of extended β-sheets,40 collagen is composed of a trimer 
of polyproline type II helices,41 the actin monomer is a globular protein,42 and keratin is built from 
a dimeric α-helix.43 Proteins may also be embedded in lipid membranes as part of a heterogeneous 
supramolecular material.46 Many of these membrane proteins play important functional roles such 
as: membrane channels, signal receptors, and energy transformers.46  
Living organisms demonstrate that supramolecular materials can be used to produce 
multifunctional organic machines. The burgeoning field of synthetic biology will rely heavily on 
understanding the design principles behind these systems. The ability to create supramolecular 
materials with tunable and multifunctional properties opens up a world of possibilities limited only 
by the human imagination and the laws of nature. 
1.2 PROTEIN-BASED SUPRAMOLECULAR MATERIALS 
Protein-protein interactions are a powerful means of generating supramolecular materials. Proteins 
and peptides (short synthetically-accessible fragments of proteins) are particularly well-suited as 
a basis for material self-assembly due to their modularity and structural diversity.39, 47 At the 
nanometer-scale level in living organisms we observe a dizzying array of supramolecular protein-
based machines and scaffolds. A few examples of their many functions include: energy collection 
(photosystem II),48 structural (cytoskeleton),42 membrane transport (aquaporin),46 supramolecular 
enzyme complexes (mitochondrial respiratory complexes).49 Many designed materials draw 
inspiration from these structures that have been observed in nature.  
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Non-covalent interactions between the functional groups of the primary amino acid 
sequence and with solvent molecules control both the structure and ultimately function of 
polypeptides.50 These interactions can give rise to local folding patterns (secondary structure). 
Interactions between secondary structure domains can generate complex folds (tertiary structure) 
and supramolecular complexes (quaternary structure). Quaternary structures can range in size from 
as small as a few nanometers to as large as micrometers (cytoskeletal fibers, collagen, viral 
capsids).51  
 Even with the vastness of polypeptide sequence space available (20n for the canonical 
amino acids, where n is the peptide length), there are only a few recurring secondary structure 
motifs: α-helix, β-sheet, β-turn, loop, and 310-helix (Figure 8).  
 
 
Figure 8. Common protein secondary structural motifs. Hydrogen bonds between main chain amides are 
depicted as dashed yellow lines. 
 
These secondary structures are defined by different patterns of hydrogen bonding between or 
within strands. α-Helices arise from a 13-membered H-bonded ring, while β-hairpin turns and 310-
helices arise from a 10-membered ring.  β-sheets occur from peptide strands in extended 
conformations and may H-bond either between sections of the same sequence or intramolecularly 
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(i.e. amyloid fibrils). Amides in loops typically only H-bond with solvent and are not useful in 
generating supramolecular polymers, except as linkers between different domains. 
Secondary structures can combine in numerous ways to form tertiary folds or 
supramolecular quaternary structures. Control over quaternary structure, since it can be the basis 
for supramolecular polymerization, is of particular interest to the development of peptide-based 
materials.52 Folding is not a prerequisite for peptide self-assembly, and interesting supramolecular 
materials have been developed from short, non-secondary structure forming peptides. These short 
peptides can be used to form supramolecular polymers similar to other small molecules through 
H-bond networks and aromatic stacking,53 or metal chelation to form peptide MOFs.54 The focus 
here will be on the self-assembly of larger oligomers where folding is an important part of 
supramolecular assembly. Common design motifs used to construct protein-based supramolecular 
polymers include: coiled coils, amyloid fibrils, protein-ligand interactions, viral capsids, and metal 
chelation.52, 55 
Coiled coils are a quaternary structure that has found wide use in the construction of 
peptide-based materials.52 Coiled coils are assemblies formed between 2-7 α-helices;56 their design 
rules are described in more detail below (Section 1.3). Early work engineering coiled-coil based 
materials resulted in strategies for forming supramolecular fibers.57 "Sticky-end" coiled coils that 
self-assemble into fibers (Figure 9) can be generated by offsetting the charge-charge interactions 
peripheral to the hydrophobic core58 or rotation of the hydrophobic core to a different helical face.59  
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Figure 9. "Sticky-ended" coiled coil heterodimers designed to form supramolecular fibers. 
(Reprinted by permission from Macmillan Publishers Ltd: Nature Materials reference 59, copyright 2003.)  
 
Fibrils can also be created through judicious placement of salt bridges and residues with low steric 
bulk.60-61 The similarity among the above examples is that they utilize exclusively naturally 
occurring amino acids without any post-synthetic modification of the oligomers. Expanding 
beyond this design constraint can have significant benefits. One technique to form larger 
assemblies from coiled coils is to join two or more strands together with a covalent linker, so that 
upon folding the subunits self-polymerize. This strategy has been used to form both linear 
supramolecular polymers62-63 as well as large self-assembling cages.64 
Peptide amphiphiles are short peptides functionalized with long alkyl tails (typically at the 
N-terminus). In this manner, they are similar to lipids being composed of a hydrophobic domain 
and a more polar head group (Figure 10).  
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Figure 10. Peptide amphiphile self-assembly. 
Self-assembly of a peptide amphiphile nanofiber (left, reproduced from reference 65, Copyright 2002 
National Academy of Sciences) and templation of a helical nanoparticle composite (right, reprinted with permission 
from Merg, A. D., et al. J. Amer. Chem. Soc. 2016, 138 (41), pp 13655–13663).66 
 
Unlike lipids, the head group in a peptide amphiphile can dictate properties through folding and 
self-assembly. Self-assembly of these molecules results in large fibers with the alkyl chains on the 
interior and peptide head groups exposed to water;65 the final morphology of which can also be 
varied through solvent effects.67 Peptide amphiphiles have also been used with great success to 
template the formation of composite materials, such as superhelical Au nanoparticle arrays33 
imparting chirality to the optical properties of the nanoparticles.66 
Another class of peptide-based SMP are cyclic peptides with alternating D,L 
stereochemistry, which can assemble into columnar nanotubes (Figure 11).68-69 
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Figure 11. 2D-structure of a eight residue cyclic peptide cyclo[-(D-Ala-Glu-D-Ala-Gln)2-] and self assembly into a 
tubular column through anti-parallel stacking of the peptides mediated by amide H-bonding. 
Reprinted by permission from Macmillan Publishers Ltd: Nature 1993,  366, 324 - 327,69 copyright 1993.  
 
The cyclic D,L-peptides are fixed into a rigid secondary structure regardless of the amino acid 
sequence. They self-assemble into columnar fibers through backbone amide hydrogen bonds and 
laterally through non-covalent interactions among side chains. Nanotube properties can be tuned 
through the choice of side chains including unnatural amino acids and chromophores to impart 
electronic properties.70 Cyclic peptide nanotubes show promising applications for antibiotics, ion 
channels biosensors, gene delivery, photoactive supramolecular polymers, and electronic 
materials.71-72 
Due to the ability of metals to impart important redox and charge transfer properties, 
protein designs incorporating metals have been long studied.73  Recent efforts have focused on 
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expanding their application to direct the self-assembly of protein-based supramolecular 
architectures.74-75 Pioneering work has shown that expressed proteins bearing metal-coordinating 
side chains can be used to this end (Figure 12A).55, 76  
 
 
Figure 12. Metal-directed self assembly of protein supramolecular architectures. 
A) Zn2+-directed protein assembly of an engineered version of cytochrome3 (RIDC3) into helical nanotubes 
or 2D and 3D crystals.  Reprinted by permission from Macmillan Publishers Ltd: Nature Chemistry reference 76, 
copyright 2012. B) Crystal structure of T122H ferritin in the presence of Zn2+ and linker benzene-1,4-dihydroxamic 
acid. C) Close-up of linker coordination to Zn2+ bridging two ferritin proteins. Adapted from ref. 77 through an open 
access ACS Editors' Choice License. Copyright 2015 American Chemical Society. 
A 
B C 
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Incorporating metal-bining amino acids (like His) into the C3 symmetric vertices of the octahedral 
ferritin quaternary structure can be used to bind a cognate small-molecule as a linker and form 
highly ordered lattices (Figure 12B,C).77  
 Metal coordination has also been used for the supramolecular organization of shorter 
synthetic peptides that form defined quaternary structures. These architectures are notable for 
coupling the orthogonal forces of highly specific peptide-directed association with metal binding78 
in a fully synthetic polypeptide ligand. Collagen has been functionalized with bipyridine to direct 
the formation of fibers, discs, and hollow spheres using divalent Fe, Cu, or Co ions (Figure 13).79-
81  
 
 
Figure 13. Schematic of bypiridine-modified collagen triple helix (Hbyp3) which self assemble into either curved 
disks (no metal ion) or hollow spheres (with a divalent ion, i.e. Fe2+). 
Reprinted with permission from Przybyla, D. E. et al. J. Am. Chem. Soc., 2013, 135 (9), 3418–3422.81 Copyright 
2013 American Chemical Society. 
 
Synthetic coiled-coils have also been modified with a variety of metal-binding moieties to produce 
supramolecular polymer and crystalline assemblies.82-84 Expansion upon this theme to form 
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highly-ordered one, two, and three dimensional crystalline assemblies and supramolecular 
polymers is the focus of Chapter 4. 
1.3 ALPHA-HELICAL COILED COILS 
Coiled coils are protein structural motifs consisting of two or more α-helices bound together in a 
bundled quaternary structure. Biologically, they function in a variety of roles such as DNA 
transcription factors, structural components, molecular motors, and receptors.85  Structurally, 
coiled coils may be parallel or antiparallel, homo- or heterooligomeric, and contain between two 
to seven helices in a single bundle. Each of these characteristics can be programmed by the amino 
acid sequence.86 As with all α-helices, coiled-coil forming sequences are described using a helical 
wheel to designate the alignment of each residue in the amino acid sequence (Figure 14).  
 
  
Figure 14.  Helical wheel diagram for an α-helix. 
 
In α-helices, two full turns of the helix are completed by a sequence of seven residues 
known as the heptad repeat. Each position around the α-helix is designated with a lower case letter 
(a-b-c-d-e-f-g). This feature of α-helices means that an alternating pattern of i, i+3, i+7, etc.  
residues share the same helical face and causes a coiled coil to have a left-handed superhelical 
twist.87 By convention, the a and d heptad positions are used to indicate the hydrophobic face of 
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the helix, which forms the buried core of the multi-helix coiled-coil assembly.87 More complex 
hydrophobic patterns like the hendecad and pentadecad also exist and give rise to coiled coils with 
a nearly parallel and right-handed supercoil, respectively.86 Due to the presence of a hydrophobic 
face within the folded α-helix, coiled-coil quaternary structure is directly coupled to the folding of 
the individual oligomers and monomeric helix is rarely observed. Observation of helical structure 
implies coiled coil formation.88 
Although the coiled-coil motif was first hypothesized by Crick in 1953 from the X-ray 
diffraction  pattern of α-keratin,89 the first coiled-coil crystal structure was not fully solved until 
1991 when the structure of the leucine zipper region of the yeast transcription factor GCN4 was 
published (Figure 15).87  
 
 
Figure 15: Sequence (top), helical wheel diagram (left) and crystal structure (right, PDB ID= 4DMD) of GCN4p1.  
Hydrophobic core packing residues are highlighted in bold. 
 
This crystal structure demonstrated that the GCN4 leucine zipper, termed GCN4p1, was a parallel 
coiled-coil homodimer exhibiting a "knobs-into-holes"89 packing motif of the hydrophobic a and 
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d residues.87 Although GCN4p1 was thought to only exist as a dimer, twenty years later it was 
discovered that under certain conditions it will adopt a parallel trimer fold.90 
Subsequent studies since the first crystal structure of GCN4p1 have greatly increased our 
understanding of the coiled-coil folding motif. Varying chain length established that at least three 
heptads are necessary to form stable folded dimers.91 Mutations to the hydrophobic core 
demonstrated that oligomerization state and stability can be controlled simply by changing the 
residues at the a and d heptad positions.92-94 A seminal study in the mid- 1990's determined the 
effects of systematically mutating these positions with Ile, Val, and Leu and created a 
nomenclature for describing GCN4p1 mutants where the letters after the 'p' indicate residues 
present at the a and d  positions, respectively.92 For example, mutating all a positions to Ile and all 
d positions to Leu leads to the peptide "GCN4pIL". Studies on pairing preferences of coiled-coil 
interfaces have shown that β-branched side chains (Ile and Val) at d positions largely favor trimers 
and tetramers while leucine at this position was more promiscuous. Mutants pIL (parallel dimer), 
pII (parallel trimer), and pLI (parallel tetramer) exhibited single oligomerization states while the 
other mutants gave rise to mixtures.92 More recently, sequences have been designed that assemble 
to form a pentamer,95 hexamer,61  heptamer96 and dodecamer.97 Typically, these higher order helix 
bundles (hexamer and above) are the result of mutating the e and g positions to alanines allowing 
room for the required close packing arrangement or mutations to the hydrophobic core. Pentamers 
are unusual in that they are created from larger hydrophobic residues at the a and d heptad positions 
like phenylalanine98 or tryptophan.95 
Placing a hydrophilic residue in the core at an a heptad position was shown to de-stabilize 
the folded stability but improve oligomerization state and topology specificity.92, 99 In general, a 
single Asn residue at an a position favors dimers while a single Gln residue favors trimers;92, 100-
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101 however, Asn at the second a position can create an atypical three-state unfolding pathway in 
which the coiled coil changes from dimer to trimer to monomer with an increase in temperature.102 
The e and g heptad positions also play a significant role in determining coiled-coil 
oligomerization state and the formation of homo- vs. hetero- assemblies. Observing from the 
GCN4p1 crystal structure that the e and g positions engage in salt bridges spanning the coiled-coil 
interface87 and knowing that the naturally occuring Fos and Jun peptides formed a heterodimer,103 
researchers designed a de novo set of heterodimeric pLL peptides designated BASEp1 and 
ACIDp1 (Figure 16).104   
 
 
Figure 16: First de novo designed heterodimer coiled-coil system
 comprising of two leucine zippers one with all glutamates (carboxylic acids) at the e and g positions 
(ACIDp1, red) and one with all lysines (primary amines) at the e and g  positions (BASEp1, blue).  Helical wheels 
are depicted facing one another as they would in the coiled coil. 
 
These sequences differ only at e and g positions: all Lys residues at these positions in BASEp1 
and all Glu residues at corresponding positions in ACIDp1. Under physiological conditions, the 
homodimers are destabilized through charge-charge repulsion while the heterodimer is favored 
through complementary charge interactions at the e/g  interface.104 These two peptides are the basis 
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for the heterodimer system used later to characterize the subunits of our coiled-coil based 
supramolecular polymer system (see Section 2.2). A later report described the crystal structure of 
a de novo designed heterotrimer that preferentially formed over the competing homo- and hetero-
dimers.101 More recently, a parallel heterotetramer has been designed.105 Unnatural residues have 
also been used to control coil-coil pairing by using complementary, variable length e and g 
positions106 or changing the size of the hydrophobic core residues.107-108 
 The knowledge of the coiled-coil structural motif that has developed over the past few 
decades has greatly increased our understanding of protein folding and allowed for a wide range 
of rationally designed structures. A number of excellent reviews86, 88, 98, 109-110 delve more into the 
details of how various mutations affect coiled-coil folding and function. Recently, researchers have 
created a de novo set of homooligomeric coiled-coil peptides four heptads in length with full 
biophysical and structural characterization.111 These sequences were intended for use by others as 
a starting point for further engineering and we made use of these in the work described in Chapter 
4. With this plethora of information available it is now largely possible to choose a desired coiled-
coil structure and then develop a sequence for that particular application. 
1.4 PROTEIN HELICES CONTAINING BACKBONE MODIFICATION 
In addition to their importance in materials, α-helices also have an important role in biochemistry. 
α-Helices make up approximately 40% of the protein secondary structure found in nature and are 
often found involved in protein-protein interfaces (PPIs).112-113 PPIs are involved in many cell 
signaling pathways and disease states, but are often considered "un-druggable" by small molecules 
since they typically encompass large, flat surface areas.114 Thus, mimicry of α-helical structure is 
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important to many biomedical applications. Several strategies for mimicking α-helices exist 
including peptide stapling115 as well as the use of non-peptide scaffolds,112 and foldamers.116 A 
number of excellent reviews have been written on helix mimicry,112, 116-118 but the focus here will 
be precedent involving the types of residues examined in Chapter 3. 
The field of folded peptide mimetics or "foldamers"119 seeks to develop oligomers with 
mixed or wholly unnatural backbones that fold to form defined structures in aqueous solution. One 
motivation for incorporating unnatural backbone units into peptides is to improve stability to 
proteolytic degradation, a key limitation of peptide therapeutics.120  
Helical secondary structure has been particularly well-studied as a foldamer design motif. 
An array of strategies has been used to create backbones that adopt helical structures. Some of 
these strategies are only modest modifications of the α-amino acid residues found in natural 
peptides (Figure 17): addition of an extra methylene unit between amides (β-residues), methylation 
of the alpha carbon (Cα-methyl residues), amide→thioamide substitution, amide→ester 
substitution, amide replacement with a 1,2,3-triazole121 and transposition of the side chain from 
Cα to N (peptoids).117, 122  
25 
 
Figure 17. Commonly used helix backbone modifiers in peptide mimicry; the canonical α-residue 
backbone is depicted at the top. 
 
More exotic helical designs have also been developed including urea-based backbones123 and 
conjugated aromatic polymers.124  
Examining prior work involving β-residues, helices have been developed using both mixed 
α/β backbones as well as pure β backbones. Peptides made up exclusively of β-residues (β-
peptides) can form helices similar to peptides with pure α-backbones, but with wider diameters 
and larger intramolecular H-bonding rings.125 Early work with pure β backbones showed oligomers 
composed of the cyclic β-residues aminocyclohexanoic acid (ACHC)126 and aminocyclopentanoic 
acid (ACPC)127 formed stable helices in organic solvents (Figure 18). 
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Figure 18. Oligomers composed of acyclic β-residues. 
A) Structures of ACPC and ACHC residues. B) Idealized ACHC decamer (left), alanine decamer (middle), and 
ACPC decamer (right). Adapted by permission from Macmillan Publishers Ltd: Nature Reference 127, copyright 
1997. 
 
Reports of oligomers composed of acyclic β-residues that fold in water quickly followed.128-129 
Seminal work in mixed α/β backbones resulted in one of the first foldamer quaternary structures 
characterized at high resolution, a coiled coil (Figure 19).130  
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Figure 19. Crystal structure of a tetrameric helical bundle formed by a mixed α/β-peptide
 Cartoon (left) and backbone H-bonding structure (right) with α-residues in yellow and β-residues in cyan; side 
chain atoms are omitted (PDB: 2OXK).. Adapted with permission from Horne, W. S. et al. J. Am. Chem. 
Soc., 2007, 129 (14), pp 4178–4180.130 Copyright 2007 American Chemical Society.  
 
The disadvantage of mixed backbone helices is that their folds are less thermodynamically stable 
than the native forms.131 Patterning of α- and β-residues within the helix can be used to control 
helical handedness.132 Control over left/right handed helix propensity was achieved by altering the 
sequence length of peptides composed of  cis-aminocyclicpentanoic acid (ACPC) residues with 
alternating L/D α-residues in various patterns (ααβ, αααβ, αβααβ, and ααβαααβ).132 
Methylation of the alpha carbon in amino acids is another well-studied modification for 
promoting helical folds. Cα-methylated residues, though rare, are naturally occurring amino acids 
found in some fungi which use them in the synthesis of non-ribosomal peptide antibiotics.133 Their 
propensity to form helical structures was first observed with aminoisobutyric acid (Aib), the Cα-
methylated version of Ala.134 Aib was found to have a more restricted Ramachandran plot than L-
α-residues with dihedral angles preferring only helical or fully extended regions.134 Helices 
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containing Aib are more stable than those formed by longer Ala peptides,135 and Aib was used 
successfully to increase folded stability of the full-length protein thermolysin.136 It has long been 
assumed that the increased thermodynamic stability that Aib imparts arises from a decrease in the 
entropy of folding based on its restricted conformational freedom.136-137 This assumption had never 
been tested with a full thermodynamic analysis until work described in Chapter 4.138 
1.5 PROJECT GOALS 
1.5.1 Origin of Linker Flexibility in Coiled-Coil Based Supramolecular Polymers 
In prior work from the Horne lab, homodimeric coiled-coil based SMPs (CC-SMPs) were 
constructed by cross-linking two peptide strands of GCN4p1 with organic linkers at the f-position 
of the second heptad.62  Unlike previous coiled-coil cross-linked fibers, where the linker was 
parallel to the fiber axis,63 linkers in this system are perpendicular due to cross-linking at an 
internal position as opposed to the termini.  Two symmetric linkers were examined in prior work: 
one based on an ethylene diamide  (EDA) core and another based on a piperizine diamide (PIP) 
core; synthesis of the cross-linked species was achieved through an SN2 reaction between a Cys 
thiol and primary alkyl halides at either end of the linkers.  Importantly, the linkers separate the 
sulfurs by 8 atoms allowing for independent folding of  the two cross-linked coiled-coil domains, 
which was not the case for disulfide cross-linked variants.62  These linkers differ by only two 
carbons, yet SMPs containing them exhibited different physical properties.  Note the rotational 
constraint of the Pip linker as opposed to the EDA linker between the amides (Figure 20). 
 
29 
 
Figure 20. Schematic of supramolecular polymer self-assembly from a subunit cross-linked with either the Pip or 
EDA linker. 
 
Non-denaturing gel permeation chromatography (GPC) indicated that the ring-constrained 
Pip linker produced assemblies with a larger hydrodynamic radius while the more flexible EDA 
linker produced assemblies with a smaller hydrodynamic radius.62  Whether or not the 
polymerization number (n) is actually significantly different could not be accurately determined 
by this method.  The more likely reason for the observed difference in hydrodynamic radius is the 
flexibility of the EDA linker causing CC-SMPs composed from it to be more compact and 
"spaghetti-like" while the those composed of the Pip linker are straighter "hair-like" fibers.  In this 
thesis, we report the molecular origin of these differences through alternate biophysical 
characterization methods of structure and dynamics in the CC-SMP backbone (Chapter 2). 
1.5.2 Design of Coiled-Coil Based Supramolecular Metallopolymers 
An alternative to covalently cross-linking coiled coils with organic linkers to promote 
supramolecular assembly is to do so through metal coordination. This strategy has been used 
extensively in the supramolecular polymer and metal organic framework fields and provided 
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inspiration for this work.23, 54, 139-141 The driving goal of this work was to design a series of coiled-
coil peptides that assemble into supramolecular architectures driven by metal coordination and 
tunable by peptide sequence (Figure 21).  
 
 
Figure 21. Schematic for generating supramolecular architectures from peptide metal coordination. Question marks 
indicate tunable aspects of the system. 
 
Incorporation of a metal chelating group into the peptide allows for the formation of 
supramolecular materials by the simple addition of a metal ion at an appropriate stoichiometric 
ratio. This assembly process can be easily tuned by the number of equivalents and identity of the 
metal.  
 We sought to control the morphology of the final supramolecular architecture through 
judicious placement of the metal-chelating site and oligomerization state of the coiled coil. The 
design of peptide sequences that assemble in the presence of metal to form crystalline and solution 
phase assemblies was pursued in parallel. Negative results were fed back into the design process 
to inform the development of subsequent systems. The result was a novel class of highly ordered 
metallopeptide architectures with analogies to MOF-based materials (Chapter 3). 
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1.5.3 Improving Helix Backbone Modification Strategies 
The B1 domain of the Streptococcal G protein (GB1) had been previously used by our lab to 
elucidate the design rules of heterogeneous backbone modification within the context of a tertiary 
fold.142 GB1 is a synthetically accessible protein containing all of the major secondary structural 
motifs (α-helices, β-sheets, β-turns, and loops). Backbone substitutions were found for each 
structural element that allowed the protein to retain its native fold.142 Modification of the helix, 
while tolerated, proved to be one of the most de-stabilizing substitutions. Subsequent full 
thermodynamic analysis of proteins incorporating acyclic and cyclic β-residues in the helix sought 
to understand the origin of this effect.131 
Although multiple strategies have been developed for helix backbone modification, 
thermodynamic comparison between them within the same system is lacking (Figure 22).  
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Figure 22. How does helix backbone modification effect the folded stability of  a tertiary fold? 
Crystal structure of the GB1 tertiary fold (PDB ID = 2QMT) with mutation sites highlighted in orange; unnatural 
amino acid types compared surround it. 
 
We turned once again to the helix of GB1 to explore this question. Calculations suggested that 
certain regioisomers of β-residues may form thermodynamically more stable helices than others.143 
It has also long been known that methylation of the alpha carbon strongly promotes the helical 
conformation.144 By careful thermodynamic analysis of each substitution type we were able to 
directly compare these different strategies for helix backbone modification alongside those 
examined by the lab previously (Chapter 4).  
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2.0  ORIGIN OF LINKER FLEXIBILITY IN COILED-COIL BASED 
SUPRAMOLECULAR POLYMERS 
The work in this chapter has been previously published as: 
Tavenor, N. A.; Silva, K. I.; Saxena, S.; Horne, W. S. "Origins of Structural Flexibility in Protein-
Based Supramolecular Polymers Revealed by DEER Spectroscopy."  J. Phys. Chem. B. 
2014, 118, 9881-9889. 
 
The crystallography experiments in this chapter were performed by Dr. W. Seth Horne.  Electron 
spin resonance data were collected and analyzed by Dr. K. Ishara Silva.  The computational 
modeling was supported in part by the University of Pittsburgh Center for Simulation and 
Modeling through the supercomputing resources provided.  A particular acknowledgement of 
thanks goes to Dr. Albert DeFusco for his help in the use of those resources. 
 
Prior work on protein-based supramolecular polymers (SMPs) generated by coiled coils cross-
linked by a short organic linker revealed that a subtle change in the structure of the linker altered 
the apparent size of the SMP.62  Upon changing the linker from a linear ethylenediamine (EDA) 
core to a cyclic piperizine (PIP), an increase in assembly size was observed by gel permeation 
chromatography (Figure 23) even though the strength of the non-covalent forces holding the 
assembly together (peptide domain dimerization) remained unchanged.62   
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Figure 23. Coiled-coil based supramolecular polymers with modular linkers. 
A) Sequences of GCN4p1 (1) and S14→C mutant (2). B) Gel permeation chromatograms of peptide 1 and 2 
cross-linked with either the EDA (gold) or PIP (magenta) linker (GPC data adapted from Ref. 62 with permission 
from The Royal Society of Chemistry). C) Supramolecular assembly of a cross-linked peptide and structures of the 
linkers. 
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An open question from this work was the physical basis for the difference in apparent size of the 
assemblies generated from EDA- and PIP-based linkers. We endeavored to answer this question 
through a detailed measurement of the conformational range of each linker. 
With the aim of better understanding the role of the linker in dictating the supramolecular 
polymer properties, we utilized a pulsed electron paramagnetic resonance (EPR) technique known 
as double electron-electron resonance (DEER) spectroscopy to measure the probability distance 
distributions between paramagnetic spin-labels across a cross-linked coiled coil subunit. DEER 
measurements interrogate the dipolar relaxation signal between two paramagnetic centers from 
which a distance probability distribution can be extracted.145 This signal appears as an decaying 
sine wave. Period length is related to the distance between spin-labels (longer periods implies 
longer distances) and signal decay rate is related to the distribution of distances present (a slower 
decay implies a narrower distance distribution).146 DEER was particularly well-suited to this task 
as it is sensitive to the dipolar resonance between paramagnetic electrons within 1.5-16 nm of one 
another.146-149 This is approximately an order of magnitude greater than the distance detected by 
the analogous NMR technique of measuring NOEs.145  
Applying DEER to the study of linker flexibility in the coiled coil supramolecular 
assemblies discussed above was acccomplished in three stages: (1) determining the ideal electron 
spin label for the system, (2) designing a system where a single subunit could be isolated and 
analyzed, and (3) constructing a molecular model based on the experimental results.   
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2.1 COMPARISON OF SPIN-LABEL STRATEGIES 
Spin labels applied in EPR can be any moiety that contains an unpaired electron.  This unpaired 
electron may either be in the form of a paramagnetic metal ion or an organic radical. An ideal spin 
label must be able to be incorporated into a molecule of interest without perturbing its structure 
and also contribute minimal conformational ambiguity in the position of the spin relative to the 
system of interest.  The most widely used organic spin-label functional group is a nitroxide radical 
composed of an oxygen bonded to a nitrogen flanked by two pairs of geminal dimethyl groups. 
This moiety can be incorporated into peptides and proteins in different ways; the two most 
common are as an MTSSL-modified Cys (denoted as ρ) and as a TOAC residue (denoted as Σ), 
depicted below (Figure 24). 
 
 
Figure 24. Structures of two commonly used nitroxide spin-labeling residues in peptides: 
MTSSL-modified Cys (ρ, left) and TOAC (Σ, right). 
 
 Incorporation of a nitroxide into a synthetic peptide may be achieved by either coupling 
the modified residue on resin or through post-synthetic modification of a functional side chain 
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(e.g. Cys). The latter approach is also readily applied to biologically expressed proteins.146 
Incorporation on resin during solid-phase peptide synthesis (SPPS) widens the repertoire of 
modifications available to include highly rigid labels like the amino acid TOAC. TOAC's high 
steric hindrance decreases the nucleophilicity of the amino group and significantly increases the 
difficulty of peptide synthesis.150 Post-synthetic modification typically utilizes MTSSL attachment 
through quantitative disulfide formation with a Cys residue.151  
 Structurally, the MTSSL moiety is less likely to perturb the folding of a protein compared 
to TOAC and may be placed at any solvent-exposed site.  A disadvantage to MTSSL labeling is 
the number of freely rotatable side-chain bonds; these increase the ambiguity in the final structural 
analysis.  The restricted conformational freedom of TOAC means that it can only be incorporated 
at sites that fall within its allowed dihedral range, which correspond to β-bend, α-helix and 310-
helix.152  This restricted freedom is advantageous for a spectroscopic probe since the functional 
group measured in the analysis (the nitroxide) is tightly coupled to the feature of interest (the 
peptide backbone).   
Since these two spin-labeling strategies (TOAC and MTSSL) have been used 
extensively,153-154 we compared the two methods to determine which would be best-suited to the 
study of the supramolecular polymer system at hand (vide supra).  The parent peptide sequence 
GCN4p1 (1) was modified by either mutation of S14 → Cys (2) for MTSSL attachment generating 
peptide 3 or mutation of E10 → Σ for TOAC incorporation generating peptide 5 (Figure 25). Peptide 
4 is a control sequence for TOAC incorporation in which a simplified analogue is used in place of 
the spin-label. 
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Figure 25. Sequences of peptides 1-5 with structures of unnatural residues
 MTSSL-modified Cys (ρ), Ahx (X), TOAC (Σ), and acetamidobenzoyl N-terminal cap (ABA). 
 
Circular dichroism (CD) thermal melts and X-ray crystallography were used to study the 
perturbation to the folded structure while DEER measurements were made to compare the 
conformational flexibility in the folded coiled-coil quaternary structure.  
2.1.1 Effect of Spin-Labeling on Peptide Folding 
Peptide 2 was synthesized as a variant of GCN4p1 (1) with the point mutation S14 → C in order to 
facilitate attachment of MTSSL.  MTSSL was attached through disulfide formation in aqueous 
buffer using known methods yielding peptide 3.151   
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Prior to synthesis of peptide 5, a structural analogue lacking the nitroxide was made using 
the related amino acid Ahx (X) at the E10 site.  This site was chosen for modification based on 
analysis of a published structure of GCN4p1 (PDB 4DMD)90 suggesting that TOAC at this position 
would not perturb the fold.  Factors that were considered in this analysis were 1) the possibility 
steric clashes with other residues, 2) loss of important intermolecular interactions (e.g. salt bridges, 
hydrogen bonds, hydrophobic core), and 3) proximity to the linker attachment site.  Mutation of 
E10 was found to least likely have an impact considering these factors.  Due to its increased steric 
bulk, Ahx required alternative coupling strategies for itself and the two subsequent residues (vide 
infra). 
Peptide 4 was crystallized by hanging drop vapor diffusion and yielded a structure (PDB 
4TL1) that was solved to 1.80 Å resolution.  Comparison with a published structure of the native 
GCN4p1 coiled coil (PDB 4DMD) resulted in a backbone alignment with a 0.29 Å RMSD between 
Cα atoms (Figure 26). 
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Figure 26. Crystal structure of peptide 4. 
A) Alignment of X-ray crystal structures of peptides 1 (PDB ID = 4DMD) and  4 (PDB ID = 4TL1), Cα 
RMSD = 0.29 Å; B) modeled overlay of the TOAC residue with the Ahx residue. 
A CD scan of peptide 4 indicated solution-phase helical structure and thus formation of the coiled-
coil dimer (Figure 27).   
 
Figure 27. CD scans (left) and melts (right) of peptides 1, 4, and 5 
Peptides were measured at 100 µM measured in aqueous HEPES buffer (10 mM pH 7). 
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The scan of peptide 4 has a lower ellipticity signal than peptide 1 which may indicate slightly less 
helical content; however the thermal melt indicated that peptide 4 has an identical folded stability 
as wild type. Confident that incorporation of TOAC at this site would not perturb the folded 
structure, we synthesized peptide 5. 
Amino acid coupling involving TOAC required alternative strategies due to its extreme 
steric bulk. Nucleophilicity of the amino group is known to be very weak (pKa ~ 6.0 for the 
conjugate acid),155 and therefore subsequent amino acids do not couple to it easily. 
Serendipitously, we discovered that Fmoc protection of the amino group is unnecessary since 
TOAC will not self-polymerize during SPPS like typical amino acids. This discovery greatly 
reduces the cost for TOAC incorporation since it may be used in synthesis as the free amino acid. 
The amino acid immediately following TOAC (Val9) was activated as the acid fluoride in order to 
achieve effective coupling.156 The difficulty of this coupling is likely a combined effect of TOAC's 
low nucleophilicity and Val's sterically hindered carboxylate resulting from the beta-branched side 
chain. The N-terminus of peptide 5 was amidated with acetamidobenzoic acid to provide a 
chromophore with a strong extinction coefficient to aid in concentration determination of the 
peptide by UV-Vis spectroscopy. Due to the acidic nature of the peptide cleavage/deprotection 
reaction, the nitroxide is converted to a hydroxylamine by protonation of the oxygen. The radical 
was regenerated by treatment with aqueous ammonia prior to HPLC purification.150, 157 
Crystallization trials of peptide 5 were unsuccessful; however, a CD scan confirmed the 
secondary structure was similar to 1, and thermal melt analysis revealed an improved thermal 
stability over wild type (Figure 27, right). Convinced that both spin-labeled peptides (3 and 5) 
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were structurally identical to the wild type we measured the DEER spectrum of the dimeric coiled-
coils formed by each.  
2.1.2 Comparison of DEER Spectra 
Samples of 3 and 5 for DEER measurements were prepared at 100 µM in 10 mM HEPES buffer, 
pH 7 with 20% glycerol (v/v). Cryoprotection with glycerol is necessary for flash freezing the 
samples resulting in a snapshot of the system at close to room temperature.146 The results of the 
DEER measurements were as were consistent with expectations based on relative label flexibilitiy. 
The coiled coil formed by the peptide labeled with MTSSL exhibited a longer and broader 
probability distribution, while the peptide labeled with TOAC gave rise to a very narrow and 
shorter probability distribution. Most probable distances for both were consistent with models 
generated from the crystal structures of related peptides 1 and 4  (Figure 28).   
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Figure 28. DEER data and structural models for peptides 3 and 5. 
A) Time-domain signals (background subtracted) of peptides 3 and 5 fit with Gaussian distributions for the distance 
distributions. B) Models of the peptides were constructed by overlaying models of the spin-labels onto X-ray 
structures of 1 (MTSSL for 3) and 4 (TOAC for 5). Adapted from Ref. 158 through an open access ACS 
AuthorChoice License. Copyright 2014 American Chemical Society. 
 
The model for the MTSSL-modified Cys containing coiled coil was built by overlaying the 
published coordinates of a MTSSL-modified Cys residue from a small helical protein151 onto Ser14 
from the X-ray structure of GCN4p1. This model gave a predicted nitroxide-nitroxide distance of 
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2.36 nm, well within uncertainty of the measured distance (most probable distance of 2.40 nm with 
a standard deviation of 0.26 nm). The large width of the probability distrbution from the MTSSL-
labeled coil coil is caused by the five rotatable bonds connecting it to the backbone. Likewise, a 
model for peptide 5 was constructed by overlaying published coordinates of TOAC from a short 
α-helix159 onto the backbone atoms of Ahx10 in the crystal structure of peptide 4. The predicted 
nitroxide-nitroxide distance in this model was 1.95 nm, once again in agreement with experiment 
(most probable distance of 1.87 nm with a standard deviation of 0.07 nm). This narrow distribution 
is on the order of bond fluctuations. This is important because when the label is placed in the 
context of the supramolecular polymer any broader distance distributions can be solely attributed 
to the linker. 
 Both of the above results are consistent with prior work160 that demonstrated TOAC gives 
rise to significantly narrower distance distributions than MTSSL. Even without spectral fitting and 
transformation to the distance domain, this is apparent in the raw time domain data. Four full 
periods of the spin relaxation decay are visible for TOAC, whereas only one period is visible with 
MTSSL. Dampening of the signal results when a larger number of distances are summed to 
produce the overall signal.146 Encouraged by the observations that TOAC does not disturb the 
coiled coil fold and exhibits a very narrow distance distribution, it was chosen as the spin-label for 
measurements on the supramolecular polymer. 
2.2 DESIGN OF A MODULAR DISCRETE SUBUNIT 
In order to measure the flexibility across a linker in our peptide-based SMPs, it is necessary to 
devise a system that consists of a single subunit flanked by two spin-labeled peptides. It had been 
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previously observed that the size of the supramolecular assembly could be controlled by addition 
of a "capping" peptide.62 This capping peptide consisted of the same primary sequence as the cross-
linked subunit minus the linker. Since the intermolecular interactions remain unaltered, this sets 
up an equilibrium of a statistical distribution of supramolecular species composed of: a) coiled-
coil dimers of the uncross-linked capping peptide, b) a single (n = 1) subunit capped by two 
uncross-linked peptides, and c) longer supramolecular oligomers composed of a variable number 
(n > 1) of cross-linked subunits terminated with the capping peptide (Scheme 1).  
  
 
Scheme 1. Statistical supramolecular assembly created by mixing a capping peptide with a cross-linked subunit
 to generate a statistical mixture of a capped polymer with variable number of subunits and dimer of the capping 
peptide. 
 
As the concentration of capping peptide increases, the length of species c decreases and the 
population of a and b increases. A 3:1 ratio of subunit : capping peptide was expected to favor the 
desired assembly b as the major component in solution based on previously reported GPC data.62 
This led us to hypothesize that spin-labeled peptide 5, though its sequence is altered slightly by 
TOAC incorporation, could be used to produce the spin-labeled assembly needed for DEER 
anlaysis. 
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Cross-linked subunits of peptide 2 were synthesized by reaction of linker 6 (EDA) or 7 
(PIP) in aqueous DMF to generate subunits 8 and 9, respectively (Scheme 2). 
 
 
Scheme 2. Synthesis of subunits 8 and 9 from peptide 2 and alkyl halide linkers 6 or 7. 
 
Mixtures of subunits 8 or 9 (100 µM) with TOAC-labeled peptide 5 (33.3 µM) were prepared in 
deuterated aqueous buffer at pH 7. Solvent deuteration was necessary to lengthen the dipolar 
relaxation time to enable measurement of longer distances.146 DEER measurements were expected 
to give a bimodal distance distribution consisting of species a and b (the nitroxide-nitroxide 
distances in species c should be too long to be detected). Based on the linker length, it was expected 
that the distance between nitroxides in species b would be approximately 4-5 nm. A peak at 1.9 
nm was also expected, as observed for peptide 5 alone.  
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 Results of the DEER measurements for both systems were nearly identical to the 
measurement on peptide 5 alone (Figure 29).  
 
 
Figure 29. DEER distance distribution results of mixing peptide 5  with cross-linked subunits
 8 (EDA, gold) and 9 (PIP, magenta) compared to 5  alone. Time domain data is given in the inset. Adapted from 
Ref. 158 through an open access ACS AuthorChoice License. Copyright 2014 American Chemical Society. 
 
From the absence of any longer distances, it was inferred that the population of desired species b 
is negligible. The lower signal to noise of 5 + 8 and 5 + 9 vs. 5 in isolation implies that some of 
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the nitroxides exist as species c, since these spins cannot contribute to the DEER signal. In 
retrospect, this can be explained by the greater Tm (71 °C) of peptide 5 versus peptide 1 (62 °C) 
(Figure 27).  From this difference in Tm, it can be reasoned that the homodimer of 5 is more stable 
than the homodimer of 1 and that the heterodimer of the two lies somewhere between. The 
difference in folded stability of the homodimers versus the heterodimers is likely sufficient to skew 
the statistical oligomer distribution observed previously upon mixing subunits 8 and 9 with peptide 
1.62 It was concluded that this strategy was not worth pursuing further and that a new system would 
have to be devised. 
The failure of the first system to produce the desired species in sufficient quantities for 
observation highlighted the need to create a system where heterodimers dominate over 
homodimers. Fortunately, the design of heterodimeric coiled coils is well precedented in the 
literature (see Chapter 1). The sequences of peptides 10, 11, and 12 were based on a set of 
previously described de novo designed complementary peptides104 designated ACIDp1 and 
BASEp1 (Figure 30).  
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Figure 30.  Sequences of Base-p1, Acid-p1 and peptides 10, 11, and 12. 
Basic residues are colored in blue, acidic residues in red and nitroxides in purple. 
 
ACIDp1 and BASEp1 are designed such that they only fold as a heterodimer; alone they remain 
unstructured.   
 The BASEp1 sequence was modified with a point mutation of K12 → C generating peptide 
10 with a point of attachment for the linkers. This site is equivalent to the point of attachment in 
the original system since they are both the f position in the second heptad of the helix.  The ACIDp1 
sequence was altered at positions 2 or 9 with TOAC to generate peptides 12 and 11, respectively. 
These positions were chosen because they are at c positions in either the first (12) or second heptad 
(11). This allows the linker dynamics to be probed at two different positions: one near the point of 
linker attachment and the other at the N-terminus. Using two different spin-label sites will allow a 
better model of linker flexibility to be built. All three peptides were also capped at the N-terminus 
with a 4-acetamidobenzoic acid chromophore to aid in concentration determination. 
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 CD measurements of the three peptides revealed a surprising observation. While the basic 
peptide (10) was poorly structured in isolation, both TOAC-labeled acidic peptides (11 and 12) 
exhibited a significant helical signature (Figure 31). 
 
 
Figure 31.  CD scans of peptides 10-12  (100 µM in 10 mM HEPES buffer, pH 7). 
Mixtures 1:1 of 10  with 11 or 12 (experimental = solid; calculated non-interacting spectra = dashed). 
 
The presence of a significant helical structure for peptides 11  and 12 is surprising since the Glu 
residues at the e and g positions destabilizes homodimer formation through charge-charge 
repulsion,104 and formation of monomeric helices are disfavored by the large hydrophobic face 
formed by Leu residues at the a and d positions88 (vide supra Section 1.3). The observed helical 
signature of peptides 11 and 12 can be attributed to TOAC's strong preference for helical dihedral 
angles152 overcoming the energetic penalty of charge-charge repulsion on the Glu residues 
allowing the coiled coil to form. Alternatively, these sequences may populate a monomeric helix 
fold.  
Mixtures of the complementary components (10 + 11 or 10 + 12) in a 1:1 ratio led to a 
significant increase in helical signature compared to theoretical non-interacting mixtures (Figure 
31). This implies that the heterodimer of 10 + 11 or 10 + 12 is a significantly more stable species 
in solution than the corresponding homodimers. From these results it can be inferred that mixtures 
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of cross-linked peptides 13 and 14 and the TOAC-labeled peptides will form the desired capped 
subunits and disfavor the undesired homooligomers.  
Subunits 13 and 14 were synthesized from the basic peptide 10 in the same manner as 
subunits 8 and 9, respectively (Scheme 3). 
 
 
Scheme 3. Synthesis of subunits 13 and 14 from peptide 10 and alkyl halide linkers 6 or 7. 
  
These two subunits were then combined with TOAC-labeled peptides 11 and 12 to form four 
binary samples. The CD results from the mixtures of peptide 11 and 12 with peptide 10 imply the 
predominant species in these samples will be the spin-label capped cross-linked subunit. These 
four mixtures were then subjected to DEER measurements for measurement of the distance 
distributions across the assembly. 
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2.3 MEASUREMENT OF LINKER FLEXIBILITY BY DEER SPECTROSCOPY 
DEER distance distributions for the four samples differed based on linker identity and spin-label 
position. All data was fit using a unimodal or bimodal Gaussian distribution. Placement of the 
spin-label near the cross-linking site (subunits capped with peptide 11) resulted in a unimodal 
distance distribution for both the PIP and EDA linker with a most probable distance of ~4.2 nm 
(Figure 32).  
 
 
Figure 32. DEER results of the heterodimeric assemblies. 
Cartoons of the structures are depicted below denoting the placement of the TOAC spin labels (spheres).  
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Although the most probable distance is similar for both linkers, the cyclic PIP linker exhibited a 
wider distance distribution (standard deviation of 0.8 nm for PIP versus 0.6 nm for EDA). Altering 
the placement of the spin-label to the N-terminus resulted in a unimodal and bimodal distance 
distribution for the EDA and PIP linkers, respectively (Figure 32). The most probable distance for 
the EDA linker was again ~4.2 nm; the bimodal distribution of the PIP linker contained most 
probable distances of ~2.3 nm and ~4.2 nm. The presence of the bimodal distribution can be seen 
in the time domain data by the presence of a second period. The presence of the second peak was 
also confirmed by fitting a model with peak suppression. An alternative model fitting procedure, 
Tikhanov regularization, suggests that a small population with a nitroxide-nitroxide distance of 
~2.3 nm may also be possible for the EDA linker.  
These results were puzzling since it was expected that the more flexible linker would give 
rise to a wider range of conformations and therefore a wider distance distribution. Another question 
posed by the DEER data was the origin of the second sub-population observed for the PIP linker. 
To gain a greater understanding of the possible conformations giving rise to these distance 
distributions, models of the subunits informed by the experimental data were built with the aid of 
molecular dynamics. 
2.4 MOLECULAR DYNAMICS-AIDED MODELING OF THE 
SUPRAMOLECULAR POLYMER 
Models of the subunit conformations were built through a combination of molecular 
dynamics (MD) simulations and static modeling informed by the experimental distance 
distributions. The modeling strategy was divided into three steps: 1) sample all possible 
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conformations of the linkers using atomic-level molecular dynamics simulations; 2) append crystal 
structure-derived models of the coiled coils onto the linker conformations, excluding those with 
steric clashes; and 3) refine the conformational library using the experimental distance 
distributions. This simplified modeling protocol was chosen over more rigorous MD simulations 
of the full system due to the high computational demands of the latter. Due to the nature of this 
modeling algorithm, the resulting ensembles are not equilibrium-weighted, but rather represent the 
range of possible conformation space that each subunit is likely to adopt. 
Conformational sampling of the linkers was performed using the EDA and PIP linker cores 
capped by a thioethyl moiety on each end as models (Figure 33).   
 
 
Figure 33. Structures of the molecules used to simulate the linker conformations by MD. 
 
Both the cis and trans conformers of the PIP linker were simulated separately since tertiary amides 
do not isomerize quickly enough on the MD timescale. Each linker model was separately simulated 
by MD for 500 ns in explicit water to obtain the full range of conformations possible.   
Coiled-coil models of peptide 1 were altered to include rotamers of Cys at position 14 of 
one chain of the dimer and TOAC residues at position 4 and 11 of the other chain. One dimer 
model was  then appended  to each side of the linkers on all possible conformations generating an 
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ensemble of subunit conformations. A set of custom Python scripts (Appendix B) were used to 
discard any subunit models that contained steric clashes. The remaining library of conformations 
was then passed on to the last step. 
Final refinement of the conformational library from step 2 removed any models 
inconsistent with the experimental DEER data. Another custom Python script removed any 
conformations where the nitroxide-nitroxide distance lay outside of one standard deviation of the 
most probable distance observed for both spin label positions by DEER. Two sets of models (one 
for each peak) were generated for the PIP linker due to the bimodal distribution for the N-terminal 
labeling site. This resulted in ~1000 models for the capped subunits of  both the EDA and PIP 
linkers for the N-terminal peaks at ~4 nm and ~500 models for capped subunit of  the PIP linker 
with a peak at ~ 2.3 nm. 
These results provided structural insights into the nature of the differences between the two 
linkers. Visualization of the ensembles focused on the point of attachment to the next subunit that 
would be present in the fully assembled supramolecular polymer (Figure 34).  
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Figure 34. Visualization of the molecular dynamics-aided modeling. 
Orange spheres represent the point of attachment to the next subunit propagating along the chain. Adapted from Ref. 
158 through an open access ACS AuthorChoice License. Copyright 2014 American Chemical Society. 
 
This is represented by displaying the Cα atoms of Ser14 as spheres in each subunit. The 
conformational ensemble generated by the EDA linker is similar to sub-population 1 (N-terminal 
distance centered around ~4 nm) of the PIP linker. Both ensembles display linker attachment sites 
over an approximately half-spherical shell. This implies a random orientation of the two coiled 
coils to one another in these ensembles. Sub-population 2 (N-terminal distance centered around 
~2.3 nm) of the PIP linker is markedly different with an ensemble covering a much narrower arc 
of conformational space. This represents structures where the dimers are roughly parallel to one 
another across the linker. 
It is hypothesized that the orientation of structures in subset 2 of the PIP ensemble gives 
rise to the macroscopic differences observed between SMPs of the two linkers. Propagation of the 
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supramolecular assembly in roughly the same direction will result in a longer persistence length 
for the PIP linker thereby leading to a less compact polymer chain compared to the EDA linker. 
This longer persistence length ultimately gives rise to the larger apparent hydrodynamic diameter 
observed by GPC. This demonstrates how a small structural difference in linker rigidity between 
the cross-linked subunits of 8 and 9 can propagate along a supramolecular polymer chains. 
2.5 CONCLUSIONS AND FUTURE DIRECTIONS 
The work described in this chapter highlights the ability of DEER spectroscopy to probe 
supramolecular polymer structure. The structural insights gained by restraining MD models with 
experimental distance distributions were able to uncover the molecular cause of the apparent size 
difference between supramolecular polymer chains differing by only two CH2 groups in an 8 kDa 
subunit. Restricting the conformational freedom of linkers between large macromolecular 
dimerization domains can be used to increase the apparent size of the final assembly without 
altering the association affinity of the non-covalent forces.161 This provides a means of controlling 
the properties of supramolecular polymer based materials. Replacement of the covalently bound 
linkers with metal chelating groups is an alternative method to organic linkers to promoting coiled-
coil SMP formation. Alteration of the peptide oligomerization state can also be used to control the 
structure of the supramolecular polymers. Both of these design strategies are explored in Chapter 
4.  
Follow-up work to this project could refine the structural models presented here. Recently 
developed techniques involving ensemble-biased metadynamics162-163 may provide a way to 
achieve more robust structural models in a reasonable computational time. Metadynamics biases 
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an MD simulation by applying a biasing potential forcing it to explore a wider range of 
conformations.164  If this biasing potential is based on experimental restraints, a more accurate 
structural model can be obtained in a shorter computational time. Simulation techniques such as 
this combined with appropriate spectroscopic techniques will greatly improve our understanding 
of complex supramolecular assemblies.  
2.6 EXPERIMENTAL 
2.6.1 General Information 
Solvents and all other reagents were purchased from Acros Organics, Aldrich, Advanced Chem 
Tech, Baker, EMD, Fluka, or Fisher and used without further purification. NovaPEG Rink Amide 
Resin, Fmoc-protected amino acids, HATU, PyBOP, and PyBrOP were purchased from 
Novabiochem. HCTU was purchased from Aapptec or Novabiochem. PyAOP was purchased from 
AK Scientific. 2,2,6,6-Tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC) was 
purchased from Santa Cruz Biotechnology or Toronto Research Chemicals and (1-Oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl)methanethiosulfonate (MTSSL) was purchased from either 
Toronto Research Chemicals or Enzo Life Sciences. 1-Amino cyclohexanecarboxylic acid (Hex) 
was purchased from TCI America. Synthesis of Fmoc-Hex-OH was adapted from the literature.165 
The Fmoc-amino acid fluorides, Fmoc-Val-F and Fmoc-Gln-F, were prepared by a known 
method.166 Crystallography reagents and tools were purchased from Hampton Research. 
Deuterated chloroform (CDCl3), dimethyl sulfoxide (d6-DMSO) and glycerol (Glycerol-d3) were 
purchased from Cambridge Isotopes Laboratory.  NMR spectra were recorded on a Bruker 
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Advance 300 or 400 spectrometer. MALDI of peptides and cross-linked subunits was collected on 
an AB Sciex Voyager DE Pro MALDI-TOF and small molecule high resolution mass spectrometry 
on a Thermo Scientific Q-Exactive Orbitrap. 
2.6.2 Peptide Synthesis 
Peptides were prepared by Fmoc solid-phase peptide synthesis (SPPS) manually with microwave-
assisted reactions in a Microwave Assisted Reaction System (MARS, CEM), on a Tribute 
automated synthesizer (Protein Technologies), or by a combination of the two. All peptides were 
synthesized on a NovaPEG Rink Amide resin support. Standard coupling solutions consisted of 5 
equivalents of Fmoc- protected amino acid with 4.9 equivalents of HCTU and 4.4% (v/v) N-
methylmorpholine in DMF (automated) or 7.5 equivalents of DIEA in NMP (microwave). 
Coupling solutions were pre-activated for 2 minutes prior to addition to the resin and vortexed for 
45 minutes (automated) or subjected to a 2 minute ramp to 70° C with a 4 minute hold 
(microwave). Fmoc deprotections were performed with 20% 4-methylpiperidine in DMF by two 
treatments of 4 minutes vortexing (automated) or one treatment with a 2 minute ramp to 80° C 
with a 2 minute hold (microwave). Resin was washed 3 times with DMF between steps. 
 The unnatural amino acids Ahx and TOAC were incorporated using alternative coupling 
strategies due to the steric hindrance of their amino groups. Fmoc-Ahx-OH was coupled with 
standard protocols except HCTU was replaced with PyBOP and the two subsequent residues were 
double-coupled. TOAC was coupled as the free amino acid with PyBOP in place of HCTU in the 
microwave with double the reaction time. No polymerization of the unprotected TOAC residue 
was observed, presumably due the high degree of steric hindrance of the N-terminal amine. The 
residue immediately following TOAC was activated as the acid fluoride156 and coupled two to 
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three times in the microwave for extended coupling times to ensure complete acylation. The N-
terminus of each peptide was either acetylated with a solution of DMF/DIEA/Ac2O (8:2:1 by 
volume) for 20 minutes at room temperature (peptides 1, 2, 4, and 5) or capped with 4-
acetamidobenzoic acid using standard microwave coupling and PyBrOP as the activating agent 
instead of HCTU (peptides 10-12).   
 Peptides were cleaved from the resin using various cocktails of TFA with scavengers and 
reaction times from 3-6 hours. Thiol scavengers were absent from cleavage cocktails of peptides 
containing nitroxides due to avoid an irreversible side reaction.150 Cocktail mixtures were as 
follows (all reagents by volume): TFA/H2O/EDT/TIS (92/3/3/1) for peptides 1, 2, and 4; 
TFA/H2O/anisole/TIS (91/3/3/3) for peptide 5; TFA/H2O/EDT/anisole/TIS (90/3/3/3/1) for 
peptide 10; and TFA/H2O/anisole/TIS (85/5/5/5) for peptides 11 and 12.  
 Deprotected peptides were precipitated from the cleavage mixtures by addition of cold 
diethyl ether, centrifuged and decanted to produce a crude solid. Purification was performed by 
reverse-phase HPLC with a preparative grade C18 column (Phenomenex, 150 Å pore size, 10 µm 
particle size) with gradients between water and acetonitrile with 0.1% TFA (peptides 11-12) or 
1% TFA (peptide 10). Nitroxide containing peptides (5, 11, and 12) were treated with 10% 
ammonium hydroxide prior to purification to regenerate the radical.150, 157 Peptides 11 and 12 were 
further purified by ion exchange chromatography on a Mono Q 5/50 GL column (GE Healthcare) 
with a gradient between 20 mM and 0.5 M ammonium formate, pH 7.7. Peptide 3 (MTSSL labeled) 
was prepared by disulfide formation of the Cys residue in peptide 2 with MTSSL. To an ice cold 
solution of 50 µM peptide 2 in 50 mM phosphate, 300 mM NaCl, pH 6.55, MTSSL was added at 
a final concentration of 500 µM (10 equivalents). The reaction proceeded for 20 minutes and was 
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then purified by preparative HPLC. Purity and identity were confirmed with analytical HPLC 
(Figure 35) and MALDI-MS (Table 1), respectively.   
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Figure 35. Analytical HPLC chromatograms of purified peptides 1-5 and 10-12. 
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Table 1. Calculated and observed average masses of proteins 1-5 and 10-12. 
# 
[M+H]+ m/z (average) 
Calculated Observed 
1 4038.7 4037.3 
2 4054.8 4054.6 
3 4239.1 4236.5 
4 4034.8 4033.1 
5 4224.9 4223.5 
10 3534.2 3535.2 
11 3696.1 3695.7 
12 3641.1 3638.5 
 
Peptide stock concentrations were determined using UV-Vis spectroscopy using the extinction 
coefficients listed in Table 2. 
Table 2. Chromophores present in peptides and subunits 1-5 and 8-14 with their overall extinction 
coefficient. 
Peptide Chromophore(s) ε (M
-1 cm-1) at the indicated 
wavelength 
1 Tyr 1,450 at 276 nm 
2 Tyr 1,450 at 276 nm 
3 Tyr, MTSSL 1,920 at 276 nm 
4 Tyr 1,450 at 276 nm 
5 Tyr, TOAC, ABA 20,451 at 270 nm 
8/9 2x Tyr 2,900 at 276 nm 
10 ABA 18,069 at 270 nm 
11/12 ABA, TOAC 18,961 at 270 nm 
13/14 2x ABA 36,138 at 270 nm 
a Extinction coefficient contributions for Tyr and ABA were obtained from 
the literature,167-168 while those for TOAC and MTSSL-modified Cys were 
determined by UV measurements on TEMPO and MTSSL, respectively. 
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2.6.3 Linker Synthesis 
 
Scheme 4. Synthesis of linkers 6 and 7. 
 
Linker 6 (EDA) was prepared by Dr. Kaylyn Oshaben and synthesized as described;62 linker 7 
(PIP) in a similar manner (Scheme 4). To a stirred solution of piperazine (421 mg, 4.9 mmol, 1 
equiv) in 4 mL of chloroform at 0 °C were simultaneously added via addition funnels 1.05 mL of 
iodoacetyl chloride (14.7 mmol, 3 equiv) in 5 mL of chloroform and 1.68 g of K2CO3 (12.25 mmol, 
2.5 equiv) in 5 mL of water. The solution was allowed to warm to room temperature and stirred 2 
h. The organic layer was isolated by extraction, concentrated, and purified using column 
chromatography (50% ethyl acetate in acetone). Fractions containing the product were 
concentrated, re-dissolved in chloroform, and filtered. The filtrate was concentrated and dried 
under vacuum to afford the product as a pale yellow solid (451 mg, 1.07 mmol, 22% yield). 1H 
NMR (400 MHz, DMSO-d6): δ 3.92 (d, J = 11.6 Hz, 4H), 3.47 (m, 8H). 13C NMR (100 MHz, 
DMSO-d6): δ 166.7, 166.5, 46.0, 45.8, 41.2, 41.1, −1.2, and −1.4. HRMS (ESI) m/z calculated for 
C8H12I2N2O2 [M + H]+: 422.9067; found 422.9078. 
N N
O
O
I
I
Linker 7 (Pip)
I
NH
O
NH
I
O
Linker 6 (EDA)
NH2 NH2
NH NH
ethylenediamine
piperazine
Cl
O
I (3 equiv. in CH3Cl)
K2CO3
 
(2.5 equiv. in H2O)
or or
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2.6.4 Peptide Linker Conjugation 
Fresh stock solutions of 2 mM linker 6 or 7 in DMF were prepared fresh for each batch. A 100 
µM solution of peptide 2 or 10 in 25 mM phosphate buffer, pH 7 was heated at 60-70 °C. A 0.1 
equivalent aliquot of linker 6 or 7 was added every 15 minutes until 0.5 equivalents of linker was 
reached.  The reaction continued for another hour after addition of the final aliquot and was 
quenched with a solution of 0.1% TFA in 1:1 water/acetonitrile. The product was concentrated by 
centrifugation through a 3 kDa cutoff filter, washed with ~10 mL of water and re-concentrated to 
a final volume of ~2 mL. Subunits were purified in the same manner as their starting material 
peptides. Identity and purity were confirmed by analytical HPLC (Figure 36) and MALDI-MS 
(Table 3).  
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Figure 36. Analytical HPLC chromatograms of purified subunits 8, 9, 13, and 14. 
 
Table 3. Calculated and observed average masses of subunits 8, 9, 13, and 14. 
# 
[M+H]+ m/z (average) 
Calculated Observed 
8 8248.7 8250.3 
9 8274.7 8275.4 
13 7207.6 7208.8 
14 7233.6 7232.6 
 
Stock concentrations of the subunits were determined by UV-Vis spectroscopy using extinction 
coefficients listed in Table 2. 
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2.6.5 Circular Dichroism 
Circular dichroism (CD) spectroscopy measurements were carried out in 1 mm quartz cuvettes on 
an Olis DSM 17 CD spectrometer. Peptide stock concentrations were determined by UV-Vis 
spectroscopy. Buffer components were syringe filtered through 0.22 µm pore filter prior to sample 
preparation. All measurements were made with a 2 nm bandwidth and 5 second integration time. 
CD scans were measured from 200-260 nm at 20 °C.  Thermal melts were measured at 222 nm 
and a baseline of 260 nm. Samples were incubated at each temperature for 2 minutes. Thermal 
melt data was fit to a two-state unfolding model169 using GraphPad Prism. 
2.6.6 Crystallography 
Crystallization trials of peptide 4 and 5 were set-up using hanging drop vapor diffusion.  
Crystals were only obtained with 4. Peptide stock solution was prepared from lyophilized powder 
at a concentration of 10 mg/mL, mixed (0.7 µL/ 0.7 µL) with crystallization buffer (0.2 M citrate 
tribasic, 0.1 M sodium cacodylate pH 6.5, and 30% (v/v) isopropanol) over a well of 0.7 mL of 
crystallization buffer, and equilibrated at room temperature overnight. A single crystal of peptide 
4 was harvested from the crystallization drop, cryoprotected with 30% (v/v) glycerol in 
crystallization buffer and flash frozen in liquid nitrogen.  X-ray diffraction data was collected on 
a Rigaku/MSCdiffractometer (FR-E generator, VariMax optics, Raxis HTC image plate detector) 
with Cu Kα radiation. The sample was kept frozen by an X-Stream 2000 low temperature system 
at 100 K.  
Data collection and refinement was performed by Dr. W. Seth Horne. Raw diffraction data 
was processed  with d*TREK. The peptide structure was solved by molecular replacement using 
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PDB 4DMD as a search model with Phaser.170 Model refinement was performed with Phenix171 in 
conjuction with manual model building in Coot.172 Data collection and refinement statistics are 
given below in Table 4. 
Table 4. X-ray diffraction data collection and refinement statistics for peptide 4. 
Data Collection  
Unit cell dimensions (Å, °) a = 83.3, b = 30.4, c = 28.0 
α = γ = 90, β = 102 
Space group C2 
Resolution (Å) 20.48–1.80 (1.86–1.80) 
Total observations 19,070 
Unique observations 6,386 
Redundancy 3.0 (3.0) 
Completeness (%) 98.1 (97.1) 
I/σ 12.9 (3.0) 
Rmerge (%) 5.5 (17.6) 
Refinement  
Resolution (Å) 20.48–1.80 
R (%) 18.7 
Rfree (%) 22.8 
Avg. B factor (Å2) 33.4 
RMSD  
Bonds (Å) 0.011 
Angles (°) 1.1 
 
2.6.7 Double Electron-Electron Resonance (DEER) Spectroscopy Measurements 
Samples for DEER measurements of peptides 5 (GCN4p1-TOAC) and 3 (GCN4p1-MTSSL) were 
prepared in 10 mM HEPES buffer with 20% (v/v) glycerol as a cryoprotectant. Samples of all 
other peptides were prepared with deuterated solvents (D2O in place of water and glycerol-d8 in 
place of glycerol). 
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All DEER measurements were performed and processed by Dr. K. Ishara Silva (Saxena 
Lab, University of Pittsburgh). DEER experiments were performed on a Bruker ElexSysE580 X-
band FT/CW spectrometer equipped with a Bruker ER4118-MD5 resonator. Sample temperature 
was regulated using an Oxford ITC503 temperature controller and an Oxford CLT650 low-loss 
transfer tube. For each measurement, ~150 μL of the appropriate sample was transferred into a 3 
mm inner diameter quartz tube, flash frozen in liquefied MAPP gas, and inserted into a sample 
cavity pre-cooled to 80 K. The four-pulse DEER experiments were carried out using a pulse 
sequence of (π/2)ν1-τ1-(π)ν1-T-(π)ν2-τ2-(π)ν1-τ2-echo.173 The pump frequency ν2 was set at the 
maximum of the nitroxide spectrum. The observer frequency ν1 was offset by ~70 MHz. The length 
of the (π/2)ν1 and (π)ν1 pulses were 16 ns and 32 ns respectively. The (π)ν2 pulse was set to 16 ns. 
Step sizes of 8 ns and 16 ns were used to measure shorter and longer distances, respectively for 
128 data points. Deuterated solvent and glycerol were used to increase the phase memory time of 
samples that were expected to give longer distances. Raw DEER data were analyzed using the 
DEERAnalysis2013174 software through MATLAB. Data were fit to a Gaussian or double-
Gaussian model and the corresponding distance distribution was generated. 
2.6.8 Molecular Dynamics Aided Modelling 
MD simulations were performed using the GROMACS 4.6.3 software package175 and the 
AMBER99sb-ildn forcefield.176 Amber-compatible force field parameters for the EDA and PIP 
linkers capped with thioethyl groups (EDA-Et2 and PIP-Et2) were prepared using Antechamber177 
and acpype.178 Three separate simulations of the linkers were performed: one for EDA-Et2, one for 
PIP-Et2 with the two amide carbonyls pointing in the same direction (cis-PIP-Et2), and one with 
the two amide carbonyls pointing in opposite directions (trans-PIP-Et2). The two different starting 
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conformers of PIP were run separately because tertiary amide isomerization is not effectively 
sampled on the timescale of the simulations. Each system was first energy minimized for 500 ps, 
equilibrated at 298K in the NVT ensemble for 100 ps, then equilibrated at 298K and 1 atm in the 
NPT ensemble for 100 ps. Simulations were run for 500 ns in explicit water with the TIP3P 
model179 at 298K and 1 atm. A Langevin thermostat was used for temperature control and a 
Berendsen barostat for pressure control.  
We prepared coiled-coil models to append to the two ends of the above set of linker 
conformers from the published structure of residues 1-30 in the dimer formed by peptide 1 (PDB 
4DMD). Coordinates for TOAC in an α-helix159 were modified to include a virtual atom at the 
midpoint of the nitroxide N–O bond and incorporated in place of residues 4 and 11 in one chain 
of the dimer. Residue 14 in the other chain was mutated to Cys, with the side chain rotamer set as 
one of the two most probable. Residues near the newly introduced Cys were changed to Ala. All 
side chains other than those listed above were removed. The above procedure generated two 
models (A and B), each a dimeric coiled coil doubly labeled with TOAC on one helix. The models 
differ only in the rotamer of the Cys that will be the point of attachment to the linker. 
Capped subunit models were generated using a set of custom-written PyMOL scripts. 
Coiled coil models A and B above were first combined with the three different linker 
conformational ensembles (10,000 frames each) to generate nine sets of capped subunit structures: 
EDA-A2, EDA-AB, EDA-B2, cis-PIP-A2, cis-PIP-AB, cis-PIP-B2, trans-PIP-A2, trans-PIP-AB, 
and trans-PIP-B2. Thioethyl groups at each end of the linker were replaced with a coiled coil by 
overlay of Cys Cα, Cβ, and Sγ atoms in the peptide with the corresponding atoms in the linker. The 
models were combined based on core linker structure to generate three capped subunit ensembles 
(EDA, cis-PIP, trans-PIP). The three capped subunit ensembles were curated to remove structures 
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with steric clashes between helices or a helix and the linker. Steric clashes were defined as peptide 
backbone Cα atoms coming within 5 Å of one another or van der Waal overlap180 involving any 
pair of atoms.  
The resulting ensembles were then filtered further to identify structures consistent with the 
observed DEER data. A model was accepted only if TOAC-TOAC spin-spin distances for both 
labeling sites fell within one standard deviation of the most probable distance observed in the 
DEER experiment. Because the N-terminal labeling site for the PIP linker gave a bimodal 
distribution in the experiment, capped subunit models based on PIP were divided into two sets 
(subset 1 and subset 2). Conformational ensembles for cis-PIP and trans-PIP linkers were 
combined to generate the three conformational ensembles shown in Figure 9: EDA, PIP (subset 
1), and PIP (subset 2). 
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3.0  IMPROVING HELIX BACKBONE MODIFICATION STRATEGIES 
The work in this chapter has been previously published as: 
Tavenor, N. A.; Reinert, Z. E.; Lengyel, G. A.; Griffith, B. D.; Horne, W. S.  "Comparison 
of Design Strategies for α-Helix Backbone Modification in a Protein Tertiary Fold." 
Chem. Commun. 2016, 52, 3789-3792. 
 
Fmoc-β2-Asn(Dcmp)-OH was synthesized by Dr. Zach E. Reinert and Brian D. Griffith.138 Fmoc-
β2-Lys(Boc)-OH and Fmoc-β2-Ala-OH were synthesized by Dr. George A. Lengyel. Proteins 15-
20 were synthesized by Dr. Zach E. Reinert. Plasmids and protocols for the expression of GB1 
proteins WT and K31A were generously provided by Dr. Timothy Cunningham and Dr. Sunil K. 
Saxena (University of Pittsburgh). Expression, purification and characterization of WT and K31A 
were performed by Dr. Zach E. Reinert. 
 
Proteins can be thought of as information-rich polymers. These polymers can be described by two 
sequences: 1) the canonical sequence of amino acid side-chains known to biochemists and 2) the 
sequence of backbone units displaying those side chains (in natural proteins an oligo-L-α-
peptide).116 Modification of the chemical connectivity of the peptide backbone can improve 
stability of polypeptides to enzymatic degradation for both structured181 and unstructured120 
oligomers with the end application being longer lasting peptide therapeutics.182 Prior efforts to 
engineer sequences with isolated backbone modifications have largely focused on mimics of α-
helix183-185 and β-sheet186-189 secondary structures.116 Prior work in our lab replaced ~20% of the 
natural backbone in a protein tertiary fold with unnatural amino acids. This resulted in a 
74 
heterogeneous-backbone that mimicked the native tertiary fold but with significant 
thermodynamic destabilization of the folded state.142  
 Replacement of individual secondary structural elements within the tertiary fold only 
incurred minor thermodynamic penalties. Even though the penalty from each modification may be 
small (~0.5-1.0 kcal/mol), these penalties are additive resulting in a significant overall 
destabilization when combined.142 There is therefore a need for backbone-modification strategies 
that retain or improve upon the stability of the native sequence. One of the secondary structures 
where the most significant improvement was needed was in the helix.  
 Inspired by the observation that incorporation of TOAC into coiled coils significantly 
improved thermal stability over the native sequences (see Chapter 2.2) and the known helix-
forming propensity of Cα-methylated residues,134, 144 we endeavored to determine whether Cα-
methylation would have a similar effect in the context of a tertiary fold. In order to place this work 
into the context of the broader field on α-helix mimicry, the results were compared to design 
strategies using various regioisomers (both acyclic and cyclic) of β amino acids, some of which 
were published previously131 (Figure 37). 
 
 
Figure 37. Backbone modification strategies of a helix in the context of a tertiary fold. 
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A) Primary sequence and secondary structure of Streptococcal protein GB1 (16); host protein for helix (gray) 
backbone modification. B) Helix variants of protein 16; sequence modifications indicated with the type and quantity 
of backbone modifications. C) Crystal structure of the GB1 tertiary fold (PDB 2QMT) highlighting the helix (gray) 
and substituted positions (orange); crystal structure only differs from host sequence at the N-terminus (MQ in crystal 
vs. DT in 16). D) Structures of the unnatural amino acid building blocks used for backbone modification with the R 
group in the building block corresponding to its natural α-amino acid counterpart; residue colors correspond to those 
highlighted in B. Adapted from Ref. 138 with permission from the Royal Society of Chemistry.  
 
 Full thermodynamic analyses and high resolution structural characterization were used to 
understand the effect that each amino acid class has on the final folded structure. Thermodynamic 
parameters for cooperative protein folding can be measured by tandem circular dichroism (CD) 
thermal and chemical denaturant melts.131, 190 The magnitude of the molar ellipticity is proportional 
to the percent of protein folded, thus fitting the data in three dimensions (molar ellipticity, 
temperature, and denaturant concentration) to a multivariate equation allows the extraction of all 
thermodynamic parameters (see Section 3.4.4). 
3.1 ΒETA RESIDUES 
Acyclic β-residues have been used extensively to mimic helices both on their own and in mixed 
α/β designs.116, 126 The main advantage of using β-amino acids as a backbone replacement is that 
the native side-chain can be retained allowing for direct comparison on the impact of the backbone 
alteration with the native sequence. There are two possible regioisomers for mono-substituted β-
residues: β2 (side-chain adjacent to carbonyl) and β3 (side-chain adjacent to amide nitrogen). β3-
Residues are more widely utilized than β2-residues due to their commercial availabilty.  
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Previous work131 examining the thermodynamic consequences of incorporating β3-residues 
into the helix of protein GB1 had determined that these substitutions are entropically stabilizing, 
but enthalpically destabilizing with an overall destabilizing effect on the folding free energy. These 
trends held true when the patterning of β-residues was altered only varying in magnitude. The GB1 
mutant (protein 16) with the best overall stability from that prior reported series131 was used as a 
baseline for thermodynamic comparisons of all other proteins in this chapter.  
The observed impacts of β3-residues on the folding of GB1 were puzzling. These building 
blocks contain an extra rotatable bond compared to α-residues. Therefore, it was hypothesized that 
β-residues would be entropically destabilizing to the folded structure due to the increased degrees 
of freedom when moving from a folded to an unfolded state. However, this simplistic analysis 
ignores the role of medium in folding; proteins do not exist in a vacuum and water plays a large 
role in determining how they fold. It was suggested that the unexpected thermodynamic effects of 
β3-residues were due to differences between solvent interactions in the unfolded versus folded 
states of the protein.131 An open question from the past work was whether these trends were unique 
to β3-residues or if the same held true for β2-regioisomers (vide infra). 
In the same study131 the impact of cyclic β3 residues based on 
aminocyclopentanecarboxylic acid (ACPC) were also examined. βcyc-Residues limit energetically 
accessible backbone conformational space by incorporating an otherwise freely rotatable bond into 
a ring.126 In the GB1 tertiary fold, β3→βcyc substitution at positions 24 and 35 (protein 17) was 
structurally well accommodated but led to only a modest increase in folded stability compared to 
protein 16. It should be noted that cyclization of the β-residues resulted in the lowest degree of 
entropic destabilization observed for any mutant. However, it was also observed in another mutant 
that removal of the lysine side-chains significantly decreased the folded stability of the proteins.131 
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The importance of retaining the Lys side-chain at position 35 will be examined in greater detail in 
Section 3.1.1 (vide infra). These results imply that the role of side-chains in determining folded 
stability is context dependent. This motivated a desire to compare alternative design strategies that 
retain important side-chain contacts while approaching native protein stability. 
3.1.1 Comparison of β2 with β3 Residues 
Motivation for studying β2-residues was two-fold: 1) computational analyses143 suggested that β2-
residues were more thermodynamically favorable to helical folds than β3-residues in 
heterogeneous-backbone α/β-peptide helices and 2) restoration of a potentially stabilizing orbital 
interaction at Asn35191 by shifting the side-chain from β3→β2. Proteins 18-20 (vide infra) were 
synthesized by SPPS (see Section 3.4.2) to test these hypotheses (Figure 37).  Proteins 18 and 19 
are single β3→ β2 mutations at the outer β3 residues: Ala24 and Asn35, respectively. Protein 20 
substitutes all four β3 residues with β2 analogues. Folding thermodynamics in each modified 
protein was probed by tandem thermal and chemical denaturation CD measurements.131, 190 High 
resolution structures were determined by X-ray crystallography (structures of 18 and 19 were 
solved to 1.95 Å and 1.80 Å resolution, respectively). 
Aside from the expected side-chain displacements, analogues 18 and 19 exhibit essentially 
identical tertiary folds as both natural backbone 15 and analogue 16 bearing an α/β3 helix (Figure 
38).  
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Figure 38. Global alignment of the folded structure of GB1 analogues bearing an α/β3 helix
 18 (A, pink) and 19 (B, magenta) with 16 (light blue). 
 
Analysis of folding thermodynamics (Figure 39) revealed individual β3→β2 replacement was 
neutral (18) to slightly destabilizing (19). Differences between 18 and 19 were small and similar 
within experimental uncertainty. Both proteins have an enthalpically stabilized fold compared to 
16 that is offset by an entropic penalty (Figure 39). This implies that the computational 
comparison143 of the two residue types is likely more accurate when calculating enthalpic than 
entropic effects. Though the exact origin of the entropy/enthalpy compensation is not clear, 
changes in the sensitivity of the folded state to chemical denaturant (m) and the heat capacity (∆Cp) 
difference between the folded and unfolded states (see Section 3.4.4, Table 6) suggest a more 
compact denatured ensemble in β2-residue containing variants vs. β3 counterparts.131  
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Figure 39. Effect of β3 to β2 substitution on the thermodynamics of folding: 
18 (β3→ β2-Ala24), 19 (β3→β2-Asn35), and 20 (all β3→ all β2). All proteins are referenced to the thermodynamic 
values for protein 16 (all four sites β3). 
 Recent literature highlights the importance of local orbital interactions in protein folding 
thermodynamics.191 One example is an intraresidue n→π* overlap in Asn involving partial 
donation of a carboxamide C=O lone pair into an antibonding orbital from the backbone carbonyl 
C=O.192 This interaction has been suggested to be worth up to 1.2 kcal mol-1 in folding enthalpy.192 
In the crystal structure of wild-type 15 (PDB 2QMT193), the α-Asn35 is positioned for this orbital 
overlap to occur, but not in β3-Asn35 from 16, presumably because the β3-residue regiochemistry 
does not allow the side-chain to adopt the necessary orientation (Figure 40).  
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Figure 40. Comparison of crystal structures depicting the side-chain orientation of Asn35 
with α- (left, 15), β3- (middle, 16), and β2- (right, 19) backbones. Putative n→π* interactions are observed for the α- 
and β2- residues, but not the β3 residue. 
In the crystal structure of 19 (PDB 5HG2), two of four chains in the asymmetric unit showed clear 
evidence for a side-chain to backbone contact at β2-Asn35 analogous to that observed for the α-
residue. Although this interaction is observed in the crystal structure, β3→ β2Asn35 substituion was 
found to be enthalpically equivalent to β3→ β2-Ala24 substitution where such an interaction is not 
possible. This implies that while β2-residues may be better at maintaining native n→π* interactions 
compared to β3-residues, these contacts do not play a significant role in folded stability in this 
particular system. 
 Replacement of all four β3-residues in 16 with β2-residues (20) resulted in a significant 
destabilization in folded stability of ~1.6 kcal mol-1, almost entirely enthalpic in origin. 
Approximately a third (0.6 kcal mol-1) of this destabilization can be explained by β3→ β2-Ala24 
(~0.1 kcal mol-1) and  β3→ β2-Asn35 (~0.5 kcal mol-1) substitutions. The remainder of the 
destabilization (~1.0 kcal mol-1) likely comes from disruption of important tertiary contacts 
between the helix and sheet of the protein. Within the wild-type 15 protein fold, Lys31 has both a 
van der Waals interaction with Trp48 and forms a salt bridge with Glu27 (Figure 41A). Both of these 
interactions are maintained with β3-Lys31 (Figure 41B), but lost with β2-Lys31. Although 
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crystallization attempts of 20 were unsuccessful, modeling the orientation of the β2 side-chain 
supports this conclusion (Figure 41C). 
 
 
Figure 41.  Crystal structures depicting important non-covalent interactions in GB1: a Van der Waals interaction 
between Lys31 and Trp48, and a salt bridge between Lys31and Glu27 in protein 15 (A, PDB 2QMT) and variant 16 (B, 
PDB 4KGR). C) Model of sidechain orientation for a β2 residue built from the crystal structure of 16. 
 
Further support for the putative role of the Lys31 side chain is found by comparing the 
stability of a bacterially expressed wild-type version of GB1 (WT) with its K31A mutant. Protein 
WT only differs from protein 15 by the first two residues MQ (WT) vs. DT (15). Loss of the Lys 
side-chain in mutant K31A results in a destabilization of ~0.9 kcal mol-1, accounting for the 
remaining energy difference between 15  and 20.  
From a design standpoint, the above results suggest that β3- and β2-residues are comparable 
in terms of fundamental folding propensity as components of heterogeneous-backbone α/β-peptide 
helices. Selection of the optimal regioisomer is context dependent and must take into account side-
chain contacts important to folding and/or function. While the above examples show how β3→β2 
substitution can be detrimental, it stands to reason that an identical shift in side-chain placement 
could be beneficial in other systems. Thus, while the commercial availability of protected β3 amino 
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acid building blocks make them a good choice for backbone modification, the more synthetically 
challenging β2 analogues are likely to be valuable in some situations. 
3.2 CALPHA-METHYLATED RESIDUES 
As discussed in Section 3.1, restraining the conformational freedom of the backbone can improve 
the folded stability of proteins. This was observed in comparison of protein 16 and 15, which differ 
in β3→ βcyclic substitution. The disadvantage of this design approach is the loss of a side-chain 
which can play a key role in tertiary interaction essential to folding (vide supra). Like βcyclic 
residues, methylation of the alpha-carbon is known to conformationaly constrain the dihedral 
angles of amino acids and promote helix formation.134  
Aminoisobutyric acid (Aib) is the Cα-methylated analogue of Ala and the simplest of this 
class of amino acids. Since it is achiral, Aib has the ability to form both left- and right-handed 
helices. When placed in the context of chiral amino acids, it will promote the helix handedness 
dictacted by the surrounding residues (i.e. a right-handed helix with L-residues).194 Aib has also 
been found to increase folded stability in both small peptides195 and protein contexts.136 In vitro 
proteolytic degradation studies incorporating Aib also indicated that it imparts a greater degree of 
protection than β3-residues.120 Protein 21 was synthesized to determine whether Aib or βcyclic 
residues are superior for stabilizing a helical fold– strategies which both have constrained 
conformational space and loss of the side-chain. Protein 21 is a variant of 16 where the outer β-
residues are replaced with Aib.  
 A crystal structure of 21 was solved to 2.15 Å resolution and revealed successful 
incorporation of the Aib residues into the mixed α/β-helical fold (Figure 42).  
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Figure 42. Crystal structure demonstrating successful incorporation of Aib residues into the tertiary fold 
comparing native sequence 15  (A, PDB 2QMT) with 21 (B, PDB 4HI1; Aib residues in green) . 
 
The free energy of folding was stabilized by 1.7 kcal mol-1 over protein 16 (2β3→2Aib) and 1.3 
kcal mol-1 over protein 17 (2βcyclic→2Aib, Figure 43). Surprisingly, this folded stability arose from 
enthalpic (∆∆Hfold° = - 4.3 kcal mol-1 vs. 17 and -4.4 kcal mol-1 vs. 16) contributions which were 
partially offset by entropic destabilization (-T∆∆Sfold° = 3.0 kcal mol-1 vs. 17 and 2.7 kcal mol-1 
vs. 16). The enthalpic stabilization likely arises from a more native-like fold of the helix. It was 
hypothesized that the entropic destabilization was due to the ability of Aib to adopt left-handed 
dihedral angles in the unfolded state. To test this hypothesis a variant using the chiral Cα-
methylated residue, Cα-methyl-Val, in place of Aib (protein 22) was synthesized. 
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3.2.1 The Impact of Chirality 
Cα-methyl-Val, a regioisomer of the βcyclic residue ACPC, highly prefers right-handed helices over 
left-handed ones.144 It is therefore an intermediate backbone rigidifier between the less constrained 
Aib and the highly constrained ACPC. All three residues contain aliphatic side-chains and exhibit 
thermodynamic trends with overall folded stability decreasing with backbone rigidity: ACPC<Cα-
Me-Val<Aib. As backbone rigidity increases enthalpic stabilization decreases while entropic 
stabilization increases (Figure 43).  
 
 
Figure 43. Effect of β3 to more rigid backbone substitutions on the thermodynamics of folding:
 21 (β3→ Aib), 22 (β3→Cα-Me-Val ), and 17 (β3→ βcyclic). All proteins are referenced to the thermodynamic values 
for protein 16 (all four sites β3). 
 
Similar to protein 21, protein 22 is more stable than both 16 (∆∆Gfold° = -1.0 kcal mol-1) and 17 
(∆∆Gfold° = -0.6 kcal mol-1). As predicted, protein 22 has less entropic destabilization (-T∆∆Sfold° 
= -2.1 kcal kcal mol-1 vs. 21) to the fold than protein 21, which is attributed to the difference in 
chirality between Aib and Cα-methyl-Val. This improvement in entropy of folding is not coupled 
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with the same degree of enthalpic stabilization found with Aib leading to an overall less stable free 
energy of folding. The differences in enthalpy between and Aib and Cα-methyl-Val are unclear, 
but may be related to the increased sensitivity of protein 22 to chemical denaturation. 
Crystallization trials with protein 22 failed to produce diffraction-quality crystals, so structural 
detail beyond the CD measurements is unavailable. 
Encouraged by the success of  proteins 21 and 22 we synthesized protein 23, a variant of 
21 retaining Aib at positions 24 and 35 with Cα-methyl-Lys replacing the β3-residues at positions 
28 and 31. Due to the synthetic difficulty of incorporating so many sterically hindered amino acids, 
insufficient material was obtained for full thermodynamic and structural analysis. However, a 
simple CD thermal melt (Figure 44A) revealed the highest melting temperature (Tm) of any GB1 
variant (79.6 ± 0.5 °C): 1.7 °C greater than protein 21 and only 2.5°C less than wild-type protein 
15 (Table 6, Section 3.4.4).  
 
 
Figure 44. Stability of protein 23. 
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A) CD thermal melt of protein 23 at 8 ± 3 µM in 20 mM phosphate buffer pH 7. B) Model of putative steric 
clash in protein 23 between Lys31 and Trp43 derived from a crystal structure of wild-type GB1 15.  
 
The lower Tm  than wild-type 15 may arise from a steric clash between the alpha-methyl carbon of 
Lys31 and Trp43 (Figure 44B). Another hypothesis is that the increased backbone rigidity decreased 
the folded stability in a manner similar to the trend seen between Aib, Cα-Me-Val, and ACPC. 
These results highlight the ability of Cα-methylation as an important design tool to stabilize helices 
in a tertiary fold with  heterogeneous backbones. 
3.3 CONCLUSIONS AND FUTURE DIRECTIONS 
The results of the experiments described in this chapter provide insight into general design rules 
for constructing helices with a heterogeneous backbone in tertiary folds. It is clear that effects of 
substitutions of unnatural residues for native ones are context dependent. While β3- and β2-residues 
are largely thermodynamically equivalent, side-chain display is important in cases where there are 
intramolecular contacts. Positions where side-chain interactions are unimportant allow for the use 
of conformationaly constrained βcyclic or Cα-methylated residues. Within this class, the order of 
stabilization was found to be Aib > Cα-methyl-Val > ACPC. Cα-methylated residues were better 
at stabilizing helices over β-residues in all cases, but synthetic difficulties may limit their utility 
somewhat.  
It is intriguing to note that neither protein 16 (4 β3- residues) nor protein 23 (4 Cα-
methylated residues) resulted in higher thermal stability than native α-residues. This may imply 
that α-residues exist at a thermodynamic sweet spot between flexibility and rigidity to impart 
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maximal thermodynamic stability to natural proteins. While the GB1 system is only a single test 
case for this hypothesis it suggests a possible explanation for the evolutionary selection of α-amino 
acids over other backbones as the building blocks of life. This is an especially interesting 
consideration in relation to the diversity of non-canonical amino acids isolated from meteorites 
and experiments mimicking pre-biotic environments.196-197 
Recent advances modifying β-sheets with γ-188 or dialkylated-187 residues have resulted in 
near native-like stability. Combining these advances with those discussed above for helix 
modification suggest that it should be possible to design tertiary folds with a significant degree of 
backbone heterogeneity that exhibit native-like structure and thermodynamic stability. Targets that 
are currently being pursued to understand the effect of modifying helices in other contexts include 
zinc fingers198 and disulfide-rich peptides along with large proteins such as ubiquitin. Furthering 
our understanding of these design principles will lead to peptide therapeutics with enhanced 
proteolytic stability. 
3.4 EXPERIMENTAL 
3.4.1 General Information 
Solvents and all other reagents were purchased from Aldrich, Baker, EMD, or Fisher and used 
without further purification. HOBt was purchased from Anaspec Inc. HCTU, NovaPEG Rink 
Amide Resin, and Fmoc-protected α-amino acids were purchased from Novabiochem. Fmoc-
protected β-amino acids were purchased from Aapptec. Fmoc-β2-Ala-OH and Fmoc-β2-
Lys(Boc)2-OH were synthesized according to published routes.199 Fmoc-Cα-Me-Val-OH was 
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purchased from Aspira. Fmoc-Cα-Me-Lys(Boc)-OH was purchased from W & J Pharma Chem 
Inc. Fmoc-β2-Asn(Dcmp)-OH was synthesized by a route developed by Dr. Zach E. Reinert and 
Brian D. Griffith.138 
3.4.2 Protein Synthesis and Expression 
Proteins 15, 16, and 17 were synthesized as described previously.131, 142 Proteins 18-20 were 
synthesized at room temperature (Method 1), while 21-23 were prepared by a combination of room 
temperature and microwave-assisted reactions (Method 2). All syntheses were carried out on a 70 
µmol scale using NovaPEG Rink Amide resin.  
Method 1. Room temperature reactions were performed on a PTI Tribute automated 
synthesizer. In a standard coupling reaction, 2.5 mL of a solution composed of 0.2 M HCTU, 0.4 
M N-methylmorpholine in DMF was added to 7 equivalents of Fmoc-amino acid relative to resin. 
After a 2 minute pre-activation, the solution was added to the resin and vortexed for 45 minutes. 
Deprotections were performed by two treatments with 3 mL of 20% v/v 4-methylpiperidine in 
DMF for 4 minutes each. The resin was washed four times with 3 mL of DMF after each coupling 
and deprotection step. After the final Fmoc deprotection, the resin was rinsed three times with 3 
mL each DMF, DCM, and MeOH. The resin was dried in a vacuum desiccator for 20 minutes prior 
to TFA cleavage.  
Method 2. Microwave reactions were performed using a CEM Microwave-Assisted 
Reaction System (MARS). Coupling cycles consisted of a 1.5 minute ramp to 90°C followed by a 
2 minute hold, while deprotection cycles consisted of a 1.5 minute ramp to 90°C followed by a 1 
minute hold.200 Coupling solutions included protected amino acid (7 equiv), HATU (6.9 equiv), 
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and DIEA (10.5 equiv) in DMF, and were preactivated for 2 minutes prior to addition to resin. 
Fmoc deprotections made use of 20% v/v 4-methylpiperidine in DMF. 
Unless otherwise indicated, synthesis was carried out by Method 1. Following are the 
modifications to the standard automated method made for specific proteins. For proteins 18-23, 
Glu56 was double-coupled, and pseudoproline dipeptides were used for residues Ala48Thr49 and 
Glu15Thr16. Pseudoproline dipeptides were coupled with PyAOP or HATU for 90 minutes at room 
temperature. For protein 21, Aib residues were coupled with PyAOP for 90 minutes and the Ala 
residues immediately following each were double-coupled with PyAOP for 90 minutes each. For 
protein 22, αMeVal residues were coupled with HATU for 90 minutes, and the resin was capped 
with DMF/DIEA/Ac2O (8/2/1, v/v/v) for 10 minutes prior to deprotection. The Ala residues 
following each were double-coupled in the microwave (Method 2), with capping. For protein 23, 
Aib35 was coupled with HATU for 90 minutes. Ala34 was double-coupled with HATU for 90 
minutes each, followed by capping. For residues 23-31, synthesis proceeded in the microwave 
(Method 2). Residues Phe30, Glu27 and Ala23 were double-coupled. Capping was done after 
αMeLys31, Phe30, αMeLys28, Glu27, and Ala23. 
All proteins were cleaved from the resin in a cocktail of TFA/H2O/EDT/TIS (92.5/3/3/1.5 
by volume) for approximately 3.5 hours on a rocker. Crude protein was precipitated from the TFA 
solution by addition of cold Et2O, and the mixture was centrifuged and decanted. The crude pellet 
was suspended in ~7 mL of 6M guanidinium, 0.025 M phosphate pH 7. The organic and aqueous 
layers of the resulting suspension were separated by centrifuge prior to purification. 
Proteins (WT and K31A) were expressed in E. coli by Dr. Zach E. Reinert following 
published protocols151 using plasmids graciously provided by Dr. Timothy F. Cunningham and Dr. 
Sunil K. Saxena (University of Pittsburgh). 
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3.4.3 Peptide Purification and Characterization 
All proteins were purified by preparative (300 Å pores, 10 µm beads) C18 reverse-phase HPLC 
using gradients composed of 0.1% TFA in water/acetonitrile. Protein identities were confirmed 
using mass spectrometry on a Voyager DE Pro MALDI-TOF instrument (Table 5).  
 
Table 5. Calculated and observed average masses of proteins 16-23, WT, and K31A. 
# 
[M+H]+ m/z (average) 
Calculated Observed 
16 6235.8 6232.8 
18 6235.8 6233.4 
19 6235.8 6234.8 
20 6235.8 6234.6 
17 6244.8 6241.0 
21 6191.7 6191.9 
22 6247.8 6247.5 
23 6191.7 6188.2 
K31A 6164.7 6164.7 
WT 6223.8 6223.0 
 
Following HPLC, proteins were further purified by anion-exchange chromatography on a MonoQ 
5/50GL column (GE Healthcare) using 0.02 M Tris pH 8 buffer eluted with increasing 
concentrations of NaCl. Following ion-exchange, protein 23 was further purified using semi-
preparative (300 Å pores, 5 µm beads) C18 reverse-phase HPLC using gradients as described 
above. Final purity of each protein was ≥95% by analytical RP-HPLC (Figure 45). 
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Figure 45.  Analytical reverse phase HPLC chromatograms of purified proteins 16-23, WT¸ and K31A.
 HPLC experiments were run on a C18 column (10 µm particle, 300 Å pore size) on gradients between water and 
acetonitrile with 0.1% TFA. 
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3.4.4 Circular Dichroism Measurements and Thermodynamics of Folding 
Circular dichroism measurements and data analysis were performed as described previously.131 
Briefly, thermal melts of proteins in aqueous phosphate buffered (20 mM, pH 7) with varying 
concentrations of guanidinium chloride (0-6 M) were collected at 2 °C increments (2 min. 
equilibration) from 2-98 °C at 220 nm and 2 nm bandwidth with 5 second integration times. 
Concentration for all proteins was 40 µM except for protein 23 which was 8 µM due to poor 
synthetic yield. All measurements were buffer subtracted and baseline corrected. Raw data was 
then fit (Figure 46) to a series of multivariate equations (Equations 1-4)131 to extract 
thermodynamic parameters using Mathematica (Wolfram).  
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Figure 46. Tandem CD thermal melt and chemical denaturation data at 220 nm for proteins 16-22, WT, and K31A. 
Raw data was fit (points) was fit (surface) to Equations 1-4 to extract thermodynamic parameters for protein folding. 
 
The free energy of protein folding (∆G) with respect to temperature (T) and a concentration of 
chemical denaturant (here guanidinium, denoted [Gdm] in M) can be described by Equation 1:  
 
Equation 1 
∆𝐺𝐺 = ∆𝐻𝐻°− 𝑇𝑇∆𝑆𝑆° + ∆𝐶𝐶𝑝𝑝 × (𝑇𝑇 − 𝑇𝑇0 + 𝑇𝑇 × 𝑙𝑙𝑙𝑙 �𝑇𝑇0𝑇𝑇 � − 𝑚𝑚 × [𝐺𝐺𝐺𝐺𝑚𝑚] 
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where ∆H° (kcal mol-1) and ∆S° (kcal mol-1 K-1) are the folding enthalpy and entropy at a reference 
temperature (T0, here T0 = 20 °C). ∆Cp (kcal mol-1 K-1) is the change in heat capacity and m (kcal 
mol-1 M-1) is the susceptibility to unfolding by a chemical denaturant, here [Gdm]. The observed 
ellipticity (θobs) is related to the free energy and temperature at a constant [Gdm] by Equation 2: 
 
where θn is the fully folded ellipticity and θu is the fully unfolded ellipticity. Based on literature 
precedent201 and the observed cooperativity of the melt data, it is was assumed that GB1 and its 
analogues followed a two-state folded/unfolded equilibrium. Folded and unfolded ellipticity 
values were assumed to vary linearly with T and [Gdm];190, 202 raw data was fit by allowing ∆H°, 
∆S°,  ∆Cp, m, and the six parameters (a-f) in Equations 3-4: 
 
 
 to vary until the best fit solution to the non-linear model composed of Equations 1-4 was found. 
Thermodynamic parameters calculated from the fits are given below in Table 6. 
 
 
Equation 2 
𝜃𝜃𝑜𝑜𝑜𝑜𝑜𝑜 = �𝜃𝜃𝑛𝑛 + 𝜃𝜃𝑢𝑢 × 𝑒𝑒�−∆𝐺𝐺°𝑅𝑅𝑅𝑅 ��
�1 + 𝑒𝑒�−∆𝐺𝐺°𝑅𝑅𝑅𝑅 ��  
Equation 3 
𝜃𝜃𝑢𝑢 = 𝑎𝑎 + 𝑏𝑏𝑇𝑇 + 𝑐𝑐[𝐺𝐺𝐺𝐺𝑚𝑚] 
Equation 4 
𝜃𝜃𝑛𝑛 = 𝐺𝐺 + 𝑒𝑒𝑇𝑇 + 𝑓𝑓[𝐺𝐺𝐺𝐺𝑚𝑚] 
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Table 6. Thermodynamic parameters for the unfolding of synthetic proteins 15-23 and expressed proteins WT and 
K31A.a 
Protein ΔH°  (kcal mol-1) 
TΔS°  
(kcal mol-1) 
ΔG°  
(kcal mol-1) 
ΔCp  
(kcal mol-1 K-1) 
m  
(kcal mol-1 M-1) 
Tm  
(°C)b 
15 22.0 ± 0.6 16.1 ± 0.3 5.9 ± 0.7 0.60 ± 0.02 1.80 ± 0.04 82.1 ± 0.1 
16 18.3 ± 0.4 15.2 ± 0.3 3.1 ± 0.5 0.53 ± 0.02 2.48 ± 0.05 61.6 ± 0.1 
17 18.4 ± 0.5 14.9 ± 0.3 3.5 ± 0.6 0.48 ± 0.02 2.00 ± 0.05 70.8 ± 0.2 
18 18.8 ± 0.6 15.8 ± 0.3 3.0 ± 0.7 0.45 ± 0.03 2.25 ± 0.07 64.0 ± 0.2 
19 18.7 ± 0.4 16.1 ± 0.3 2.6 ± 0.5 0.48 ± 0.02 2.36 ± 0.04 61.4 ± 0.4 
20 17.0 ± 0.3 15.5 ± 0.3 1.5 ± 0.4 0.48 ± 0.02 2.45 ± 0.04 47.7 ± 0.2 
21 22.7 ± 0.6 17.9 ± 0.5 4.8 ± 0.7 0.44 ± 0.02 1.57 ± 0.04 77.9 ± 0.1 
22 19.9 ± 0.4 15.8 ± 0.3 4.1 ± 0.5 0.46 ± 0.02 1.73 ± 0.04 76.2 ± 0.1 
23c - - - - - 79.6 ± 0.5 
WT 23.0 ± 0.5 17.9 ± 0.3 5.1 ± 0.6 0.57 ± 0.02 1.71 ± 0.04 78.5 ± 0.3 
K31A 22.7 ± 0.4 18.5 ± 0.3 4.2 ± 0.5 0.67 ± 0.02 1.77 ± 0.03 67.6 ± 0.1 
a Thermodynamic values are at 298 K and reported errors are from parameter uncertainties in the fit. b Midpoint of the 
CD thermal unfolding transition in the absence of chemical denaturant. c Protein 23 measured at 8 µM (0 M denaturant 
only) instead of 40 µM due to poor synthetic yield. 
3.4.5 Crystallography 
Crystals were grown using the hanging drop vapor diffusion method. Stock solutions (18 mg/mL 
for 18, 20 mg/mL for 19 and 21) were mixed (0.7 µL + 0.7 µL) with crystallization buffer (Table 
7) and allowed to equilibrate at room temperature over a well of that buffer.  
 
Table 7. Crystallization buffer formulations for proteins 18, 19, and 21. 
Protein Buffer 
18 200 mM NaOAc pH 4.6, 20% PEG 4000 
19 100 mM Na Cacodylate pH 6.5, 0.15 M Mg(OAc)2, 20% PEG 4000 
21 100 mM NaOAc pH 4.5, 0.2 M (NH4)2SO4, 20% PEG 4000 
 
Harvested crystals were cryoprotected with 30% v/v glycerol in the mother liquor then flash frozen 
in liquid nitrogen. X-ray diffraction data were collected using Cu/Kα radiation on a Rigaku/MSC 
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diffractometer (FR-E generator, VariMax optics) with a Saturn 944 CCD detector for 18 and 21 or 
a RAXIS HTC image plate detector for 19. Crystals were maintained at 100 K during diffraction 
experiments with an X-Stream 2000 low-temperature system.   
Raw diffraction data were processed with d*TREK. Structures were solved by molecular 
replacement with a published structure of the expressed wild-type GB1 (PDB 4QMT) as a search 
model. Model refinement was performed with Phenix,171 and manual real-space model building 
was accomplished using Coot.172 Final data collection and refinement statistics may be found in 
Table 8. Protein 19 exhibited signs of twinning as determined by Xtriage in Phenix, and the final 
structure was refined with a twin fraction of 0.27 and twin law of (H, -L, -K). 
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Table 8. X-ray data collection and refinement statistics for proteins 18, 19, and 21. 
 18     19    21 
Data Collection    
Unit cell dimensions 
(Å, °) 
a = 92.8, b = 22.4,  
c = 65.3 
α = γ = 90, β = 134.1 
 
a = b = 51.9, 
c = 96.4 
α = β = γ = 90 
a = 74.4, b = 73.4, 
c = 79.4 
α = γ = 90, 
β=99.3 
Space group C2 P41 C2 
Resolution (Å) 23.44-1.95 (2.02–1.95) 
51.95-1.80 
(1.86-1.80) 
41.15-2.15 
(2.23-2.15) 
Total observations 34,719 297,770 260,925 
Unique observations 7,188 22,477 22,880 
Redundancy 4.8 (3.2) 13.25 (13.18) 11.40 (3.04) 
Completeness (%) 97.8 (90.4) 95.0 (90.5) 99.2 (93.2) 
I/σ 18.5 (3.6) 25.3 (4.9) 15.9 (4.2) 
Rmerge (%) 6.9 (15.2) 6.6 (40.5) 13.7 (23.9) 
Refinement    
Resolution (Å) 23.44–1.95 51.95-1.80 41.15-2.15 
R (%) 19.9 19.9 21.71 
Rfree (%) 23.0 21.7 25.23 
Avg. B factor (Å2) 22.1 27.3 24.33 
RMSD    
Bonds (Å) 0.005 0.006 0.005 
Angles (°) 1.04 1.13 1.018 
Twinning    
Twin fraction n/a 0.27 n/a 
Twin Law n/a H, -K, -L n/a 
PDB ID 5HFY 5HG2 5HI1 
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4.0  DESIGN OF COILED-COIL BASED SUPRAMOLECULAR 
METALLOPOLYMERS 
A portion of this work has been previously published as: 
Tavenor, N. A.; Murnin, M. J.; Horne, W. S. "Supramolecular Metal-Coordination 
Polymers, Nets, and Frameworks from Synthetic Coiled-Coil Peptides." J. Am. 
Chem. Soc.  2017, 139, 2212-2215. 
 
Matthew J. Murnin synthesized peptides 33 and 34 and set-up crystal trays for both of these 
peptides. Synchrotron experiments were carried out by remote collection using the Southeast 
Regional Collaborative Access Team (SER-CAT) beamline 22ID at the Advanced Photon Source 
(APS), Argonne National Laboratory. A special thanks to Dr. William F. Furey for organizing the 
beamline usage. All EPR measurements were collected and analyzed by Matthew J. Lawless 
(Saxena Lab, University of Pittsburgh). 
 
Expanding upon the work described in Chapter 2, we endeavored to design coiled coil–based 
supramolecular materials based on a more facile synthetic approach. One of the disadvantages of 
the organic linkers employed in our prior systems was the necessity of a second round of 
purification after cross-linking. This increases the time and materials required and results in a 
lower final yield. Moreover, disassembly of these materials was only possible by unfolding the 
protein quaternary structure through thermal or chemical denaturation.  
 Motivated to overcome the above limitations, we envisioned an alternative way to promote 
supramolecular assembly through metal coordination as a means of orthogonal control over the 
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assembly to protein folding. This strategy has been used extensively in the supramolecular polymer 
and metal organic framework fields, which provided inspiration for this work.140, 203-204 
Incorporation of a metal chelating group into the coiled-coil peptide should allow for the formation 
of supramolecular materials by the simple addition of a metal ion at an appropriate stoichiometric 
ratio. This assembly process can then be easily tuned by the number of equivalents and identity of 
the metal (Figure 47).  
 
 
Figure 47. Cartoon representation of the chelation and subsequent supramolecular assembly of a dimeric 
coiled-coil peptide with a metal coordinating group. 
 
Control over the size and structure of the resulting material can be realized through judicious 
placement of the metal coordinating group and the oligomerization state of the coiled coil. 
4.1 CHOICE OF METAL BINDING SIDE CHAIN 
While several natural amino acid residues can chelate metals (His, Asp, Glu, Cys), we sought to 
apply an unnatural one that would be orthogonal to side-chain functional groups found among the 
canonical amino acids. The properties desired for a metal chelating group were: 1) a small number 
of coordination modes, 2) ability to tightly chelate a range of metal ions, and 3) easy attachment 
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to the peptide. Terpyridine (Tpy), a tridentate aromatic ligand that binds divalent transition metal 
ions with high affinity in either a bis- or mono- complex (Figure 48), was identified as an 
ideal candidate.  
 
 
Figure 48. Generic mono (A) and bis-Tpy (B) complexation
 where M2+ is a divalent transition metal ion.  
 
Tpy has long been used in supramolecular chemistry to form supramolecular 
polymers.205-207 Synthesis of derivatives is well-established,208 and 4'-carboxy-2,2':6',2''-
terpyridine (where R = COOH) is accessible in a single step allowing for easy attachment 
to a lysine residue on resin. We hypothesized that supramolecular polymerization of the 
Tpy-functionalized peptide ligands could be controlled by the stoichiometry of the divalent 
transition metal ion by favoring either the mono- or bis-Tpy complex (Figure 48) thereby 
promoting either disassembly or polymerization, respectively. Supramolecular assembly of 
the peptides was investigated with the transition metal ions Zn2+, Cu2+, Co2+, Ni2+, Cd2+, 
and Ru2+.  
Cu2+ proved uniquely well-suited among this series in promoting formation of highly 
ordered supramolecular architectures (see Section 4.2), albeit by a coordination mechanism 
different than the initial design. The utility of Cu2+ as an EPR spectroscopic probe for 
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complex systems also allowed for the characterization of solution phase assemblies formed 
from terpyridine-modified peptides (see Section 4.3). 
4.2 DESIGN OF CRYSTALLINE METALLOPEPTIDE ASSEMBLIES 
 
Figure 49. A) Sequences of peptides used for design inspiration111 and B) terpyridine-modified peptides 24-38.
 Lowercase letters denote heptad positions, and gray shaded residues occupy the hydrophobic core of the folded 
coiled-coil quaternary structure; these residues control oligomerization state of the expected favored assembly 
(dimer, trimer, or tetramer), which is indicated for each peptide as subscripts along with the type and number of Tpy 
residues. (C) Helical wheel diagram with a map of heptad positions looking down the axis of an α-helix. (D) 
structures of unnatural residue Z (magenta). (E) Schematic of  expected oligomerization state of each peptide with 
location of terpyridine side chains (magenta shading) in relation to the hydrophobic core (gray shading).  
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We began our efforts to generate ordered supramolecular lattices with the series of peptides 24-26 
(Figure 49). These peptides were intended to form dimeric, trimeric, and tetrameric quaternary 
structures, and their sequences were based on well-established design rules for α-helical coiled 
coils.56, 85, 98 Positions along each individual chain that make up a coiled-coil fold are denoted 
abcdefg; this lettering is based on the ~7 residue repeat of an α-helix (Figure 49C). Positions a and 
d in each heptad make up the buried interface between helices in the quaternary structure, and the 
identity of these residues is the primary determinant of oligomerization state. Residues at e and g 
sites often participate in inter-helix electrostatic contacts that help to stabilize the assembly. Heptad 
positions b, c, and f are solvent exposed and have little impact on folding.  
Peptide 24 bears Ile at a positions, Leu at d positions, and a single a-position Asn; all these 
features should work in concert to promote a dimeric coiled coil fold.56, 85, 98 The hydrophobic core 
of peptide 25 (Ile at both a and d) was intended to specify a trimeric assembly, while that of peptide 
26 (Leu at a, Ile at d) a tetrameric bundle.56, 85, 98 It was hypothesized that differences in the 
oligomerization state could predictably tune the morphology of the supramolecular assembly 
leading to linear polymers, hexagonal nets, or tetrameric nets from dimer (24), trimer (25), and 
tetramer (26) coiled coils, respectively (Figure 50). 
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Figure 50. Hypothesized supramolecular lattices formed by a dimer, trimer and tetramer. 
 
In the series 24-26, the Tpy functionality was attached to each peptide via a Lys side chain 
(residue Z) at a solvent-exposed f-position near the midpoint of the sequence. Based on the 
symmetry of the coiled-coil quaternary structure expected from each sequence (Figure 49E), we 
hypothesized the addition of divalent metal would lead to either linear supramolecular polymers 
(for 24), hexagonal nets (for 25), or tetragonal nets (for 26). Crystallization was attempted in the 
presence of a range of divalent transition metals (Co2+, Ni2+, Cu2+, and Zn2+) along with Mg2+ and 
Ca2+ as controls. Crystals were obtained, but only with Ca2+ and Mg2+. From this, we concluded 
the terpyridine side chain was likely not participating in the lattice formation and therefore did not 
pursue this series further for crystalline assembly.  
We hypothesized that one factor that might be hindering an ordered metal-directed 
assembly process in 24-26 was the flexibility of the side chain linking the terpyridine to the 
backbone. Therefore, we next probed the consequence of shortening this side chain by replacing 
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the Z residue with an analogue (X) derived from diaminobutanoic acid instead of Lys. Making this 
substitution in peptide 26 led to peptide 27 (Figure 51).  
 
 
Figure 51. Design of peptide 27.
 (A) Sequence of peptide 27 with the Tpy X side-chain highlighted in blue and hydrophobic core residues in gray. 
(B) Structure of the Tpy X residue and (C) desired peptide oligomerization state. 
 
Crystals of peptide 27 were successfully grown in the presence of a variety of divalent metals 
(Mg2+, Ca2+, Cu2+, or Zn2+). One of these crystals produced a strong diffraction pattern. The 
structure of this crystal was solved (data not shown) leading to two key observations: (1) the 
peptide had assembled to form a pentameric helix bundle instead of the expected tetramer and (2) 
the Tpy side chains were not involved in the formation of the lattice. With respect to the former 
point, we reasoned that extending the sequence by an additional heptad would lead to greater 
specificity for the desired tetrameric oligomerization state. 
Thus, we prepared peptide 28, a longer variant of 27 but with the same tetramer-promoting 
hydrophobic core composition (Ile at a positions, Leu at d positions). We performed crystallization 
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trials with 28 and a range of divalent transition metals (Co2+, Ni2+, Cu2+, and Zn2+). Metal:peptide 
stoichiometries were varied from 0.3-6 equivalents in the presence of bis-TRIS with added 
formate, PEG 4000, or no precipitating agent. These experiments yielded microcrystals as well as 
amorphous aggregates but no diffraction-quality crystals. The observation of assembly to form 
microcrystals under dilute aqueous conditions lacking any precipitating agent led us to hypothesize 
that the metal ions and Tpy side chains were playing a key role in lattice formation.  
 
 
Figure 52. Design of four heptad sequences with a single terpyridine. 
(A) Sequences of peptide 28-32 with the Tpy X side-chain highlighted in blue and hydrophobic core residues in 
gray. (B) Structures of the Tpy X and Z residues and (C) peptide oligomerization state. 
 
Peptides 29 and 30 were designed as dimeric and trimeric variants of 28, respectively 
(Figure 52). Both peptides contain the shorter X sidechain to promote a more ordered assembly 
than the 24-26 series. Variants of the tetramer (31) and dimer (32) were also synthesized with the 
longer Z sidechain to examine the effect of linker length. Although crystalline materials were not 
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generated from this peptide series, the dimers (29 and 32) and tetramers (28 and 31) were used to 
study the solution-phase assembly of well-ordered metallopolymers (see Section 4.3). 
The results obtained for peptide 28 were the most promising for crystallization among 
experiments carried out to that point, and we noted that the expected fold consisted of four Tpy 
groups per coiled coil (one in each chain of a C4 symmetric tetramer). An alternate way to achieve 
a coiled-coil assembly bearing four metal-chelating side chains would be to incorporate two Tpy 
in a dimer forming sequence. We considered that such a peptide might lead to a more ordered 
lattice and further hypothesized introducing the Tpy groups near the helix termini would minimize 
the number of favorable packing arrangements among dimers in the crystal. Based on the above 
reasoning, we prepared peptides 33 and 34 (Figure 53). 
 
 
Figure 53. Design of coiled coil dimers with two Tpy residues. 
(A) Sequence of peptides 33-34 with the Tpy X side-chain highlighted in blue and hydrophobic core residues in 
gray. (B) Structure of the Tpy X residue and (C) peptide oligomerization state with Tpy side chain display. 
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The design of peptide 33 was based on two primary considerations: (1) residues at a/d 
positions were selected to enforce a dimeric fold and (2) two Tpy residues were incorporated at 
solvent-exposed postitions—one near the N-terminus in the first heptad at position f and the other 
near the C-terminus in the fourth heptad at position e. The reasoning behind offsetting the heptad 
positions was to promote coordination in more than just a linear chain. Peptide 34 differs from 33 
only in having both Tpy residues at the f positions of the first and second heptad. This was done 
to promote a ribbon-like assembly. 
Although crystallization experiments of the peptides were attempted with an array of 
transition metal ions (Co2+, Ni2+, Cu2+, Zn2+, and Cd2+) known to form bis-terpyridine 
complexes,209-211 only Cu2+ produced diffraction-quality crystals. This result was surprising since 
Cu2+ has the lowest propensity among the series to form the desired Tpy-M2+-Tpy coordination 
motif preferring to form ternary complexes instead.212  
Initial crystallization experiments of peptide 33 and 34 utilized Cu2+ and Zn2+ and a range 
of precipitating agents with bis-TRIS buffer—guided by its prior use as a weak competitor for 
Zn2+ in the growth of crystalline protein arrays.76 These initial efforts yielded intergrown crystals. 
Optimization efforts focused on varying the buffer, additive, metal ion and precipitating agent. 
Crystals were only able to be grown in the presence of a weakly chelating buffer and Cu2+. These 
efforts finally yielded a diffraction quality single crystal of peptide 33 (crystal form a) in the 
presence of citrate (weak chelating buffer), CuCl2 (metal ion salt) and PEG 4000 (precipitating 
agent). The structure of this crystal was solved to 2.2 Å resolution (Figure 54, PDB ID 5U59). We 
also obtained small crystals of peptide 34 in the presence of Cu2+, but the best diffraction of these 
crystals was weak (processed to 5.4 Å) and we were unable to find a molecular replacement 
solution. 
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Figure 54. Structure of peptide 33 form a. 
A) Crystal structure of peptide 33 (form a, PDB ID 5U59) grown in the presence of citrate; B,C) Tpy-Cu2+-citrate 
coordination between peptides; and D) linear supramolecular polymer generated through the interface in panel B 
(Adapted with permission from Tavenor, N. A., et al. J. Amer. Chem. Soc. 2017, 139 (6), pp 2212–2215. Copyright 
2017 American Chemical Society).  
 
Supporting our central hypothesis, the noncovalent interactions that make up the crystal 
lattice consist entirely of (1) coiled-coil hydrophobic interfaces and (2) inter-chain contacts 
involving Tpy residues and Cu2+ ions. The asymmetric unit consists of a single α-helix, and the 
dimeric coiled-coil is created by a crystallographic 2-fold symmetry axis propagated through the 
lattice by the C2 spacegroup. The dimer quaternary structure (Figure 54A) is virtually identical to 
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that of a variant lacking the Tpy residues.111 The remaining two crystallographically independent 
contacts between chains involve proximal Tpy residues coordinated to Cu2+ (Figure 54B,C). 
However, neither showed the simultaneous coordination of Cu2+ by two Tpy side chains (Figure 
48B). Rather, a carboxylate from citrate in the crystallization buffer replaced one of the terpyridine 
moieties (Figure 54B,C) at both sites.  
Unique among the first row transition metals is the propensity of Cu2+ to form CuAB type 
complexes over the corresponding CuA2 or CuB2 complex.212  When bound to multi-dentate 
aromatic nitrogen ligands like terpyridine and its derivatives, there is a very strong propensity to 
bind an anionic oxygen ligand to form a ternary complex.212-213  This motif was observed in all 
solved crystal structures (vide infra). Such terpyridine-Cu2+-carboxylate complexes (Figure 55) 
are known and have been shown to be stable in aqueous solution.213-214  
 
 
Figure 55. Structure of a terpyridine-Cu2+-carboxylate complex with variable substituents. 
 
This terpyridine-Cu2+-carboxylate motif formed the basis for the supramolecular 
organization of the crystal lattice by a different mode at each Tpy site.  The site at Tpy7 forms a 
linear supramolecular polymer which propagates through the lattice (Figure 54D). This is held 
together by hydrogen bonds between the citrate molecules coordinated to the Tpy-Cu2+ complex 
(Figure 54B). The second site at Tpy27 supports the lattice through hydrophobic stacking of the 
Tpy aromatic groups; a motif which was found to be common in all structures (vide infra). This 
N
N
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interaction allows the crystal to form along another vector as predicted by the design strategy (vide 
supra). 
The above result led us to reason that more rigid carboxylate ligands than citrate may be 
able to bridge Cu2+-bound Tpy residues to generate a MOF-like assembly. To test this hypothesis, 
we refocused optimization efforts with an aim to obtain crystals of peptide 33 replacing citrate 
with a bis-carboxylate linker: cis- and trans-1,4-cyclohexanedicarboxylic acid, malonate, tartrate, 
tricine, or terephthalate. It had also been previously observed that the combination of bis-TRIS 
buffer and Cu2+ most readily produced crystals under a wide range of conditions. Combining this 
observation with the effort to replace citrate with an alternative carboxylate linker yielded a new 
crystal form (b) of peptide 33 from a bis-TRIS buffer containing terephthalate, and the structure 
of this crystal was solved to 3.2 Å resolution (Figure 56, PDB ID 5U5A). 
111 
 
Figure 56. Structure of peptide 33 form b.
 A) Crystal structure of peptide 33 (form b, PDB ID 5U5A) grown in the presence of terephthalate; B,C) 
Tpy-Cu2+-Glu coordination between peptides; and D) linear polymer generated by the coordination in panel C 
(Adapted with permission from Tavenor, N. A., et al. J. Amer. Chem. Soc. 2017, 139 (6), pp 2212–2215. Copyright 
2017 American Chemical Society). 
 
Like crystal form a, the asymmetric unit of crystal form b consists of a single α-helix, and 
the coiled-coil dimer is created by a crystallographic symmetry axis. The peptide folds are virtually 
identical in the two crystals, and the contacts that make up the lattice are composed entirely of 
coiled-coil hydrophobic interfaces and Cu2+-bound Tpy residues in both. Despite these similarities, 
the lattices differ fundamentally in the packing between coiled coil units. In crystal form b, every 
carboxylate participating in a Tpy-Cu2+-carboxylate motif comes from a Glu side chain on a 
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neighboring peptide (Figure 56B,C). Two types of such interfaces exist in the lattice: one between 
two neighboring coiled coils (Figure 56B) and the other linking four chains in two coiled coils 
(Figure 56C). These Tpy-Cu2+-Glu complexes generate a highly symmetrical lattice in the P6122 
spacegroup. From its absence in the lattice, we hypothesize the terephthalate may facilitate 
crystallization by acting as a stabilizer and leaving group for bound Cu2+ at the edge of the growing 
crystal since it played a key role in obtaining diffraction-quality single crystals.  
Embedded in the lattice is an extended supramolecular polymer consisting of alternating 
peptide-peptide and metal-coordination interfaces (Figure 56D). This is generated through the 
complexes formed by two Tpy7-Cu2+-Glu14' creating a strong double cross-linked brace between 
coiled coils. This prevents rotation around the linker stabilizing the supramolecular polymer to 
form a lattice in contrast to the supramolecular polymers described in Chapter 2 which are singly 
cross-linked. Coordination site two (Tpy27-Cu2+-Glu22") connects the chain to a different 
symmetry-related copy than the first site generating the six-fold screw axis (Figure 57A). 
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Figure 57. Lattice organization of peptide 33 crystal form b. 
A) Six-fold screw axis (unit cell shown as gray box) of the asymmetric unit (magenta) generated by coordination 
site two (Tpy27-Cu2+-Glu22") and B) path through coordination bonds from one peptide chain back to its 
complementary partner (light blue). Cu2+ ions are display as brown spheres. 
 
This leads to an interesting feature of crystal form b—every coiled coil is connected to every other 
chain through Tpy-Cu2+-Glu coordination. This feature can be visualized by mapping a path 
through coordination bonds from one peptide chain back to its complementary partner in the dimer 
(Figure 57B). Since the asymmetric unit is a single chain, this implies the infinite connectivity of 
the framework analogous to MOFs derived from small molecule ligands.  
The serendipitous result that Tpy-Cu2+-Glu coordination could lead to the formation of 
highly ordered supramolecular assemblies of metallopeptides led to the design of peptides 35-38. 
Based on the observations for dimeric coiled-coil peptide 33, we sought to construct related 
assemblies from trimer and tetramer forming sequences using this Tpy-Cu2+-Glu coordination 
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motif. The four peptides 35-38 were created to form lattices using coiled coils with three-fold (35 
and 36) or four-fold (37 and 38) symmetry (Figure 58).  
 
 
Figure 58. Design of tetrameric and trimeric coiled coils with engineered Tpy-Cu2+-Glu interactions. 
A) Sequence of peptides 35-38 with the Tpy X side-chain highlighted in blue and hydrophobic core residues in gray; 
residues designed to chelate one another are in orange and purple. B) Structure of the Tpy X residue and C) peptide 
oligomerization state with Tpy side chain display. 
 
All four peptides formed crystals, and three of these four resulted in structures that were solvable 
by molecular replacement. However, only two (35 and 37) were of high enough resolution for full 
refinement and structural elucidation. 
For peptide 35, the design hypothesis was that at b/c positions Tpy and Glu would interact 
to form a trigonal crystal lattice with trimers parallel and offset to one another. Thus, we 
incorporated Tpy at residue 3 (b position) and residue 25 (c position); additional Glu residues were 
introduced at positions 10 (b position) and 18 (c position) in an effort to provide the complementary 
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coordinating group to complete each Tpy-Cu2+-Glu motif. Summarizing the design of peptide 35, 
the intended coordination mode was: Tpy3(b)→Glu18'(c) and Tpy25(c)→Glu10(b)' (heptad register 
of the residue in parentheses). Although the predominant interaction observed in the crystal, 
Tpy25(c)→Glu22(g)' differed from this design, it was nevertheless able to give rise to an ordered 
lattice. 
Crystals of trimeric coiled-coil peptide 35 were grown in the presence of bis-Tris and Cu2+ 
and the structure was solved to 2.4 Å resolution (Figure 59, PDB ID 5U5B).  
 
 
Figure 59. Structure of peptide 35. 
A) Crystal structure of peptide 35 (PDB ID 5U5B); B,C) Tpy-Cu2+-Glu coordination between peptides; and D) 3-
dimensional framework generated by this coordination (Adapted with permission from Tavenor, N. A., et al. J. 
Amer. Chem. Soc. 2017, 139 (6), pp 2212–2215. Copyright 2017 American Chemical Society). 
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The asymmetric unit consists of the expected trimeric fold (Figure 59A), and the coiled coils are 
held together in the lattice entirely by Tpy side chains. Among four crystallographically 
independent interfaces, the same Tpy-Cu2+-Glu coordination motif seen for peptide 33 form b 
(Figure 59C,B) is seen at most sites, alongside hydrophobic stacking of the aromatic systems 
minus Glu coordination (Figure 59B). These contacts generate an extended framework (Figure 
59D) consisting of four-fold symmetric helical fibers (oriented along the 41 screw-axis).  
Peptide 36 also contains a trimer-forming hydrophobic core and was designed to have 
alternating Tpy/Glu residues along the f-positions in order to facilitate a more open lattice than 
peptide 35. It was expected that adjacent coiled coils would coordinate either 1) anti-parallel to 
one another to create sheets that would interface flush to one antother or 2) parallel, but offset, to 
create a Tpy/Glu zipper lattice where adjacent sheets would be coordinated together. We grew 
crystals of peptide 36, however the best crystal (spots visible at ~3.4 Å resolution) degraded too 
quickly under synchrotron X-ray radiation to obtain a complete dataset (processable to ~6.5 Å 
resolution). Optimization has yet to yield a satisfactory crystal. If the design hypothesis is correct, 
it may be that the more open framework of the lattice is less stable and more easily perturbed by 
mechanical handling or environmental factors. 
Peptide 37 was intended to form sheets through Tpy14(f)→Glu7(f) coordination with the 
coiled-coil tetramers anti-parallel and offset relative to one another. To decrease the likelihood of 
charge repulsion hindering self-assembly, the two other f position Lys residues in the starting 
sequence were replaced with Gln.  
Crystals of peptide 37 were successfully grown in the presence of bis-Tris and Cu2+ with 
citrate and 1,6-hexanediol as additives, and the structure was solved to 2.1 Å resolution (Figure 
60, PDB ID 5U5C).  
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Figure 60. Structure of peptide 37. 
A) Crystal structure of peptide 37 (PDB ID 5U5C); B,C) Tpy-Cu2+-Glu coordination between peptides; D) 2-
dimensional net generated by the lattice (Adapted with permission from Tavenor, N. A., et al. J. Amer. Chem. Soc. 
2017, 139 (6), pp 2212–2215. Copyright 2017 American Chemical Society). 
 
The asymmetric unit consists of six chains: four in a parallel coiled-coil tetramer, and the 
other two creating a second tetrameric assembly through a 2-fold symmetry axis. The tetramer fold 
is virtually identical to that of the variant without Tpy residues,215 indicating the unnatural side 
chains direct assembly behavior independently of peptide folding. The single Tpy residue in each 
chain participates in a Tpy-Cu2+-Glu interface with a neighboring tetramer in the lattice. The 
expected Tpy14(f)→Glu7(f) interaction was observed in two of six chains in the asymmetric unit; 
in the other four chains, Tpy14(f) coordinated to Glu1(g).  
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Although, the exact interacting residues differed from the initial design, the lattice did 
contain the expected overall assembly, consisting of coiled-coil tetramers antiparallel to closest 
neighbors and an infinitely propagating 2-dimensional tetragonal net (Figure 60D). These nets 
stack in layers via contacts between complementary (all N to C) peptide termini to form the third 
dimension of the lattice. Layer interfaces alternate pegs and holes facilitating a highly ordered 
lattice (Figure 61A). 
 
 
Figure 61. Lattice organization of peptide 37. 
A) Knobs into holes layering of peptide 37 with the interface stabilized by 1,6-hexanediol (green, inset). B) 
Patterning of the tetramers within each layer; the six crystallographically unique peptide chains are colored 
differently. Cu2+ atoms are displayed as brown spheres. 
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The interface between layers is stabilized by an ordered 1,6-hexanediol molecule (Figure 61A-
inset). Within each layer, the two crystallographically unique tetramers pack in an AAB pattern of 
rows (Figure 61B). This patterning generates two different types of channels passing through the 
lattice. The alignment of the Cu2+ centers through these channels could be useful for studying 
charge transfer through the material. Combined, these interactions propagate the six chains of the 
asymmetric unit into the P21212 lattice. 
In contrast to peptide 37,  which was designed to form layer interfaces with alternating 
pegs and holes, peptide 38 was designed to form 2-dimensional nets with flush interfaces. This 
was to be achieved through coordination of Tpy14→Glu21 of adjacent coiled coils to form a 
tetragonal lattice.  It was anticipated that this design would be more compact than peptide 37 and 
contain a lower solvent content.   
Although the crystal structure of tetrameric peptide 38 was unable to be fully refined, a 
molecular replacement solution (in space group P4222) provided some insight (Figure 62). As 
intended, 2-dimensional sheets stack to form the third dimension of the crystal lattice by packing 
identical termini against one another (N to N and C to C, Figure 62B).  
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Figure 62. Crystal structure of peptide 38 with orange spheres representing the Cα of the Tpy residue: 
A) view down the axis of the tetramer and B) 2D parallel sheets which stack to form the third dimension of the 
crystal; N-termini are colored in dark blue while C-termini are colored in red. 
 
Due to the low resolution of the diffraction (3.65 Å resolution), placement and coordination 
environment of the Tpy residues were too ambiguous to determine, and full structural refinement 
was not possible. Optimization of the crystallization conditions may yet yield a complete picture 
of this peptide's assembly architecture. It is likely that the flush layers of the crystal packing can 
more easily slide past one another giving rise to more disorder and the lower diffraction resolution. 
It may be possible to stabilize the lattice with an appropriate additive similar to the role 1,6-
hexanediol plays at the interface between nets of peptide 37; efforts along this vein are ongoing. 
Although crystals were successfully grown with peptides 33-38, only a handful of these 
were able to be fully refined to elucidate the structure. CD scans and thermal melts of peptides 
with fully refined structures indicate that peptides were fully folded under the conditions of the 
crystallization experiment (Figure 63). 
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Figure 63. CD scans (left) and melts (right) of peptides 33, 35, and 37 
at 25 µM in aqueous HEPES buffer (10 mM, pH 7) with 100 µM CuCl2. (Adapted with permission from Tavenor, 
N. A., et al. J. Amer. Chem. Soc. 2017, 139 (6), pp 2212–2215. Copyright 2017 American Chemical Society). 
 
Collectively, these results provide a glimpse into a new class of highly ordered 
supramolecular architectures that can be generated through the combination of coiled-coil 
interfaces and terpyridine-Cu2+ coordination. Crystallization experiments of previous peptide 
designs were used to inform later designs finally leading to a series of highly-ordered crystalline 
assemblies. Iterating this design process further should enable the design of highly ordered 
metallopeptides with predictable supramolecular architectures. Due to the difficulty of 
crystallizing many of the sequences; solution-phase studies of a subset of the peptides was also 
undertaken in an attempt to probe the assembly of ordered soluble architectures. 
4.3 SOLUTION-PHASE ASSEMBLY 
Solution-phase experiments were undertaken to understand the role of Cu2+ in controlling the 
assembly of the coiled-coil based supramolecular metallopolymers. The peptide series 28-32 (vide 
supra, Figure 52) was designed with this goal in mind. These peptides all contain a single Tpy 
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residue at position 14 (helix register f in the second heptad), a solvent-exposed site with a 
projection approximately normal to the coiled-coil axis. The peptides differ only in their 
hydrophobic cores giving rise to different oligomerization states (dimer, trimer or tetramer) and 
the length of the Tpy side-chain (X < Z). Although not observed in the crystalline assemblies 
(Section 4.2), it was hypothesized that the bis-Tpy complex may still form in solution in the 
presence of 0.5 equiv of Cu2+.210 Experiments were designed to determine how peptide sequence 
and Cu2+ stoichiometry affect the location of metal junctions within the assemblies and the 
preferred assembly modes of the peptides.  
These structural properties were probed by a combination of biophysical techniques, 
similar to the approach used to characterize the supramolecular polymers in Chapter 2. As the 
simplest system, characterization initially focused on the dimeric peptides 29 (with shorter Z side-
chain) and 32 (with longer X side-chain) and then expanded to include the more complex 
oligomerization states (peptides 28, 30, and 31). The effect of Cu2+ on assembly properties was 
studied using both sub-stoichiometric and excess amounts (ratio of 0.5 and 1.5 equiv of Cu2+ 
relative to peptide, respectively). These ratios were determined based on the change in 
coordination environment observed in an EPR titration of Cu2+ with a side-chain analogue (ligand 
40, vide infra Figure 66). 
Experimental evidence (vide infra) obtained for the supramolecular peptide assemblies 
support the hypothesis that a mixture of assembly modes exists in solution. A simplified model of 
this equilibrium for the dimer peptide is presented below (Figure 64). 
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Figure 64. Schematic of dimeric peptide assembly with 0.5 or 1.5 equivalents of Cu2+. 
Cα atoms of important residues are highlighted as colored spheres: Tpy14 (yellow), Glu (orange), and Glu15 (purple). 
 
This model assumes that the Cu2+ coordination is either in the form of Tpy-Cu2+-Glu or Tpy-Cu2+-
(H2O)n based on the EPR data (vide infra, Section 4.3.1). The assemblies shown in Figure 64 do 
not represent the full array of possibilities since there are four different Glu residues that can 
coordinate with Tpy-Cu2+ to form a ternary complex; a limitation of the current peptide designs. 
At 1.5 equivalents Cu2+, it is assumed that every Tpy site is occupied based on the strength of the 
binding association between Tpy and Cu2+.210  
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A combination of analytical methods was used to determine which assembly mode is likely 
to predominate. Dynamic light scattering was used to measure relative particle sizes. CD scans 
and melts probe the helicity and thermal stability of the coiled coil quaternary structure. 
Continuous wave (CW) and 2D pulsed Hyperfine Sub-level CORrElation (HYSCORE)  EPR 
measurements probed the coordination environment around the Cu2+ ions. Finally, DEER 
spectroscopy was used to measure distances between Cu2+ centers in supramolecular systems and 
determine the relative local concentration of Cu2+ ions. 
4.3.1 Cu2+ Coordination Environment Determined by EPR 
We considered four possible coordination modes for the interaction of Cu2+ with peptides 
containing both Tpy and Glu residues (Figure 65).  
 
 
Figure 65. Possible coordination states of the Tpy-Cu2+ complex: 
A) bis-Tpy-Cu2+, B) hydrated mono-Tpy-Cu2+, C) Tpy-Cu2+-Glu', and D) Tpy-Cu2+-Glu' with a distal non-chelating 
Tpy' (primes indicate another peptide chain). 
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Consistent with the crystalline assemblies, EPR titration of ligand 40 with Cu2+ and HYSCORE 
measurements suggests the bis-Tpy complex is not populated in the peptides (vide infra). This 
leaves the mono-complex where the empty ligand sites are occupied by water or Glu—the Cu2+-
bound Tpy may π-stack with other Tpy residues, as seen in the crystalline assemblies. Note that 
the immediate coordination environment of states C and D are identical; D merely contains a 
nearby Tpy residue which hydrophobically stacks with the one within the immediate coordination 
environment. A combination of continuous wave and pulsed EPR techniques were used to 
distinguish between the four possiblities. 
Continuous wave (CW) EPR (Figure 66) indicates a shift in Tpy-Cu2+ binding 
environments in high vs. low equivalent samples. 
 
 
Figure 66. Coordination of Cu2+ with ligand 40. 
A) CW-EPR titration of ligand 40 (300 µM) with CuCl2 in aqueous NEM buffer (40 mM pH 7.4); arrows indicate 
the shift in the spectrum upon reaching 1.5 equiv Cu2+. B) Proposed coordination complex of Cu2+ and ligand 40 
from 0.33-1.0 equiv Cu2+. 
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The hyperfine and g-tensor parameters of the 80 K Cu2+ CW spectrum (extracted via simulation) 
are very sensitive to the immediate coordination environment. The spectra obtained for all samples 
of complex 40 are consistent with the lineshape of a Type II copper center (square planar, 4 
equatorial ligands, 2 axial).216 In type II Cu2+ centers, the unpaired electron only interacts with the 
planar 𝐺𝐺𝑥𝑥2−𝑦𝑦2 orbital and contributions from the axial ligands are negligible.216 From 0.33-1.0 
equiv of Cu2+ with ligand 40, the hyperfine and g-tensors of the EPR spectrum are consistent with 
a mono-coordinated terpyridine complex with 1 equatorial oxygen.217 When 1.5 equiv of Cu2+ is 
reached, a new spectral component appears and the g⊥ peak shifts downfield along with the 
presence of a new peak in the g|| region. These features both imply a decrease in N coordination.218 
The broadening of the g⊥ peak is indicative of a superposition of the two components' spectra; 
indicating the presence of two Cu2+ coordination rather than just one.  
This second coordination state is consistent with Cu2+ coordinated to four equatorial 
oxygens (water). The presence of free Cu2+ was at first ruled out due to the presence of the NEM 
buffer which is well-known to precipitate out unbound Cu2+ ions as [Cu(OH)2]n rendering them 
EPR inactive.219 However, spectral simulations of a two component system containing the Tpy-
Cu2+ monocomplex and free CuCl2 in water are able to reproduce the spectra seen at 1.5 equiv 
Cu2+ (Figure 67).  
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Figure 67. Spectrum of free Cu2+ compared to experimental spectrum of ligand 40 with 1.5 equivalents of Cu2+. 
4.3.1.1  CW EPR of Peptides 
The spectra obtained for samples of all four peptides (28, 29, 31, and 32) with 0.5 and 1.5 
equivalent of Cu2+ are consistent with the lineshape of a Type II copper center (4 equatorial 
ligands, 2 axial).216 The hyperfine and g-tensor values for the Cu2+ spectrum of the 0.5 equivalents 
sample for all peptides are consistent with 3 nitrogens and 1 oxygen equatorially bound (Figure 
68).216  
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Figure 68. Proximal coordination of Cu2+ in Tpy-modified peptides. 
A) CW-EPR spectra of peptides 28, 29, 31, and 32 with either 0.5 (red) or 1.5 (blue) equiv of Cu2+. B) 
Proximal coordination states supported by the data. 
 
This is consistent with Tpy-Cu2+-Glu or Tpy-Cu2+-(H2O)n coordination;217 both of which would 
be expected to result in similar spectra. In all samples, the same hyperfine and g-tensor values also 
fit the Cu2+ CW spectrum of the Tpy ligand alone (Figure 66) with up to a 1:1 ratio of Cu2+:Tpy 
and formation of the bis-Tpy-Cu2+ is inconsistent with the observed CW data.217  
Upon addition of excess Cu2+, a second component corresponding to free Cu2+ is observed, 
as seen for the model ligand (Figure 69).  
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Figure 69. Spectral simulations of excess Cu2+ peptide samples compared to experimental data. 
A) Simulated CW spectra of peptides 28, 29, 31, and 32 with free Cu2+ subtracted out compared to experimental 
data ; B) Free Cu2+ spectrum compared to experimental spectrum of peptide 28 with 1.5 equivalents of Cu2+. 
 
Overall, results are consistent among all four peptides with the only variation being between the 
ratio of the two components at 1.5 equivalents Cu2+ when altering the oligomerization state; the 
dimers have a higher proportion of the second component than the tetramers (Figure 68A). Based 
only on the CW data, any of the supramolecular assembly models are possible since it is not 
possible to distinguish between  Tpy-Cu2+-Glu or Tpy-Cu2+-(H2O)n coordination (Figure 68B). 
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4.3.1.2 HYSCORE EPR of Peptides 
2D pulsed Hyperfine Sub-level CORrElation (HYSCORE) EPR spectroscopy reveals the atoms 
coordinated distally to the Cu2+ center.  The FFT HYSCORE spectra of all samples shows strong 
cross-peaks about 14 MHz (Figure 70), indicating strongly coordinating distal solvent 
hydrogens.220 
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Figure 70. Distal coordination of Cu2+ with Tpy-modified peptide ligands. 
HYSCORE spectra of ligand 40 (A) and peptide 29 (B) with 0.5 (top) and 1.5 (bottom) equiv of Cu2+; spectra of 
peptides 28, 31, and 32 are identical to that of 29. The arrow indicates a the signal for the presence of a distal 
nitrogen. Coordination states (C, D) and plausible supramolecular assembly model supported by the HYSCORE 
spectrum for 0.5 (C, D, E) and 1.5 (D, F) equivalents of Cu2+. 
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This strong H signal would not be expected for a bis-Tpy-Cu2+ complex lending support to the 
hypothesis that only mono-Tpy (Tpy-Cu2+-(H2O)n or Tpy-Cu2+(H2O)-Glu) coordination is present 
in all samples. Both mono-Tpy coordination modes would give rise to this signal due to the 
presence of coordinating water ligands and are likely in equilibrium with one another; the crystal 
structure of peptide 35 contained both coordination states (vide infra, Section 4.2) supporting this 
hypothesis. 
In addition to features expected from distal hydrogen, peaks stemming from distal nitrogen 
are present for the peptides with 0.5 equivalents Cu2+, but disappear upon addition of 1.5 
equivalents Cu2+. This peak is not present in the corresponding sample of the small molecule 
analogue, ligand 40, implying this is a unique feature of the peptides. As evident from crystal 
structures (Section 4.2) of similar peptides, it is possible that the Tpy-Cu2+(H2O)-Glu coordination 
is coupled with another Tpy residue interacting through hydrophobic stacking in the 0.5 equivalent 
case. The close proximity of the two stacked Tpy could give rise to the distal nitrogen signal. Due 
to the ambiguity of distinguishing between coordination Glu or H2O this is the strongest evidence 
that the peptides are forming supramolecular polymers.  
The absence of the nitrogen signal with the addition of 1.5 equiv of Cu2+ suggests that 
hydrophobic stacking of a Tpy ligand to a Tpy-Cu2+(H2O)-Glu coordination is no longer the 
preferred mode of assembly, possibly due to electrostatic repulsion between the positively charged 
Cu2+ centers. This could either be a result of a change in the morphology of the supramolecular 
assembly or a lower degree of supramolecular polymerization.  
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4.3.2 Particle Sizing with Dynamic Light Scattering 
DLS can be used to measure the relative size of particles in solution.  Larger particles exhibit 
scattering events that have a longer correlation time, while smaller particles exhibit shorter 
correlations.221  Mathematical models can be used to derive the particle size from the resulting 
correlation data.  However, current theoretical models break down when the materials are 
heterogeneous and non-spherical (two characteristics of the system examined here).222-224  With 
this caveat in mind, we have presented the raw correlation data as a qualitative measure of 
supramolecular assembly properties. Apparent hydrodynamic diameters are included only as a 
means of relative comparison. Peptide 29 was also cross-linked with Ru2+ to form a bis-Tpy-Ru2+ 
complex resulting in subunit 43 (Scheme 5).  
 
 
Scheme 5. Cross-linking reaction of peptide 28 or 29  with Ru2+ to produce subunit 42 or 43, respectively. 
 
Unlike the copper complexes, bis-Tpy Ru(II) complexes do not readily exchange and are even 
stable under HPLC.225 Thus, this subunit acts as the reference point for the formation of the 
supramolecular polymers from an inert coordination complex. 
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Dynamic light scattering (DLS) measurements of the dimeric peptides 29 and 32 suggest 
that supramolecular assemblies are created in small quantities upon addition of Cu2+ (Figure 71).  
 
 
Figure 71. DLS correlation curves of dimeric peptides 29 (blue) and 32 (black)
 in the presence of 0.5 (solid, A) or 1.5 equiv (dashed, B) Cu2+. Assembly of Ru2+ cross-linked peptide 43  is shown 
as a reference point for both cases. All measurements were performed with 300 µM (peptides 29 and 32) or 150 µM 
(subunit 43) in aqueous 10 mM HEPES buffer (pH 7) with 0.1 M NaCl. C) Cartoon models of the supramolecular 
polymer formed by the peptides in the presence of Cu2+. 
 
Peptides 29 and 32 were measured in the presence of 0.5 and 1.5 equivalents of Cu2+.  Apparent 
average hydrodynamic diameters were 186±7 nm (29) and 600±100 nm (32) with 0.5 equivalents 
of Cu2+. Peptide 29 increased to 830±60 nm with 1.5 equivalents of Cu2+ while peptide 32 
decreased to 390±20 nm. Peptides 29  and 32 in the absence of copper resulted in no correlation 
signal. The apparent size of assemblies generated by subunit 43 was 300±60 nm. 
Consistent with the DEER data (vide infra, Section 4.3.3), in the presence of 0.5 
equivalents of Cu2+ peptide 32 has a larger particle size than peptide 29.  This difference in particle 
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size is due to three possible effects related to peptide stability and linker length. First, 32 contains 
the longer Z side chain; increasing the side-chain length intuitively increases assembly size by 
increasing the space between peptide monomers.  Second, even though the side chain is longer, 
with 0.5 equivalents of Cu2+ peptide 32 has less conformational freedom than peptide 29 (see 
Section 4.3.3); an effect which is known to increase particle size in an analogous system (see 
Chapter 2).158 Third, although the length of the Tpy side-chain itself does not affect the coiled-coil 
fold, it does influence the extent of destabilization due to complexation with Cu2+ (Figure 72).  
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Figure 72. CD scans and melts for dimeric peptides 29 (black) and 32 (blue)
 at 100 µM in aqueous HEPES buffer (10 mM, pH 7) with 0, 0.5 or 1.5 equivalents of CuCl2. 
 
In the absence of Cu2+, both peptides have a similar midpoint in the thermal melting curve (Tm): 
74.4 ± 0.1 °C (29) and 74.7 ± 0.1 °C (32). Upon addition of 0.5 equivalents of Cu2+, the midpoint 
of the thermal melting curve decreases for both peptides compared to corresponding samples 
lacking Cu2+ (∆Tm = -9.0 ± 0.2 °C and -10.6 ± 0.1 °C for 32 and 29, respectively, Figure 72).  The 
Tms of peptide 32 in the presence of Cu2+ are higher at 65.7 ± 0.2 °C (0.5 equiv Cu2+) and 62.5 ± 
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0.1 °C (1.5 equiv Cu2+); whereas for peptide 29 the Tms are 63.8 ± 0.2 °C (0.5 equiv Cu2+) and 
58.9 ± 0.1 °C (1.5 equiv Cu2+). The higher folded stability of peptide 32 in the presence of Cu2+, 
though slight, could contribute to the increase in the assembly size of peptide 32 compared to 
peptide 29.161 
Upon addition of excess Cu2+, meant to favor monovalent Tpy coordination, assemblies of  
peptide 29 increased in size while those of peptide 32 decreased in size (Figure 71). This can likely 
be explained by the difference in conformational flexibilty between the two linkers.  The greater 
degree of flexibility of the Lys allows peptide 32 to collapse into a more compact material similar 
to the effect seen with the EDA linker in Chapter 2.158    
Replacing the Cu2+ ion with Ru2+ to create a covalently bound bis-Tpy cross-linked peptide 
results in a supramolecular polymer larger than that with Cu2+ (Figure 71B).  Surprisingly, the Tm 
of this cross-linked Ru2+subunit is much lower than the analogous Cu2+ cross-link (47.5 °C vs. 
63.8°C, Figure 73).   
 
 
Figure 73. CD scan (A) and melt (B) of subunit 43
 at 50 µM in aqueous HEPES buffer (10 mM pH 7). 
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This is likely either due to the fact that 100% of the peptides are cross-linked in the case of Ru2+ 
or hints that the coordination environments of the two metals are not isomorphous as would be 
expected if Cu2+ formed solely bis-Tpy complexes, a conclusion also supported by the EPR data. 
The high degree of coiled-coil destabilization may also explain why assemblies based on the Ru2+ 
cross-link are smaller than those formed by 32 in the presence of Cu2+. The lower molar ellipticity 
observed in the CD scan (measured pre-melt at 20 °C) vs. the melt at the same temperature may 
be due to kinetic trapping which is stabilized upon cooling to 2°C. This is supported by the 
presence of visible aggregates post-melt. 
4.3.3 Assembly Morphology 
Double Electron-Electron Resonance (DEER) measurements obtained from the materials also 
demonstrate formation of a supramolecular metallopolymer (Figure 74A, B). 
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Figure 74. DEER measurements of dimer peptides in the presence of 0.5 equiv Cu2+. 
A) Time domain spectrum and resulting distance distribution (B) for dimeric peptides 29 (black) and 32 (blue); 
dashed vertical mark the most probable distance for each peak. C) Equilibrium between assembly modes based on 
the DEER data. 
 
Upon addition of 0.5 equiv Cu2+, peptide 29 assembles into supramolecular oligomers with a most 
probable distance between the linkers of 3.0 nm with a second peak at 5.1 nm (Figure 74B). Since 
it is not possible for the copper ions on the same coiled coil to be this far apart, we infer that there 
must be at minimum of three copper ions in the system to produce this signal. The shorter peak 
likely results from copper ions chelated one subunit away while the longer peak must result from 
coppers two subunits away along the supramolecular polymer.  
Note that the ratio of population between the two peaks (0.2) is not what would be expected 
for an infinite assembly (1) or even for two coiled coils joining together. This implies that there is 
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only a small number of coiled coils assembled into longer oligomers and that most of them exist 
in structures containing at 2-3 copper ions (Figure 74C). While the DLS measurements on these 
samples showed large assemblies, DLS is biased to the observation of large particles and cannot 
be considered quantitative for determining the ratio between polymerized and unpolymerized 
material.222 
Increasing the length of the side chain by two methylene units (peptide 32) results in a 
increase in the most probable distance between copper ions of 0.4 nm. There is also a small shift 
of 0.2 nm in the longer-distance peak. Interestingly, the longer side chain, which is expected to be 
more flexible, gives rise to a narrower distance distribution implying it has less conformational 
freedom than the shorter side chain. It is not clear why this might be the case, but we hypothesize 
that the longer side chain may be able to more easily find an energy minimum due to its ability to 
search a larger conformational energy landscape.  
Addition of excess Cu2+ alters the equilibrium of the Tpy residue coordination states 
resulting in the disappearance of  peaks around 5 nm (Figure 75).  
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Figure 75. DEER measurements of dimer peptides in the presence of 1.5 equiv Cu2+. 
A) Time domain spectra and B) distance distribution of peptides  29 and 32. C) Assembly model based on 
the DEER data. 
 
This absence implies that large assemblies containing more than two Cu2+ ions are not prevalent 
enough to be observed and that the majority of coiled coils exist independently of one another. 
Since the only way to form the supramolecular assemblies is through formation of Tpy-Cu2+-Glu 
linkages, this implies that the population of this linkage has also decreased. This is the strongest 
evidence that there is a decrease supramolecular polymer formation caused by increasing the Cu2+ 
ion concentration. Even though supramolecular assembly formation is decreased considerably it 
does not completely disappear as evident from the DLS data (vide supra, Section 4.3.2). 
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4.3.3.1 Altering Coiled-Coil Oligomerization State 
Peptides 28 (tetramer) and 30 (trimer) were designed to explore the effect of altering the coiled-
coil oligomerization state on the assembly and structure of the materials.  The only evidence that 
these peptides differ in their assembly morphology comes from measuring the distances between 
Cu2+ ions. CW and HYSCORE spectra are consistent with the dimer peptides.  DEER spectroscopy 
of the peptides in the presence of 0.5 equivalents Cu2+ yields more complex spectra than the dimers 
indicating the formation of higher dimensional materials (Figure 76).  
  
 
Figure 76. DEER measurements of peptides with higher order oligomerization in the presence of Cu2+.
 Distance distribution  for tetrameric peptide 28 (A, orange) and trimeric peptide 30 (B, green) in the presence of 0.5 
(solid) or 1.5 (dashed) equiv Cu2+. C) Cu2+- Cu2+ distances (nm) observed in the crystal structure of peptide 37 (PDB 
ID 5U5B). 
 
Both the tetramer (Figure 76A) and trimer (Figure 76B) distance distributions exhibit a set of three 
peaks. Two of these overlap and are centered at 5.3 and 3.1 nm. As seen previously with the dimer 
peptides, the longer peak at 5.3 nm indicates the formation of supramolecular polymers. The 
shortest distance peaks differ only slightly in most probable distance 1.9 (28, tetramer) and 2.0 nm 
(30, trimer). The peaks in the tetramer sequence are much narrower, indicating more ordered 
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assemblies.  The double peaks at ~3 and ~2 nm likely arise from the close proximity of the four 
Cu2+ ions in the tetramer; each Cu2+ ion can resonate with three other Cu2+ ions creating the 
observed distribution. These distances are very close to what was observed in the crystal structure 
of peptide 37 (Figure 76C); in both peptides the Tpy X residue is located at position 14. For the 
trimer the origin of both peaks is less apparent, but may be due to an asymmetry between the three 
Cu2+ sites.  
Upon addition of excess Cu2+ the longer distance vanishes for both peptides (Figure 76B,C) 
and is replaced by a single broad peak at 2.7. This is to be expected if the majority of Tpy groups 
are now mono-coordinated allowing for an increased flexibility of the side-chain to create a single 
distance distribution similar to the model proposed for the dimer system. The absence of the longer 
peak at ~5.3 nm indicates that supramolecular assembly formation has significantly decreased. 
 Due to the higher degree of order apparent in its assembly, the tetramer was chosen to 
examine the role of increasing the side-chain length to compare with the dimer series. Peptide 31 
is a variant of peptide 28 containing the longer Z side chain in place of the shorter X side chain. 
Upon addition of 0.5 equiv Cu2+, peptide 31 forms supramolecular assemblies as indicated by the 
peak at 5.1 nm; distances for the other two peaks are at 1.7 and 3.0 nm (Figure 77).   
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Figure 77. DEER distance distribution  for tetrameric peptide 31
 (purple) in the presence of 0.5 (solid) or 1.5 (dashed) equiv Cu2+. 
 
Interestingly, all of the major peaks for this peptide are shorter than in peptide 28 even though the 
side-chain is longer. Although the origin of this phenomenon is not clear it may be that the more 
flexible side-chain is able to form a more compact structure resulting in the shorter distances. 
When 1.5 equiv of Cu2+ are present the distance distribution converges to a single peak at 3.0 nm, 
0.3 nm longer than the shorter X side-chain. Since the disappearance of the longer distance occurs 
for all peptides in the presence of 1.5 equiv Cu2+, this further supports the hypothesis that the 
majority of coiled coils are in an isolated state under these conditions. 
Although the subunits of the assembly generated from peptide 31 with 1.5 equivalents of 
Cu2+ are closer in proximity than those in peptide 28 (5.1 vs. 5.3 nm, respectively), the overall 
assembly size by DLS is larger for peptide 31 (Figure 78). 
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Figure 78. DLS correlation curves of dimeric peptides 28 (orange) and 31 (purple)
 in the presence of 0.5 (solid, A) or 1.5 equiv (dashed, B) Cu2+. Assembly of Ru2+ cross-linked subunit 42  is shown 
as a reference point for both cases. All measurements were performed with 300 µM (peptides 28 and 31) or 150 µM 
(subunit 42) in aqueous 10 mM HEPES buffer (pH 7) with 0.1 M NaCl. 
 
Consistent with the DEER data, the DLS suggests that peptide 31 generates more heterogeneous 
assemblies as evident by the tailing of the correlation curve. The larger assembly size of 31 vs. 28 
can be explained by the lower helicity of 28 compared to 31 in the presence of 0.5 equivalents 
Cu2+ (Figure 79).   
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Figure 79. CD scans and melts for tetrameric peptides 28 (orange) and 32 (purple)
 at 100 µM in aqueous HEPES buffer (10 mM, pH 7) with 0, 0.5 or 1.5 equivalents of CuCl2. 
 
Both uncoordinated peptides have Tm values > 100 °C. Unlike the dimer peptides, both tetramers, 
while still destabilized by addition of Cu2+, have similar stabilities in the presence of the metal ion. 
With 0.5 equivalents of Cu2+, they still retain Tm values > 100 °C; unlike with the dimer peptides. 
However, there is a noticeable decrease in drop peptide 31's helicity when coordinating Cu2+; this 
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may explain the smaller assembly sizes observed in the DLS. In the presence of 1.5 equivalents of 
Cu2+ the Tm values are equivalent at 86.1 ± 0.4 °C (31) and 86.2 ± 0.4°C (28).  
Cross-linking peptide 28 with Ru2+ to create subunit 42 once again results in larger 
assemblies compared to the parent peptide. This is accompanied by a decrease in thermal stability 
(Tm = 86.4 ± 0.5 °C for peptide 42, Figure 80).  
 
 
Figure 80. CD scan (A) and melt (B) of Ru2+ cross-linked subunit 42 
at 50 µM in aqueous HEPES buffer (10 mM pH 7). 
 
This result is consistent with that seen for the dimer peptides, except that no visible aggregation 
was observed post-melt. It is interesting to note that peptide 28 with 1.5 equivalents of Cu2+ and 
subunit 42 have identical Tm values along with nearly identical DLS correlation curves. 
4.3.3.2 DEER Modulation Depth and Background Slope Analysis 
Besides the distance distribution, DEER was also used to determine the number of Cu2+ ions in the 
spin system and relative local Cu2+ concentration. The decrease in the modulation depth in samples 
from 0.5 to 1.5 equivalents of Cu2+ (Figure 81A) is indicative of fewer Cu2+ ions in the spin system. 
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This data further supports the hypothesis that large assemblies are disfavored when the Cu2+ is 
increased. 
  
 
Figure 81. Relative amount of Cu2+ ions within the spin system and local concentrations. 
A) Background subtracted time domain DEER signal showing the decrease in modulation depth upon addition of 
excess Cu2+. B) Logarithmic scale of the DEER background decay signal. The slope is proportional to the local 
concentration of bound Cu2+.  
 
This decrease in modulation depth from 0.5 equiv to 1.5 equiv was consistent across all peptides. 
Furthermore, the raw DEER time domain signal can be analyzed to extract the local concentration 
of bound Cu2+. Addition of excess Cu2+ results in a larger local concentration (Figure 81B) 
indicative of more bound Cu2+ per peptide. The increase in local concentration, but decrease in 
modulation depth strongly supports the hypothesis that the supramolecular structure is disrupted 
upon addition of excess Cu2+. Coupled with the change in the HYSCORE spectrum with the loss 
of the nitrogen signal, it is likely that most of the peptides exist in a disassembled state. However, 
this disassembly is incomplete as there is also evidence for some degree of larger assemblies from 
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DLS measurements (vide supra, Figure 71B). Another possibility is that the local concentration 
increases due to binding of the excess Cu2+ by glutamates. 
 Combining all of the available data (CD, EPR and DLS) allows a picture of the 
supramolecular assembly to be established (Figure 82); although only the dimer peptide is depicted 
for ease, this model can be extrapolated to the other oligomerization states as well.  
 
 
Figure 82. Supramolecular polymer assembly model of dimer peptides. 
 
In the presence of 0.5 equiv of Cu2+, the predominant assembly mode is likely state B with a 
significant presence of state A and an unknown amount of state C. State A is likely lower in 
population since the longer distance peak observed in the DEER has a much smaller area than the 
shorter distance. DLS data imply that some some large assemblies do exist though. States B and 
C are more likely than state E due to the presence of the nitrogen signal observed in the HYSCORE 
data. In the presence of 1.5 equiv of Cu2+, the predominant assembly state is state E with a small 
amount of state D. Evidence for this is most readily seen from the DEER data by the absence of 
any longer distances. De-polymerization likely results from charge-charge repulsion between the 
Tpy-Cu2+ moieties, so that water coordination becomes favored over glutamate coordination. The 
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destabilization of the peptide fold observed by CD melts with addition of excess Cu2+ may be 
evidence of this hypothesis. However, larger assemblies must still exist as evidenced by the 
particle sizes seen by DLS. It is likely though that these assemblies are formed through non-
specific aggregation since EPR samples which were not immediately flash-frozen showed signs of 
aggregation. 
4.4 CONCLUSIONS AND FUTURE DIRECTIONS 
The results presented in this chapter represent the first steps toward a new class of protein-based 
materials that can be generated by combining the metal chelating power of terpyridine with the 
self-assembly of coiled-coil peptides. Control over the coordinating residues should be possible 
by matching the number of glutamate and terpyridine groups in each sequence. Assemblies formed 
from two different sequences should also be possible if one contains glutamate and no terpyridine 
residues while the other contains terpyridine and no glutamate residues. Derivatization of the 
terpyridine moiety should enable the exploration of an array of electronic and catalytic 
functionality,226-229 enabling the development of new nanomaterials. Future designs of crystalline 
assemblies will take these ideas into consideration.  
 Although a tentative model has for solution-phase supramolecular assembly has been 
presented here, there are still some unanswered questions concerning these systems that need to 
be addressed. Determination of the identity of Glu coordination may be determined through 
synthesizing a series of peptides identical those described here each with a different Glu 
isotopically labeled with 18O then looking for the presence of Cu2+-18O coupling with HYSCORE. 
EPR measurements on these samples should disambiguate both the coordination mode and identity 
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of Glu binding. Likewise, peptides with only a single Glu residue could be designed to improve 
the order of the assemblies by only providing a single coordination site. 
In an effort to study the originally proposed bis-Tpy-M2+ complex by EPR, Co2+ could be 
used in place of Cu2+ as the spectroscopic probe. Co2+ also has a higher affinity for bis-Tpy 
complexes230 than Cu2+ and should therefore promote the formation of larger, more specific 
assemblies. The complication of using Co2+ is its coordination is less studied than that of Cu2+ and 
contains two possible spin states (Cu2+ has only one) , which can even vary for the same ligand 
system.231 DEER measurements on Co2+-Co2+ systems are also unprecedented in the literature 
although there is an example of a DEER measurement between a Co2+ and nitroxide center.232 
Solubility may also be a concern using cobalt since all crystallization screens involving Co2+ 
precipitated into large aggregates. Pioneering the use of Co2+-Co2+ DEER measurements could 
also be useful in other contexts like the structure of zinc fingers where Co2+ long been used in place 
of Zn2+ to monitor binding by UV-Vis spectroscopy.233 
4.5 EXPERIMENTAL 
4.5.1 General Information 
HATU, NovaPEG Rink Amide Resin, and Fmoc-protected α-amino acids were purchased from 
Novabiochem. HCTU was purchased from Aapptec. Fmoc-L-Dab(Alloc)-OH was purchased from 
ChemImpex. Solvents and all other reagents were purchased from AcrosOrganics, Aldrich, 
AlfaAesar, Fisher, or Hampton Research.  
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4.5.2 Terpyridine Side-chain Analogues 
4.5.2.1 Synthesis  
Synthesis of Compound 39. 
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Scheme 6. Synthesis of 4'-carboxy-2,2':6',2''-terpyridine (compound 39). 
 
4'-Carboxy-2,2':6',2''-terpyridine (39) was synthesized as described previously (Scheme 6).208 
1HNMR and high-resolution MS data matched published values. 
 
Synthesis of Ligand 40. 
 
Scheme 7. Synthesis of ligand 40 from compound 39. 
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Synthesis of 40  (Scheme 7) was adapted from the literature.234 A solution of 39 (279.7 mg, 1.009 
mmol) in excess thionyl chloride (18 mL) was refluxed for 3 hours.  Solvent was removed to 
dryness by vacuum distillation to afford the acid chloride intermediate, which was used without 
further purification.  To the acid chloride, a solution of excess ethanolamine (7 mL) in dry 
dichloromethane (7 mL) was added dropwise at 0 °C under nitrogen resulting in a translucent red 
solution.  The reaction was stirred overnight under nitrogen at room temperature resulting in a 
cloudy purple suspension.  The reaction was precipitated into water (50 mL) and extracted three 
times with dichloromethane (50 mL each).  Solvent was removed via vacuum distillation.  The 
resulting solid was re-suspended in minimal ethanol and precipitated with water (100 mL).  The 
precipitate was filtered and dried under high vacuum to obtain the product as a white solid (219.6 
mg, 68% yield). 1HNMR (400 MHz, DMSO-d6) δ 9.06 (t, J = 5.6 Hz, 1H), 8.84 (s, 2H), 8.77 (dq, 
J = 4.8, 0.8 Hz, 2H), 8.66 (d, J =8 Hz, 2H), 8.05 (td, J = 7.6, 1.6 Hz, 2H), 7.54 (ddd,  J =7.6, 4.8, 
1.2 Hz, 2H), 4.80 (t, J = 5.6 Hz, 1H), 3.58 (q, J = 6 Hz, 2H) , 3.41 (q, J = 6 Hz, 2H) ppm; 13CNMR 
(100 MHz, DMSO-d6) δ 164.8, 155.7, 154.6, 149.4, 144.2, 137.6, 124.7, 121.0, 118.4, 59.5, 42.4 
ppm; HRMS (ESI) m/z calculated for C18H17N4O2 [M+H]+: 321.1352; found 321.1351. 
Synthesis of Complex 41. 
 
Scheme 8. Synthesis of complex 41 from ligand 40. 
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Synthesis of complex 41 (Scheme 8) was adapted from the literature.235 A solution of RuCl3•H2O 
(31 mg, 0.15 mmol, 1 equiv) in EtOH/H2O (1:1 v/v, 12 mL) was bubbled with Ar for 20 min.  The 
de-oxygenated solution was heated and stirred under Ar at ~90 °C for 4 hours.  A solution of ligand 
40 (96 mg, 0.30 mmol, 2 equiv) in EtOH/H2O (1:1 v/v, 20 mL) was bubbled with Ar for 30 min. 
then added to the ruthenium solution.  The solution was left to stir at ~90 °C overnight.  The 
product was purified by reverse phase HPLC using a gradient between water and acetonitrile with 
0.1% TFA.  Pure fractions were combined and lyophilized yielding the red TFA salt.  1HNMR  
(400 MHz, MeCN-d3) δ 9.34 (d, J = 2.4 Hz, 4H);  8.91 (s, broad, NH);  8.71 (d, J = 8 Hz, 4 H),  
7.92 (td, J= 8, 1.2 Hz, 4 H), 7.37 (d, J = 5.2 Hz, 4H); 7.15 (td, J = 6.6, 1.2 Hz, 4H); 3.85 (t, J = 5.2 
Hz, 4H); 3.71 (q, J = 5.2 Hz, 4H);  3.58 (s, broad, OH) ppm; 13CNMR (100 MHz, 0.1M NaPhos 
pH 7 in 10% D2O/90% H2O) δ 167.4, 157.2, 155.6, 152.0, 140.5, 138.2, 127.5, 125.6, 121.1, 60.1, 
42.7; 13CNMR (100 MHz, MeCN-d3) δ 166.2, 164.8, 158.7, 156.4, 153.5, 139.2, 128.6, 125.8, 
122.7, 118.3, 44.5 ppm;* HRMS (ESI) m/z calculated for C36H32N8O4Ru [M]+2: 371.0790; found 
371.07640 (z = 2). *(second aliphatic peak not visible) 
4.5.2.2 Molar Absorptivity Determination 
A stock solution of ligand 40 (2.9 mg in 10 mL, 905 µM) was prepared in H2O/DMSO (80%/20%, 
v/v).  Samples were prepared from the stock solution by dilution with H2O  at concentrations of 
7.5, 15, 30, 60, and 90 µM.  UV-Vis spectra of each sample was measured from 200-600nm and 
referenced to H2O.  The molar absorptivity at 310 nm was determined using Beer's law to be 
8400±200 M-1 cm-1 (Figure 83). 
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Figure 83. Molar absorptivity measurement of ligand 40. 
A) Absorbance spectra of ligand 40 from 7.5-90 µM and B) determination of its molar absorptivity at 310 nm. 
 
Stock solutions of complex 41 were prepared in triplicate at a concentration of 10.0 mM in 
0.2 M sodium phosphate pH 7.  Samples were prepared in triplicate from the three stock solutions 
by dilution with 0.2 M sodium phosphate pH 7 to 2.5, 5, 10, 20, 40, and 80 µM and measured from 
200-800nm referenced to a solution of 0.2 M sodium phosphate pH 7.  A molar absorptivity of 
21,900 ± 100 M-1 cm-1 at 486 nm was found using Beer's law (Figure 84). 
 
 
Figure 84. Molar absorptivity measurement of complex 41. 
A) Absorbance spectra of complex 41 from 2.5-80 µM and B) determination of its molar absorptivity at 486 nm. 
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4.5.3 Peptide Synthesis 
Peptides 24-38 were synthesized by manual microwave-assisted Fmoc solid phase methods using 
a CEM MARS microwave and NovaPEG Rink Amide resin. Typical coupling reactions were 
performed with a 1.5 min ramp to 90 °C followed by a 2 min hold at that temperature, and Fmoc 
deprotections performed with a 1.5 min ramp to 90 °C followed by a 1 min hold at that 
temperature.200 Coupling solutions were composed of Fmoc-protected amino acid (5 equiv relative 
to resin), HCTU (4.9 equiv), and DIEA (7.5 equiv) in NMP. Fmoc deprotections used 20% v/v 4-
methylpiperidine in DMF. The resin was washed three times with DMF between each reaction. 
Full-length peptides were acetyl capped by treatment with DMF/DIEA/Ac2O (8/2/1, v/v/v) at room 
temperature for 20 mins. 
Terpyridine-modified side chains were introduced by coupling Fmoc-Lys(Alloc)-OH (to 
produce residue Z) or Fmoc-Dab(Alloc)-OH (to produce residue X) at the desired sites during 
synthesis of the full-length chain and subsequent on-resin conversion as detailed below (Scheme 
9). 
 
 
Scheme 9. Alloc deprotection and Tpy attachment to the produce side-chain Z (n=3) and X (n=1). 
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Alloc was removed by treatment of resin with Pd(PPh3)4 (0.25 equiv relative to Dab) and 
phenylsilane (24 equiv) in anhydrous CH2Cl2 under Ar for 0.5 h.236 Resin was washed three times 
each with DCM, THF, DMF, 0.02M sodium diethyldithiocarbamate in DMF, and DMF.237 
Carboxylic acid 39208 (5 equiv relative to Dab) was then coupled to the resulting amines with 
HATU (4.9 equiv) and DIEA (7.5 equiv) in NMP according to the microwave heating protocol 
detailed above. Resin was washed three times each with DMF, CH2Cl2, and MeOH and dried in a 
vacuum desiccator for 20 min prior to cleavage.  
Peptides 24-36 were cleaved from the resin by treatment with TFA/H2O/EDT/TIS 
(92.5/3/3/1.5 by volume) for ~4 h. Peptide 37 and 38 were cleaved from the resin 
TFA/H2O/EDT/Anisole/TIS (90/3/3/3/1 by volume) for ~3.5 h. After filtration, crude peptides 
were precipitated from the TFA cleavage solution with cold Et2O, and the suspension was 
centrifuged and decanted. Pellets were re-dissolved in 6 M guanidinium, 25 mM phosphate pH 7 
and stored in the freezer until purification. 
Peptides were purified via preparative reverse phase HPLC on C18 (150 Å pore size, 10 
µm particle size) columns using gradients between 0.1% TFA in water and 0.1% TFA in 
acetonitrile. The purity and identity of each peptide was confirmed by analytical HPLC (Figure 
85) and MALDI-TOF mass spectrometry (Table 9), respectively. 
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Figure 85. Analytical HPLC chromatograms of purified peptides 24-38. 
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Table 9. Calculated and observed average masses of proteins 24-38. 
# 
[M+H]+ m/z (average) 
Calculated Observed 
24 2882.4 2881.7 
25 2858.4 2858.5 
26 2801.3 2799.8 
27 2773.3 2771.8 
28 3306.8 3306.0 
29 3365.0 3364.5 
30 3363.8 3363.6 
31 3334.8 3333.1 
32 3393.1 3391.0 
33 3595.8 3595.5 
34 3595.8 3595.0 
35 3768.5 3768.7 
36 3540.1 3539.2 
37 3307.8 3307.9 
38 3307.8 3306.7 
4.5.3.1 Peptide Ru2+ Cross-Linking 
Ruthenium(II) cross-linked subunits 42 and 43  were synthesized and purified from peptides 28 
and 29, respectively, following a similar procedure as that of complex 41 with the peptides 
substituted for ligand 40. Identity of the products was confirmed by MALDI-TOF spectrometry 
(Table 10) and purity by analytical HPLC (Figure 86). 
Table 10. Calculated and observed average masses of subunits 42 and 43. 
# 
[M-H2O]+ m/z (average) [M]2+ m/z (average) 
Calculated Observed Calculated Observed 
42 6694.6 6694.8 3356.3 3355.6 
43 6811.0 6809.9 3414.5 3416.6 
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Figure 86. Analytical HPLC chromatograms of purified subunits 42 and 43. 
4.5.4 Circular Dichroism 
CD measurements were performed in 1 mm quartz cuvettes on an Olis DSM 17 CD spectrometer. 
All buffer components were syringed filtered through a 0.22 µm pore filter. Scans were measured 
from 200-260 nm at 1 nm increments with a 2 nm bandwidth and 5 sec integration time at each 
wavelength. Melts were monitored at 222 nm from 2-98 °C with 4 °C temperature steps and 2 min 
equilibration at each temperature. All scans and melts were baseline corrected against buffer 
blanks measured in the same cuvette. Raw scan data were smoothed and melts fit to a two-state 
unfolding model169 using GraphPad Prism. 
4.5.5 Crystallography 
Crystals of peptides 33, 35, 37, and 38 were grown by hanging drop vapor diffusion. Stock 
solutions (15 mg/mL for 33 and 38, and 7.5mg/mL for 35 and 37) in water were mixed (0.7 µL + 
0.7 µL) with the crystallization buffer indicated in Table 11 and equilibrated at room temperature 
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over a well of the same buffer (700 µL). Two different crystal forms of peptide 33, denoted a and 
b, were obtained under different growth conditions. It is worth noting that all peptides gave rise to 
crystals in the presence of only BIS-TRIS buffer and Cu2+ salt, but these were usually not single 
(with the exception of peptide 35).  
 
Table 11. Crystallization buffer conditions foe peptides 33 (forms a and b), 35, 37, and 38. 
Peptide Buffer 
33 (crystal form a) 0.1 M sodium citrate pH 6.0, 3 mM CuCl2, 15% w/v PEG 4000 
33 (crystal form b) 0.1 M BIS-TRIS with 2 mM terephthalic acid pH 6.5, 10 mM CuCl2, 10% w/v PEG 4000 
35 0.1 M BIS-TRIS pH 6.5, 10 mM CuCl2 
37 0.095 M BIS-TRIS pH 6.5, 9.5 mM CuCl2, 5 mM sodium citrate pH 5.6, 0.125 M 1,6-hexanediol 
38 0.1 M BIS-TRIS with 1 mM terephthalic acid pH 6.5, 10 mM CuCl2, 10% w/v PEG 4000 
 
Crystals were harvested, cryoprotected with solutions of 30% v/v glycerol in mother liquor, 
and then flash frozen in liquid nitrogen. X-ray diffraction data for peptide 33, crystal form a, were 
collected using Cu/Kα radiation on a Rigaku diffractometer (FR-E generator, VariMax optics) with 
a Saturn 944 CCD detector. Data for peptide 33, crystal form b, along with peptides 35, 37, and 
38 were collected at the Advanced Photon Source at Argonne National Laboratory on beamline 
22-ID operated at a wavelength of 1.0 Å. 
Raw diffraction data were processed using d*TREK. Structures were solved by molecular 
replacement using Phaser.170 Truncated versions of the following published structures were used 
as search models: peptide 33 (PDB 4DZM, residues 2-30), peptide 35 (PDB 4DZL, residues 2-
29), peptides 37 and 38 (PDB 3R4A, residues 2-29). Refinement was performed using Phenix171 
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in tandem with Coot172 for manual real-space model building. TLS parameters were used in the 
refinement of crystal form b of peptide 33. Geometric restraints for the terpyridine-modified Dab 
residue were generated using the REFMAC238 monomer library sketcher in the CCP4 software 
suite.239 Geometric restraints for the coordination of Cu(II) by the terpyridine residue was based 
on a crystal structure of bis(2,2':6',2''-Terpyridyl)-copper(II) hexafluorophosphate (CSD entry 
BEJPUB),240 and restraints for the binding between carboxylates and terpyridine-Cu(II) residues 
from the crystal structure of µ2-succinato-bis[aqua(2,2':6',2''-terpyridine)copper(II)] dinitrate 
dihydrate (CSD entry PUHWIZ).241 Final data collection and refinement statistics are listed in 
Table 12. 
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Table 12. Data collection and refinement statistics for peptides 33 (forms a and b), 35, and 37. 
Peptide 33 (crystal form a) 33 (crystal form b) 35 37 
Data Collection     
Unit Cell 
Dimensions (Å, °) 
a=36.3, b=52.2, c=25.6 
α=γ=90, β=104.0 
a=b=57.1, c=80.2 
α=β=90, γ=104.0 
a=b=77.6, c=55.1 
α=β=γ=90 
a=114.3, b=38.6, c=44.2 
α=β=γ=90 
Space Group C2 P6122 P41212 P21212 
Mosaicity 1.40 1.05 0.71 2.05 
Resolution 29.21-2.20 
(2.28-2.20) 
31.15-3.23 
(3.35-3.23) 
38.81-2.40 
(2.49-2.40) 
29.09-2.10 
(2.18-2.10) 
Total Reflections 20805 10970 48001 40191 
Unique Reflections 2391 1430 6926 11924 
Redundancy 8.70 (4.42) 7.67 (8.15) 6.93 (7.19) 3.37 (3.42) 
% Completeness 99.6 (97.6) 99.6 (100.0) 99.3 (100.0) 99.3 (100.0) 
Rmerge % 5.3 (21.2) 11.7 (29.8) 9.6 (39.7) 11.0 (38.8) 
I/σ (averaged) 29.0 (3.8) 11.0 (3.7) 10.8 (3.8) 6.0 (2.3) 
I/σ (unaveraged) 9.6 (1.9) 4.3 (1.5) 4.5 (1.8) 3.6 (1.6) 
Refinement     
Resolution (Å) 26.09-2.20 31.15-3.23 38.88-2.40 29.09-2.10 
R (%) 22.9 30.0 25.6 26.5 
Rfree (%) 25.7 31.3 28.2 27.6 
Avg. B factor (Å2) 35 89 55 35 
RMSD     
Bonds (Å) 0.003 0.005 0.003 0.006 
Angles (°) 1.068 1.288 1.040 0.881 
 
Although full structural refinement was not possible for peptide 38, a molecular 
replacement solution was found in space group P4222 with two chains of the tetramer from PDB 
ID 3R4A as a search model; the asymmetric unit also consists of only two chains (half the 
tetramer). Data collection statistics are shown below in Table 13. 
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Table 13. Data collection statistics for peptide 38. 
Data Collection  
Unit Cell 
Dimensions (Å, °) 
a=b=37.3, c=94.33 
α= β=γ=90 
Space Group P4222 
Mosaicity 1.21 
Resolution 37.33-3.65 
(3.78-3.65) 
Total Reflections 5319 
Unique Reflections 885 
Redundancy 6.01 (6.14) 
% Completeness 97.9 (100.0) 
Rmerge % 0.070 (0.322) 
I/σ (averaged) 10.7 (3.2) 
I/σ (unaveraged) 4.6 (1.6) 
4.5.6 Dynamic Light Scattering 
All DLS measurements were made in a 1 cm quartz cuvette on a Malvern Zetasizer Nano 
ZS90 with a 632.8 nm laser and an angle of 90° at a temperature of 20°C. Peptide assembly 
samples were prepared containing 600 µM peptide with 300 µM (0.5 equiv) CuCl2 in 10 
mM HEPES pH 7 (28-29 and 31-32)  or 150 µM peptide in 0.1 M NaCl, 10 mM HEPES 
pH 7 (subunits 33-34) then equilibrated overnight at room temperature. Each sample was 
measured 5-9 times and the averaged correlation curve reported. 
4.5.7 EPR Measurements 
All EPR measurements were performed and analyzed by Matthew J. Lawless (Saxena Lab, 
University of Pittsburgh). 
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4.5.7.1  Sample Preparation 
Samples used in EPR experiments were 150 µL containing 20% v/v glycerol as a 
cryoprotectant. Concentration of ligand 40 and peptides 28-32 was kept at 300 µM while 
63Cu2+ concentration was either 150 µM or 450 µM for the 0.5 equivalent and 1.5 equivalent 
samples respectively. Solvent pH was controlled with 40 mM NEM at pH 7.4. Upon 
addition Cu2+ addition samples were vortexed to mix. Under one minute after mixing 
samples were placed in a quartz tube (3 mm inner diameter by 4 mm outer diameter), flash 
frozen in liquefied MAPP gas, and inserted into a sample cavity pre-cooled to 80 K. Experiments 
were performed at either 80K or 20K using an Oxford ITC503 temperature controller and 
an Oxford CF935 dynamic continuous flow cryostat connected to an Oxford LLT 650 low-
loss transfer tube. 
4.5.7.2 Continuous Wave Measurements 
CW experiments were performed on a Bruker ElexSys E580 CW/FT X-band spectrometer 
with a Bruker ER4118X-MD5 resonator. The CW spectra were collected consisting of 1024 
data points using a center field of 3100 with a 2000 G sweep width. A modulation depth of 
4 G, a modulation frequency of 100 kHz, a conversion time of 20.48 ms and a time constant 
of 10.24 ms were used. 25 scans were collected for all spectra. Spectral simulations were 
performed with the Bruker Simfonia software. 
4.5.7.3 HYSCORE Measurements 
The two dimensional, four-pulse HYSCORE experiment was performed at X-band 
frequencies on either a  Bruker ElexSys E580 CW/FT X-band spectrometer with a Bruker 
ER4118X-MD5 resonator or a Bruker ElexSys E680 CW/FT X-band spectrometer 
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equipped with a Bruker EN4118X-MD4 resonator. The pulse sequence used was as 
follows: π/2 – τ – π/2 – τ1 – π – τ2 – π/2  – echo, where the π/2 and π pulse lengths were 16 
ns and 32 ns respectively. τ1 and τ2 were both stepped out by 16 ns. Spectra were all collected 
at the field corresponding with maximum echo intensity detected by the echo-detected field 
swept spectrum. Data acquisition was 16 hours. Raw data was baseline corrected, zero filled 
and fast Fourier transformed. The fast Fourier transformation was reported as a contour 
plot. 
4.5.7.4 DEER Measurements 
The dead time free four pulse DEER experiment was performed at X-band frequencies on 
a Bruker ElexSys E680 CW/FT X-band spectrometer equipped with a Bruker EN4118X-
MD4 resonator. All DEER experiments were performed at 20 K. The pulse sequence used 
was as follows: (π/2)ν1 – τ1 – (π)ν1 – T – (π)ν2 – τ2 – (π)ν1 – τ2 – echo.242 The observer 
pulse lengths, (π/2)ν1 and (π)ν1, were 16 ns and 32 ns respectively. The pump pulse length, 
(π/2)ν2, was 16 ns. The delay, T was incremented by a step size of 20 ns for 128 points. 
The pump frequency, ν2, was positioned at the maximum of the echo detected field swept 
Cu2+ spectrum. The observer frequency, ν1, was offset 150 MHz downfield from the pump 
pulse. The raw time domain DEER data were analyzed via DeerAnalysis2013243 using 
Tikhonov regularization. Data acquisition ranged from 6 to 12 hours. 
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5.0  CONCLUSION AND FUTURE PERSPECTIVES 
Proteins are excellent scaffolds for the design of novel materials and structures. Structural control 
at the sequence level allows for a great degree of tunability and modularity in their properties. By 
incorporating synthetic cross-links and unnatural building blocks we can expand this structural 
and functional diversity even further.  
The work described in this thesis highlights three projects that have increase our 
understanding of helical design strategies for the creation of supramolecular polymers (Chapter 2), 
crystalline metal-coordinated architectures (Chapter 3), and stabilization of tertiary fold mimics 
(Chapter 4). Macroscopic differences between similar linkers were shown to arise from the 
presence of two sub-populations within the conformations of the more rigid cross-linked subunit. 
Through replacement of the covalent linker with metal-coordination in tandem with rationally 
designed oligomeric helical bundles, a new class of metallopeptides which give rise to crystalline 
supramolecular architectures was developed. Cα-methylation of amino acids incorporated into a 
helix were found to impart a greater thermodynamic stabilization to mixed-backbone tertiary fold 
mimics than β-residues.  
The knowledge of protein design described within this thesis will assist in the future design 
of novel protein mimics and protein-based materials. By incorporating Cα-methylated residues 
into helices within other tertiary fold contexts, it can be determined if the observation of the GB1 
system was general or an anomaly. The Tpy-Cu2+-Glu motif described in Chapter 4 may prove 
useful in designing assemblies comprised of multiple oligomerization states. The Tpy-modified 
residue may also provide a scaffold to develop Co2+-Co2+ DEER spectroscopy enabling structural 
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analysis of  materials formed through bis-terpyridyl coordination. It will be exciting to see what 
novel materials and applications may arise based on the design motifs described herein. 
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APPENDIX A 
NMR SPECTRA 
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APPENDIX B 
MOLECULAR DYNAMICS-AIDED MODELLING SCRIPTS 
Below are the scripts used to model and curate the results of the molecular dynamics simulations 
of the linkers described in Section 2.6.8. All scripts are written in Python and were run in Pymol 
on the Center for Simulation and Modeling's supercomputer. Inputs for each script are the output 
of the previous script. Script "ClashTest.py" (B.1) appends two coiled-coil dimers to each structure 
within the library of linker conformations generated by MD simulations then tests for steric clashes 
within each structure; only those without steric clashes are retained. Script "DblRngFilter.py" (B.2) 
removes any conformations inconsistent with the experimental DEER data. Script "Get 
Frames.py" (B.3) reduces the library of final conformations to a manageable number for 
visualization. 
B.1 CLASHTEST.PY 
#ClashTest3 changes:  added in clash checks for outer helix with inner helix terminii 
#ClashTest4 changes: changes helix clash checking to a function and then runs using the two major rotamers of Cys 
#ClashTest5 changes: now checks for linker atom clashes with adjacent helix 
#ClashTest6 changes: now checks for outer to outer helix N and C terminii clashes 
#ClashTest6 changes: Redefines CA-CA clashes as its own function 
import pymol 
from pymol import cmd 
import sys,getopt 
 
## AAD 2014-02-06 
# Process command line arguments. There is no longer a need for separate py files 
try: 
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  opts,args = getopt.getopt(sys.argv[1:],"hl:i:") 
except getopt.GetoptError: 
  print "Arguments are required" 
  print "Usage: pymol -qrc ClashTest.py -- -l <linker> -i <input.pdb>" 
  cmd.quit() 
for opt,arg in opts: 
  if opt == '-h': 
    print "Usage: pymol -qrc ClashTest.py -- -l <linker> -i <input.pdb>" 
    cmd.quit() 
  elif opt == '-l': 
    if arg == 'EDA': 
      inputLinker = arg 
    elif arg == 'PipC': 
      inputLinker = 'PipC' 
    elif arg == 'PipT': 
      inputLinker = 'PipT' 
    else: 
      print "<linker> must be either EDA, PipC or PipT" 
      print "  " + arg + " is not accepted" 
      cmd.quit() 
  elif opt == '-i': 
    inputfile = arg 
 
 
#Load Linker MD file 
print("ClashTest6 started.") 
print "  Linker is " + inputLinker 
print "  Input file is " + inputfile 
 
#DEFINE function LnkClshChk: 
#Checks for linker atom clashes with the specified helix 
def LnkClshChk (Helix, linker, ResChk, frame): 
        clash = "no" 
#Van der Waals radii obtained from  Table II of Seeliger, D. and de Groot, B. L. Proteins, 2007. 68: 595-601.    
        HlxAtms = ['CB','CA','N','O',] 
        #CB, CA, N and linker C's radii are the sum of the carbon/nitrogen's radius plus their hydrogen's radius 
        HlxAtmRad = [3.08, 2.51, 2.42, 1.41] 
        if (linker == 'EDA'): 
         LnkrAtmRad = [3.08, 1.41, 2.42, 3.08, 3.08, 2.42, 1.41, 1.43] 
         if (Helix == 'B'): 
          CC = 'AB' 
          LnkrAtms = ['CA1', 'O1', 'N1', 'C1', 'C2', 'O2', 'N2', 'CO1'] 
         elif (Helix == 'D'): 
          CC = 'CD' 
          LnkrAtms = ['CA2', 'O2', 'N2', 'C2', 'C1', 'O1', 'N2', 'CO2'] 
                else: 
                        print "Non-adjacent helix chosen." 
                        return 
        elif (linker == 'PipC' or 'PipT'): 
         LnkrAtmRad = [3.08, 1.41, 3.08, 3.08, 3.08, 3.08, 1.41, 1.43] 
         if (Helix == 'B'): 
          CC = 'AB' 
          LnkrAtms = ['CA1', 'O1', 'CR1', 'CR2', 'CR3', 'CR4', 'O2', 'CO1'] 
         elif (Helix == 'D'): 
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          CC = 'CD' 
          LnkrAtms = ['CA2', 'O2', 'CR3', 'CR4', 'CR1', 'CR2', 'O1', 'CO2'] 
                else: 
                        print "Non-adjacent helix chosen." 
                        return 
 else: 
                print "Linker undefined." 
  return 
        for resnum in ResChk:       
                for hatms in HlxAtms: 
                        atomA = ("CC_" + CC + "_%05d and chain " + Helix + " and resi %d and name " + hatms)%(frame, resnum) 
                        for lnkatms in LnkrAtms: 
                                if frame >= 10000: 
                                        atomB = ("traj_%05d and chain Z and name "+lnkatms)%frame 
                                else: 
                                        atomB = ("traj_%04d and chain Z and name "+lnkatms)%frame 
#Distance cutoff for specific atom types from Table III of Seeliger, D. and de Groot, B. L. Proteins, 
2007. 68: 595-601. 
                                #Default is sum of atom van der Waal's radii 
                                if (hatms == 'O' and lnkatms == 'N1' or 'N2') or (hatms == 'N' and lnkatms == 'O1' or 'O2'):  
                                        cutoff = 2.82 
                                elif (hatms == 'O' and lnkatms == 'O1' or 'O2'): 
                                        cutoff = 3.3 
                                elif (hatms == 'CA' and lnkatms == 'O1' or 'O2'): 
                                        cutoff = 3.18 
                                else:                         
                                        cutoff =  sum (hatms + lnkatms) 
                           atmdist = cmd.dist("tmpdist", atomA, atomB) 
                                if (atmdist < cutoff and atmdist > 0): 
            clash = "yes" 
                                        print "Linker clash of %g Angstroms from a %g Angstroms cutoff."%(atmdist, cutoff) 
                                        break 
                                elif (atmdist >= cutoff): 
                                        clash = "no" 
                                else: 
                                        clash = "Error" 
                                        break 
                        if clash == "yes": 
                                break 
                if clash == "yes": 
                        break 
 return clash 
 
#DEFINE function CaClshTst: 
def CaClshTst(Helix1, Helix2, frame, CC1='AB', CC2='CD', TotResHlx1=30, TotResHlx2=30, cutoff=5.5): 
        clash = "no" 
        for resnumA in xrange(1, TotResHlx1+1): 
         atomA = ("CC_" + CC1 + "_%05d and chain " + Helix1 + " and resi %d and name CA")%(frame, resnumA) 
                for resnumB in xrange(1, TotResHlx2+1): 
          atomB = ("CC_" + CC2 + "_%05d and chain " + Helix2 + " and resi %d and name CA")%(frame, resnumB) 
          cadist = cmd.dist("tmpdist", atomA, atomB) 
          cmd.delete("tmpdist") 
                        if cadist < cutoff and cadist > 0: 
                  clash = "yes" 
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                  print "%c/%c clash of %g Angstroms."%(Helix1, Helix2, cadist) 
                  break 
                        elif cadist < 0: 
                                print cadist 
                                clash = "Error" 
                                print "Error in starting pdb file %c or %c chain."%(Helix1, Helix2) 
                                break 
                if clash == "yes": 
                        break 
        return clash                
 
#DEFINE function ClshTst: 
# create n identical objects for CoiledCoilAB and CoiledCoilCD [n must match number of states in traj.pdb] 
# fit CA+CB+SG for each copy of CoiledCoilAB and CoiledCoilCD to the corresponding atoms in one of the states of 
traj.pdb 
#merge all CoiledCoilAB into single object and merge all CoilCoilCD into single object 
def ClshTst (CC1, CC2, states, cutoff=5.5, totresB=30, totresD=30, clashnum=0, finsts=0):   
        for idx in xrange(1,states+1): 
         print "Frame: %d"%idx  
         cmd.copy("CC_AB_%05d"%idx,CC1) 
         cmd.copy("CC_CD_%05d"%idx,CC2) 
                if idx >= 10000: 
                        cmd.pair_fit("CC_AB_%05d and resn CYS and name CA"%idx,"traj_%05d and name 
CM1"%idx,"CC_AB_%05d and resn CYS and name SG"%idx,"traj_%05d and chain Z and name S1"%idx,"CC_AB_%05d 
and resn CYS and name CB"%idx,"traj_%05d and chain Z and name CE1"%idx) 
                 cmd.pair_fit("CC_CD_%05d and resn CYS and name CA"%idx,"traj_%05d and name 
CM2"%idx,"CC_CD_%05d and resn CYS and name SG"%idx,"traj_%05d and chain Z and name S2"%idx,"CC_CD_%05d  
and resn CYS and name CB"%idx,"traj_%05d and chain Z and name CE2"%idx) 
                else: 
                        cmd.pair_fit("CC_AB_%05d and resn CYS and name CA"%idx,"traj_%04d and name 
CM1"%idx,"CC_AB_%05d and resn CYS and name SG"%idx,"traj_%04d and chain Z and name S1"%idx,"CC_AB_%05d 
and resn CYS and name CB"%idx,"traj_%04d and chain Z and name CE1"%idx) 
                        cmd.pair_fit("CC_CD_%05d and resn CYS and name CA"%idx,"traj_%04d and name 
CM2"%idx,"CC_CD_%05d and resn CYS and name SG"%idx,"traj_%04d and chain Z and name S2"%idx,"CC_CD_%05d  
and resn CYS and name CB"%idx,"traj_%04d and chain Z and name CE2"%idx) 
         clash = "no"                                            
                #Check for linker clashes with adjacent helices 
                ResChk = [10, 11, 13, 15, 17, 18] 
                LnkrHlcs = ['B', 'D'] 
                print "Linker/helix clash test running." 
                for Helix in LnkrHlcs: 
                        clash = LnkClshChk (Helix=Helix, linker=linker , ResChk = ResChk, frame=idx)                     
                        if clash == "yes": 
                                break 
                print "Linker/helix clash test finished." 
                if clash == "no": 
                        CaHlcs = [('B','D'), ('B','C'),('A','D'),('A','C')] 
                        for Helix1, Helix2 in CaHlcs:                
                          clash = CaClshTst(Helix1=Helix1, Helix2=Helix2, frame=idx) 
                                if clash == "yes": 
                                        break 
                if clash == "yes":                 
                        clashnum = clashnum + 1                                 
                        print "Clash %d found."%clashnum                 
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                        cmd.delete("CC_AB_%05d"%idx) 
                        cmd.delete("CC_CD_%05d"%idx) 
                        if idx >= 10000: 
                                cmd.delete("traj_%05d"%idx) 
                        else: 
                         cmd.delete("traj_%04d"%idx) 
                        cmd.delete("site1") 
                        cmd.delete("tmpdist") 
                 continue                 
                elif clash == "no": 
                        print "No clashes." 
                 finsts = finsts + 1 
                 cmd.create("CC_AB_MD","CC_AB_%05d"%idx,0,finsts) 
                 cmd.create("CC_CD_MD","CC_CD_%05d"%idx,0,finsts) 
                 cmd.delete("CC_AB_%05d"%idx) 
                 cmd.delete("CC_CD_%05d"%idx) 
                        if idx >= 10000: 
                                cmd.create("Linker_MD","traj_%05d"%idx,0,finsts)                                 
                                cmd.delete("traj_%05d"%idx)                               
                        else: 
                                cmd.create("Linker_MD","traj_%04d"%idx,0,finsts) 
                         cmd.delete("traj_%04d"%idx) 
                 cmd.delete("site1") 
                        cmd.delete("tmpdist") 
                 continue 
                else:                         
                        print "Error! Program terminated early." 
                        break    
        ClshRslt = [clashnum] 
        return ClshRslt 
 
#Define rotamer combinations to check 
CysRotComb = [(1,1), (1,2), (2,2)] 
comb = 1 
nxtfrm = 1 
 
#Initialize clashnum variable 
clashnum = 0 
 
#Check for clashes in each rotamer combination and output non-clashing conformations 
for ABrot, CDrot in CysRotComb:  
        cmd.load(inputfile,"traj") 
        linker = inputLinker 
        cmd.alter("traj", "chain='Z'") 
        print "Linker trajectory file opened successfully." 
         
        #Count number of linker conformations 
        states = cmd.count_states("traj") 
        cmd.split_states("traj") 
        cmd.delete("traj")         
 
        #load coiled-coil chain A and B 
        cmd.load("PDB/CoiledCoilAB_r%d.pdb"%ABrot,"CoiledCoilAB") 
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        #load coiled-coil chain C and D 
        cmd.load("PDB/CoiledCoilCD_r%d.pdb"%CDrot, "CoiledCoilCD") 
         
        #Run Clash Test for rotamer combination 
        ClshTstRslt = ClshTst(CC1="CoiledCoilAB", CC2="CoiledCoilCD", states=states, clashnum=clashnum) 
 
        #Merge non-clashing coiled coils and linker traj into one trajectory object 
        print "Merging linker and coiled coil trajectories..." 
        cmd.create("CCSMP_TempMD%d"%comb, "CC_AB_MD or CC_CD_MD or Linker_MD") 
        cmd.create("CCSMP_FinalMD", "CCSMP_TempMD%d"%comb,0,nxtfrm) 
        nxtfrm = nxtfrm + cmd.count_states("CCSMP_TempMD%d"%comb) 
         
        #Reset and clashnum 
        clashnum = ClshTstRslt[0] 
         
        #Delete old objects 
        cmd.delete("CoiledCoilAB") 
        cmd.delete("CoiledCoilCD")         
        cmd.delete("CC_AB_MD") 
        cmd.delete("CC_CD_MD") 
        cmd.delete("Linker_MD") 
        cmd.delete("tmpdist")         
        comb = comb + 1 
 
#Output final number of clashes 
print "\nThere were %d frames with clashes out of %d frames checked."%(clashnum, states*(comb-1)) 
print "There were %d frames with no clashes."%(states*(comb-1)-clashnum) 
#remove extraneous atoms 
print "Removing extraneous or duplicitous atoms..." 
cmd.remove("CCSMP_FinalMD and chain Z and name HM1+HM2+HM3+HM4+HM5+HM6+CM1+CM2+CE1+CE2") 
cmd.remove("CCSMP_FinalMD and resn CYS and name SG+2HB+3HB+HG") 
 
#Save Non-clashing frames 
print "Saving final output..." 
basename = inputfile.split(".")[0] 
 
cmd.save (basename+"."+inputLinker+".Final.pdb", "CCSMP_FinalMD", 0) 
cmd.save (basename+"."+inputLinker+".Finalr1r1.pdb","CCSMP_TempMD1",0) 
cmd.save (basename+"."+inputLinker+".Finalr1r2.pdb","CCSMP_TempMD2",0) 
cmd.save (basename+"."+inputLinker+".Finalr2r2.pdb","CCSMP_TempMD3",0) 
print "Clash test finished." 
B.2 DBLRNGFILTER.PY 
import pymol 
from pymol import cmd 
import sys,getopt 
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## NAT 2014-03-02 
# Process command line arguments. There is no longer a need for separate py files 
 
 
try: 
  opts,args = getopt.getopt(sys.argv[1:],"hl:i:") 
except getopt.GetoptError: 
  print "Arguments are required" 
  print "Usage: pymol -qrc ClashTest.py -- -l <linker> -i <input.pdb>" 
  cmd.quit() 
for opt,arg in opts: 
  if opt == '-h': 
    print "Usage: pymol -qrc ClashTest.py -- -l <linker> -i <input.pdb>" 
    cmd.quit() 
  elif opt == '-l': 
    if arg == 'EDA': 
      inputLinker = arg 
    elif arg == 'PipC': 
      inputLinker = 'PipC' 
    elif arg == 'PipT': 
      inputLinker = 'PipT' 
    else: 
      print "<linker> must be either EDA, PipC or PipT" 
      print "  " + arg + " is not accepted" 
      cmd.quit() 
  elif opt == '-i': 
    inputfile = arg 
   
#The following function, DistWin, filters conformations that fall into a given distance range between two atoms 
def DistWin (resnum, states, start, end, objname, finsts=1, AtmNamA='SPN', AtmNamB='SPN', ChainA='A', ChainB='C'):   
        startnm = str(start/10.0) 
        endnm = str(end/10.0) 
        finalname = objname + startnm + "-" + endnm + "nm"         
        for frame in xrange(1,states+1): 
         print "Frame: %d"%frame  
                atomA = (objname + "%04d and chain " + ChainA + " and resi %d and name " + AtmNamA)%(frame, resnum) 
                atomB = (objname + "%04d and chain " + ChainB + " and resi %d and name " + AtmNamB)%(frame, resnum) 
                SpnDis = cmd.dist("tmpdist", atomA, atomB) 
                cmd.delete("tmpdist") 
 
                if SpnDis >= start and SpnDis <= end: 
                        cmd.create(finalname,objname + "%04d"%frame,0,finsts) 
                        finsts = finsts + 1 
                        print "This one's on the team!" 
                        print "Team members: %d"%finsts 
                else:    
                        print ("You don't make the cut!") 
                        cmd.delete(objname + "%04d"%frame) 
        return finsts, finalname 
def RngFilt (resnum, Ranges, outname, inname): 
#Set distance range selections here in Angstroms: 
        for start, end in Ranges:        
                #Count number of linker conformations 
                states = cmd.count_states(inname) 
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                cmd.split_states(inname) 
                cmd.delete(inname) 
                FinConf, finalname= DistWin(resnum=resnum, states=states, start=start, end=end, objname=(inname + "_")) 
                startnm = start/10.0 
                endnm = end/10.0 
                print "There were %d conformers in the range %g to %g nm."%(FinConf, startnm, endnm) 
                cmd.create(outname + finalname, finalname, 0) 
                nextname = (outname + finalname) 
        return nextname 
cmd.load(inputfile, "ConfLib")    
print "Conformer library opened successfully." 
if inputLinker == 'EDA': 
  Range1 = [(36, 45)] 
  Range2 = [(32.7, 50.9)] 
  nextname1 = RngFilt(resnum=11, Ranges = Range1, outname="Inner_", inname="ConfLib") 
  print nextname1 
  nextname2 = RngFilt(resnum=4, Ranges = Range2, outname="NTerm+", inname = nextname1) 
  print nextname2 
  cmd.save("DblFilt"+inputLinker+".pdb", nextname2, 0) 
elif inputLinker == 'PipC' or 'PipT': 
  Range1 = [(31.8,47.8)] 
  Range2 = [(30.1,53.9)] 
  Range3 = [(19.7,26.7)] 
  nextname1 = RngFilt(resnum=11, Ranges = Range1, outname="Inner_", inname="ConfLib") 
  cmd.save(InputLinker+"InnerFilt.pdb", nextname1) 
  print nextname1 
  nextname2 = RngFilt(resnum=4, Ranges = Range2, outname="NTermLong+", inname = nextname1) 
  print nextname2 
  cmd.save("DblFilt"+inputLinker+".pdb", nextname2, 0) 
  cmd.load(InputLinker+"InnerFilt.pdb", InputLinker+"InnerFilt") 
  nextname3 = RngFilt(resnum=4, Ranges = Range3, outname="NTermShort+", inname = InputLinker+"InnerFilt") 
  print nextname3 
  cmd.save("DblFilt"+inputLinker+".pdb", nextname3, 0) 
 
import pymol 
from pymol import cmd 
import sys,getopt 
B.3 GETFRAMES.PY 
 
## NAT 2014-10-04 
# This script outputs a smaller set of frames from a large trajectory file. 
 
try: 
  opts,args = getopt.getopt(sys.argv[1:],"hl:i:") 
except getopt.GetoptError: 
  print "Arguments are required" 
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  print "Usage: pymol -qrc ClashTest.py -- -l <linker> -i <input.pdb>" 
  cmd.quit() 
for opt,arg in opts: 
  if opt == '-h': 
    print "Usage: pymol -qrc ClashTest.py -- -l <linker> -i <input.pdb>" 
    cmd.quit() 
  elif opt == '-l': 
    if arg == 'EDA': 
      inputLinker = arg 
    elif arg == 'PipC': 
      inputLinker = 'PipC' 
    elif arg == 'PipT': 
      inputLinker = 'PipT' 
    else: 
      print "<linker> must be either EDA, PipC or PipT" 
      print "  " + arg + " is not accepted" 
      cmd.quit() 
  elif opt == '-i': 
    inputfile = arg 
 
def GetFrames (frames_out, inname): 
  states = cmd.count_states(inname) 
  remainder = states % frames_out 
  states = states - remainder 
  step = states / frames_out 
  cmd.split_states(inname) 
  cmd.delete(inname) 
  idx = 1               
  for frames in xrange(1, states, step):         
    cmd.create(inputfile+"_SmallSet", "ConfLib_%04d"%frames, 0, idx) 
    idx = idx + 1 
    print idx 
  return  
cmd.load(inputfile, "ConfLib")    
print "Conformer library opened successfully." 
if inputLinker == 'EDA': 
  GetFrames(frames_out = 1000, inname = "ConfLib") 
elif inputLinker == 'PipC' or 'PipT': 
  GetFrames(frames_out = 500, inname = "ConfLib") 
cmd.save("DblFilt"+inputLinker+"_SmallSet.pdb",inputfile+"_SmallSet", 0)             
cmd.quit 
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APPENDIX C 
A SET OF TOAC-LABELED COILED-COIL HOMODIMERS 
A side project springing from collaboration with the Saxena lab sought to measure the dihedral 
angles between pairs of TOAC spin-labels using orientational selective DEER experiments within 
the context of a coiled coil dimer (GCN4p1). Three peptides (Figure 87) were synthesized with 
the spin-label in the second heptad at three different solvent-exposed sites (heptad positions b, c, 
and f).  
 
 
Figure 87. Sequences of peptides C1-C3. The spin-labeled amino acid TOAC (Σ) is denoted in bold. 
 
Detailed below is the synthesis, purification and characterization of each peptide along with 
sample preparation for the EPR measurements. 
....|....|....|....|....|....|... 
gabcdefgabcdefgabcdefgabcdefgabcd 
Ac-RMKQLEDKVΣELLSKNYHLENEVARLKKLVGER-NH2 (C1) 
Ac-RMKQLEDKVEΣLLSKNYHLENEVARLKKLVGER-NH2 (C2) 
Ac-RMKQLEDKVEELLΣKNYHLENEVARLKKLVGER-NH2 (C3) 
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C.1 TOAC-LABELED PEPTIDE SYNTHESIS AND PURIFICATION 
C.1.1 General Information 
Solvents and all other reagents were purchased from Acros Organics, Aldrich, Advanced Chem 
Tech, Baker, EMD, Fluka, or Fisher and used without further purification. NovaPEG Rink Amide 
Resin, Fmoc-protected amino acids, HATU, PyBOP, and PyBrOP were purchased from 
Novabiochem. HCTU was purchased from Aapptec or Novabiochem. PyAOP was purchased from 
AK Scientific. 2,2,6,6-Tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC) was 
purchased from Santa Cruz Biotechnology or Toronto Research Chemicals. MALDI of peptides 
was collected on an AB Sciex Voyager DE Pro MALDI-TOF. 
C.1.2 Peptide Synthesis 
Peptides C1 and C2 were synthesized using solid-phase Fmoc methods on an automated 
synthesizer at room temperature for residues with residues 8-11 coupled manually with 
microwave-assisted heating (Method 1). Peptide C3 was synthesized manually using microwave-
assisted heating (Method 2). Automated couplings and deprotections were performed on a PTI 
Tribute automated synthesizer while microwave-assisted couplings were performed on a CEM 
Microwave-Assisted Reaction System (MARS).  
Method 1. In a standard automated coupling reaction, 2.5 mL of a solution composed of 
0.2 M HCTU, 0.4 M N-methylmorpholine in DMF was added to 7 equivalents of Fmoc-amino 
acid relative to resin. After a 2 minute pre-activation, the solution was added to the resin and 
vortexed for 45 minutes. Deprotections were performed by two treatments with 3 mL of 20% v/v 
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4-methylpiperidine in DMF for 4 minutes each. The resin was washed four times with 3 mL of 
DMF after each coupling and deprotection step. After residue 12, the synthesizer was paused and 
residues 8-11 were synthesized manually using micrwave-assisted heating. TOAC was coupled as 
the free amino acid with PyBOP (5 equiv TOAC, 4.9 equiv PyBOP, 12.5 equiv DIEA in NMP) in 
the microwave with a 2 minute ramp to 70 °C and an 8 minute hold. For peptide C1, residue 9 was 
double coupled using TFFH (5 equiv Fmoc-amino acid, 5equiv TFFH, 12.5 equiv DIEA). For 
peptide C2, residues 10 and 9 were double coupled using TFFH.   For both peptides, residue 8 
(Lys) was double coupled with PyAOP (5 equiv Fmoc-Lys-OH, 5 equiv PyAOP, 7.5 equiv DIEA). 
Fmoc deprotections were performed with one treatment of 20% v/v 4-methylpiperidine in DMF 
with a 2 minute ramp to 80° C and a 2 minute hold. Resin was washed 3 times with DMF between 
steps. 
Method 2. Standard coupling solutions consisted of 5 equivalents of Fmoc- protected amino 
acid with 4.9 equivalents of HCTU and 7.5 equivalents of DIEA in NMP. Coupling solutions were 
pre-activated for 2 minutes prior to addition to the resin then subjected to a 1.5 minute ramp to 90° 
C with a 2 minute hold. Fmoc deprotections were performed with 20% 4-methylpiperidine in DMF 
with a 2 minute ramp to 80° C with a 2 minute hold. Resin was washed 3 times with DMF between 
steps. Residue 18 (His) was coupled by stirring at room temperature for 45 minutes. TOAC at 
position 14 was coupled the same way as in Method 1. Leu at position 13 was coupled as the 
activated acid fluoride; Fmoc-Leu-F was prepared by a known method.166 
After the final Fmoc deprotection, the N-terminus of each peptide was acetylated with a 
solution of DMF/DIEA/Ac2O (8:2:1 by volume) for 20 minutes at room temperature. The resin 
was rinsed three times with 3 mL each DMF, DCM, and MeOH. The resin was dried in a vacuum 
desiccator for 20 minutes prior to TFA cleavage. Cleavage conditions for all peptides was 
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TFA/H2O/Anisole/TIS (91/3/3/3 v/v/v/v) for 4.5 hours. Peptides were then precipitated in ~40 mL 
of chilled Et2O, centrifuged and decanted resulting in a crude solid. The nitroxide radical was 
regenerated by treatment with of 10% NH4OH for ~4 hours. 
Peptides were purified by reverse phase HPLC on a C18 column then lyophilized. Identity 
and purity was confirmed by MALDI-MS (Table 14) and analytical HPLC (Figure 88), 
respectively. The impurity prior to the main peak in peptide C1 is due to the a small population of 
the TOAC residue in the hydroxylamine form rather than nitroxide. 
 
Table 14. Calculated and observed masses of peptides C1-C3. 
# 
[M+H]+ m/z (average) 
Calculated Observed 
C1 4106.8 4106.3 
C2 4106.8 4105.3 
C3* 4163.5 [M+NH4]+ 4164.2 
*Most abundant peak was [M+NH4]+ for peptide C3 due to treatment with NH4OH. 
 
 
Figure 88. Analytical HPLC chromatograms of purified peptides C1-C3. 
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C.2 BIOPHYSICAL MEASUREMENTS 
C.2.1 Circular Dichroism Melts and Scans 
CD spectroscopy measurements were carried out in 1 mm quartz cuvettes on an Olis DSM 17 CD 
spectrometer. Peptide stock concentrations were determined by UV-Vis spectroscopy. Buffer 
components were syringe filtered through 0.22 µm pore filter prior to sample preparation. All 
measurements were made with a 2 nm bandwidth and 5 second integration time. CD scans were 
measured from 200-260 nm at 20 °C.  Thermal melts were measured at 222 nm with a baseline of 
260 nm from 2-98 °C with 4° increments. Samples were incubated at each temperature for 2 
minutes. Thermal melt data was fit to a two-state unfolding model169 using GraphPad Prism. 
 
 
Figure 89. CD scans and melts of peptides C1-C3. 
190 
C.2.2 Sample Preparation for DEER 
Peptide sample were prepared at a concentration of 100 µM in aqueous HEPES buffer (10 mM, 
pH 7) with 20% v/v glycerol as a cryoprotectant. Samples were then given to Dr. K. Ishara Silva 
for orientational selective DEER measurements. 
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